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Literature Review 
The Effects of Fear-based versus Harm-reduction Drug Education Approaches on Youth 
Substance Use Behaviour 
Abstract 
There appear to be two main philosophies toward drug education; one underpinned by a 
moral stance against drug use, which tends to adopt fear-based approaches, and another 
based in harm-reduction which focuses on maximising health should people decide to 
use drugs. Unfortunately, many drug education campaigns do not assess appropriate key 
outcome measures for the impacts to be evaluated in a satisfactory manner. Meta-
analyses have found that variables from the Theory of Planned Behaviour (TPB) (Ajzen, 
1991) can account for moderate to large variances in behavioural intentions and 
behaviours over a range of activities. Substance-related TPB studies, which typically 
include minor extensions or additions in the model, support the model's efficacy in 
predicting both intentions and behaviour. However, the Prototype Willingness Model 
(PWM) (Gibbons, Gerrard, Blanton, & Russell, 1998) has been shown to explain 
additional variance in actual behaviour above the TPB, in substance use behaviours 
which are not premeditated. By incorporating the PWM components as well as other 
additional variables such as moral norms, descriptive norms, knowledge, into the TPB, it 
is possible to synergise the strengths of the models to evaluate the impact of fear-based 
and harm reduction drug education more comprehensively. Furthermore, whilst the 
extended TPB model may assist in explaining and predicting key outcomes of substance 
use behaviours after exposure to drug education materials, persuasion models such as the 
Elaboration Likelihood Model (ELM) (Petty & Cacioppo, 1986) can help explain as well 
as optimise the persuasive processes in drug education. As the internet is one of the most 
popular sources of substance-related information today, using a comprehensive social 
cognition model such as the extended TPB model to research the key outcomes of the 
online fear-based and harm reduction drug education approaches, could be useful in 
empirically establishing, and refining, the efficacies of these approaches. 
1 Introduction to global approaches to drug education 
Issues surrounding the themes of substance use, illicit or otherwise, have always 
evoked strong views from both sides of the philosophical spectrum, influencing both 
substance related policies and programs. At a policy level, there appear to be two main 
approaches to drug education - on one hand, programs underpinned by a moral stance 
against drug use typically lead to campaigns designed to induce an abstinent population 
(sometimes classed as "zero tolerance" toward drug use in society), often using fear as a 
key campaign mechanism, and on the other hand, programs that take no moral stance on 
drug use per se but rather focus on maximising public health tend to lead to campaigns 
based on the philosophy of harm-reduction. 
Fear-based campaigns are typically grounded on the intuitive premise that fear is 
a strong motivator for attitude change to avoid a noxious consequence (Rogers, 1975). A 
fear-based education campaign would highlight the negative aspects of a particular 
issue, often emphasising extreme but uncommon events, whilst minimising any positive 
aspects (see Figure 1 for example). In relation to illicit drugs, fear-based campaigns are 
usually favoured politically as they appear to have high face validity and do not 
challenge most social norms and values. 
Research in the area of drug education (Munro & Midford, 2001; Reyna & 
Farley, 2006) show that the actual outcomes of such fear-based approach are generally 
weak, possibly because young people, the usual target population of such campaigns, are 
already very aware of the risks of substance use, and the stigma that is generated by such 
a negative environment drives those who actually need help underground. 
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Figure I . Example of online fear-based campaign material from www.drugfreeworld.org 
(Foundation for a Drug-Free World , 2007). 
Opponents of such zero-tolerance policies suggest an alternative approach to 
drug education, commonly known as harm-reduction. Harm-reduction is defined as "a 
policy or programme directed towards decreasing adverse health, social and economic 
adverse consequences of drug use even though the user continues to use psychoactive 
drugs at the present time (Single, 1995, p.239)" . Although critics often view this as a 
sign of permissiveness or even encouragement of illegal substance use, proponents view 
this as a realistic prioritisation of goals, that aims to deal with the immediate issues but 
does not impose any long-term objective on the person (Single, I 995) (see Figure 2 for 
example). 
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Figure 2. Example of on line harm-reduction campaign material from 
www.thegooddrugsguide.com (The Good Drugs Guide, 2007) . 
In the United States, the National Youth Anti-Drug Media Campaign 
(NY ADMC), whose goal is to "pursue a vigorous advertising and public 
communications program dealing with the dangers of drug use by youth (Orwin et al. , 
2006, p.xvi)" , is funded by Congress and is one the largest campaigns of its kind, having 
been fully implemented since 1999. The campaign themes included building resistance 
skills (learning how to refuse offers of using substances), normative education 
(education on how widespread the use of substances are amongst peers and what their 
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peers thought about it), negative consequences (learning about the damaging effects of 
substance use) and early intervention, but the emphasis on these themes varied 
throughout the campaign duration. However, the message that drug use is likely to cause 
various harmful social, psychological, and physical effects has generally been the 
consistent, primary emphasis throughout the campaign. The Australian equivalent, the 
National Drug Campaign (NDC) (Pennay et al., 2006), was launched in two separate 
phases: Phase One, launched in 2001, targeted parents of children aged 8 - 17, whilst 
Phase Two, launched in 2005, targeted youths directly. The campaign's fear-based 
information was disseminated through various means including television 
advertisements, print advertising and online advertising. The screenplay of the NDC 
television advertisement on ecstasy (methyelenedioxymethamphetamine, MDMA) was: 
The commercial opens on a scene in a nightclub. A girl is lying on the floor. She 
has collapsed and is sweating profusely. Her friends are frantic around her. 
They ask her if she is a/right and roll her over. Her distraught boyfriend watches 
on. The camera moves rapidly through a nearby television showing a film clip 
into in the bedroom of a 16 year old girl. She is sitting forlornly on her bed, tears 
rolling down her cheeks. Her boyfriend says he's not sure why she takes ecstasy 
as she gets so depressed coming down. The camera moves rapidly through the 
glass of the girl's window and into the window of a building across the road into 
a dental surgery. A young man is in the chair with a dentist operating on his 
mouth. We hear the young man's thoughts, as well as the dentist's voice during 
the examination. Over a rapid montage of damaged teeth close-ups and the guy's 
agonised face, we hear the dentist remark on how the front teeth have cracked 
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through grinding. We also hear the young man's worried thoughts. The camera 
moves rapidly through a picture on the wall. The curtains in the picture suddenly 
become curtains around a bed in an intensive care unit in a hospital. They pull to 
one side as we see a young man experiencing toxic meltdown. Hospital staff are 
frantically trying to reduce his body temperature as his distraught parents look 
on. We hear the worried voice of his girlfriend. A super[visor] appears and we 
hear: "Ecstasy. You don't know what it'll do to you. " (Pennay et al., 2006, p. 
207) 
The aforementioned advertisement is a classic example of a fear-based 
information; amplifying the worst possible scenario ofMDMA use whilst insinuating 
numerous health risks and possible death using excessive dramatic scenes. Whilst the 
effects portrayed in the advertisement were reflective of the adverse effects ofMDMA 
use, commonly known as 'serotonin syndrome'; the rate of morbidly and mortality of 
MDMA use, when not used in conjunction with other psychoactive substances, is low in 
comparison to its prevalence of use (Degenhardt, Copeland, & Dillon, 2005; Koesters, 
Rogers, & Rajasingham, 2002; Silins, Copeland, & Dillon, 2007). 
The official findings of the US NY ADMC by Orwin et al. (2006) showed that 
there :were very high exposure and recall by parents and youth groups of the campaign 
material, and both groups evaluated these ads positively. Whilst the campaign showed 
intended effects for the parents, such as increases in talking about drugs with children 
and increased monitoring of their children's behaviour, there were no significant 
positive effects for the youth group. 
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Instead, the authors found that there were significant delayed effects of weaker 
anti-drug norms after exposure to the campaign material, i.e. increasing beliefs that more 
people use cannabis than was in actuality, as well as indications that exposure to the 
campaign led to significantly higher rates of cannabis initiation. They hypothesised that 
the campaign's high exposure inadvertently sent a meta-message that drug use among 
young people was more prevalent than it actually was, which subsequently translated 
into increased initiation among previously non-using youth due to the perceived norm of 
high use among peers. Furthermore, Orwin and colleages also found no evidence that 
higher exposure to the campaign led to reduced use or abstinence amongst youths who 
had already started using cannabis. 
Similar to the American NY ADMC results, there was very high recall of the 
Australian NDC advertisements and its messages by parents and youth alike (Pennay et 
al., 2006). However, the formal evaluation of the NDC (Pennay et al., 2006) showed that 
whilst 42% of the 1490 youths (aged between 13 and 20 years) interviewed about the 
campaign reported the NDC had influenced them to avoid using drugs or situations 
where they may be used, the remaining 58% reported various ambiguous responses such 
as "thinking about consequences of using drugs", "communicating with friends about 
drugs" or no influence at all. The same post-campaign study showed that young people 
were also more likely to agree that cannabis, MDMA and methamphetamine were all 
associated with 'being lazy and lethargic'' aggression and depression - which is factually 
inaccurate - possibly indicating the presence of demand characteristics contaminating 
the overall results. 
Whilst the favourable results in terms of advertisement recall and recognition 
attained were similar to the American campaign, data on other significant variables such 
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as social norms and actual initiation, which showed reverse effects in the US, were not 
examined in the Australian NDC evaluation (Pennay et al., 2006). Hawthorne (2001) 
argues that measures of any drug education's success depends on its goals and suggested 
that if educational gains were the aim, then increases in knowledge, self esteem, refusal 
skills or attitudes towards drug use would be adequate indicators of success. As such, 
although the NDC was trumpeted as a success in its evaluation, as the NDC evaluation 
primarily examined campaign awareness, recall of NDC ads, attitudes towards drugs and 
ease/difficulty in discussing about drugs with parents, there was an inadequate range of 
significant indicators of actual effectiveness in reducing or eliminating the target 
population's drug use behaviours. Nonetheless, the findings about the 'likelihood of 
accepting an offer of drugs', which was in fact a key behavioural indicator, was 
ironically given less prominence over message recall. Indeed, Hawthorne (2001) asserts 
that if a program's goal was to decrease or eliminate drug experimentation, use and 
misuse, public health criteria such as reduction in drug-related health problems and 
fatalities would be the ultimate indicator of success, which was implied, but not 
examined in the NDC evaluation. 
In line with that argument, a large project which focused on identifying as well 
as reducing alcohol-related harm, through providing alcohol utility information 
(education surrounding the contexts of alcohol use), various skills practices (e.g. social 
resistance skills) and group discussions about identifying and reducing alcohol-related 
harm in student suggested scenarios, was carried out in 14 secondary schools in Western 
Australia, known as the School Health and Alcohol Harm Reduction Project (SHAHRP). 
This showed a reported significant decrease in alcohol-related harm (McBride, 
Farringdon, Midford, Meuleners, & Phillips, 2004). When compared with a control 
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group that ran regular alcohol education programs, the results showed that the SHAHRP 
program caused larger, and earlier, decreases in alcohol consumption. The SHAHRP is 
considered a harm-reduction based program due to its nature of informing participants of 
both the utilities of alcohol in certain circumstances, its potential dangers, as well as 
ways of using it in a safe and moderate manner. This is in contrast to abstinence-based 
programs which expect recipients to completely refrain from any substance use, 
typically by exaggerating the dangers of any use. 
In addition to the aforementioned findings, the researchers (McBride et al., 2004) 
found that there was also a delay in alcohol initiation as well as signs of students 
reverting from being unsupervised drinkers to supervised drinkers and supervised 
drinkers to non-drinkers, i.e. participants shifted from drinking without any adult 
supervision to drinking under supervision, as well as from drinking supervised to not 
drinking at all. The findings established that the harm reduction project's results were 
comparable, if not better, than abstinence based programs. It may indeed be a better 
alternative to abstinence based programs because it appears to have impacted upon the 
entire sample rather than only those without prior experience with alcohol. 
The United Kingdom's drug strategy has incorporated approaches from both 
philosophies toward drug education: showing overall signs of being abstinence-based, 
yet understanding and exploiting the benefits of using harm reduction interventions 
(Home Office, 2002, 2007). One of the most popular drug campaigns in the UK to date 
is the "FRANK" campaign (www.talktofrank.com) which is depicted as a non-
judgmental and often humorous source of information, but when further information is 
solicited, it then explicitly and solely highlights the negative effects of drugs, revealing 
its philosophical basis in abstinence. A review of the campaign from 2004 to 2006 
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showed that this strategy caused popularity gains amongst parents, but lost credibility 
amongst young people (Home Office, 2006). This phenomenon may be explained by the 
findings of Boys, Marsden, Griffiths, Fountain, Stillwell and Strang (1999) who 
established that among young people in the UK who were most likely to use 
psychoactive substances, future consumption is not significantly affected by negative 
experiences. This could imply that when drug education sources focuses simply on the 
negative effects of substances, it may not affect the opinions or behaviours of young 
people and may inadvertently cause them to disregard the entire source. Based on the 
study's findings, the authors strongly recommended that the complexity behind 
substance use behaviours be appreciated and to promote alternative ways of satisfying 
such needs instead of merely highlighting negative effects of such drugs. 
White, Degenhardt, Breen, Bruno, Newman and Proudfoot (2006) studied the 
risk and benefit perceptions of regular MDMA users in Australia and found that they are 
mostly knowledgeable about drug-specific risks and the array of physical and 
psychological harms. In light of that, White and colleagues suggest that in order for 
health promotion messages to be considered credible and acceptable to users, benefits of 
drug use should be acknowledged. This view was supported by Chambers, Connor and 
McElhinney's (2005) survey that found many young people requested accurate and 
unbiased information from professionals, and that the pleasures associated with 
substance use be acknowledged (Chambers et al., 2005). Shock tactics, a key element of 
fear-based campaigns were implied to have negative effects, or at best, nothing positive. 
This suggests that harm-reduction based health promotion information, as it 
acknowledges positive as well as negative consequences of use, is more likely to be 
credible and more effective for young people as well as current substance users, in 
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contrast to the sole emphasis on negative aspects produced by fear-based, zero-tolerance 
promotion campaigns. 
Since the Australian government formed the "Tough on Drugs in Schools" policy 
in 1997, federal level responsibility for school drug education was moved from the 
health department to the education department (Midford, 2007). With that change in 
management, Midford (2007) notes that outcome evaluations for these programs shifted 
from research evidence and behavioural changes to a focus on practitioner experience 
and knowledge gain. He then postulated that the shift away from objective, behavioural 
criteria would result in unrealistic goals as a consequence of susceptibility to political 
considerations and perceived moral obligations, with funding being channelled into 
politically favourable programs but not backed by evidence. This is an untenable 
scenario for health promotion because the criteria to which the success of a drug 
education campaign would be marked against would be inappropriate at best, and 
grossly misleading at worst. 
2 Health-related theoretical models 
Indeed, many health promotion campaigns have fallen into the trap of gauging 
insufficient and/or superficial measures that do not necessarily translate into real 
outcomes. Attitudes for instance, a key target of drug education campaigns, have been 
studied by social psychologists for a long time as a key determinant of behaviour, but 
the link between the two is not exactly straightforward nor simple (Cooke & Sheeran, 
2004; Glasman & Albarracin, 2006). Attitude change alone is seldom sufficient to 
explain or predict actual behavioural changes. There are many variables that mediate the 
link between attitudes and behaviours, and among the more prominent theories that 
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attempt to explain the pathways that surround behaviour are the Protection Motivation 
Theory (PMT), the Health Behaviour Model (HBM), the Theory of Reasoned action 
(TRA), the Theory of Planned Behaviour (TPB) and the Prototype/Willingness Model 
(PWM) (Azjen, 1991; Gibbons, Gerrard, Blanton et al., 1998; Harrison, Mullen, & 
Green, 1992; Milne, Sheeran, & Orbell, 2000). Thus, in order to evaluate the 
effectiveness of drug education campaigns comprehensively, it is important to have an 
empirically-supported conceptual framework that can explain the various links to 
behaviour in order to understand the effectiveness of programs aiming to influence these 
factors. 
2.1 Protection Motivation Theory (PMT) 
The original Protection Motivation Theory (PMT), as proposed by Rogers 
(1975), was a simple model that attempted to tie together prominent concepts of the time 
in regard to fear appeals, which are persuasive messages that attempt to evoke fear from 
an audience, and attitude change, with no addition of novel hypotheses and assumptions. 
Rogers suggested that fear appeals can be used to persuade people to avoid a noxious 
situation by embracing recommended attitudes and subsequent actions. 
The original model proposed that the three key components of fear appeals are 
the magnitude uf noxiousness (i.e. severity), the probability of a noxious event (i.e. 
vulnerability), and the efficacy of a protective response (i.e. response efficacy). Self-
efficacy was included as the fourth core factor in a subsequent revised model (Rogers, 
1983). 
Rogers (1975; 1983) asserted that attitude changes due to protection motivation, 
which is primarily evoked by the cognitive appraisal processes in the face of a 
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threatening event, rather than the emotional state of fear. Nonetheless, the PMT assumes 
that the decision maker will be predisposed to heuristic judgments, i.e. 'mental 
shortcuts', and the intensity of emotions elicited from the fear appeal rather than logical 
deliberations necessarily. 
The model (see Figure 3) suggests that exposure to fear appeals would initiate 
two simultaneous processes in an individual - a threat appraisal process and a coping 
appraisal process. The threat appraisal process is expected to assess the consequences of 
acting maladaptively, whereby provoking an individual to consider the benefits of 
maintaining the current behaviour against the perceived vulnerability to, and severity of, 
a threat. On the other hand, the coping appraisal process is used to assess the 
consequences of coping adaptively, whereby the individual considers about how likely a 
change in behaviour can help deal with the threat, how much control the person has over 
the behaviour, as well as what the costs are in changing the behaviour. The sum of these 
views would then determine how motivated the person is to take the suggested 
protective action. 
According to the PMT, in a hypothetical situation where an individual is 
presented with a anti-drug fear appeal, the Australian NDC for example, the person 
would firstly weigh in their minds the benefits of using the drugs by how dangerous the 
effects are of the drugs are, and how likely they would be affected by these negative 
effects. In parallel to that, the individual would also think about how much control they 
have over the use of the substance and how effective a protective response, namely not 
using the drugs (or minimising harmful patterns of use) would be. The costs of 
performing these actions, such as not fitting in with peers, feeling bored and so on, 
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would then also considered. Finally, based on these processes, the person would then 
choose whether to use substances or not. 
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Figure 3. A visual representation of the Protection Motivation Theory (PMT) model. 
2.2 Health Behaviour Model (HBM) 
The Health Behaviour Model (HBM) is another prominent health-related 
theoretical model, which, in its earliest form, appeared similar to the PMT. However, 
Rosenstock (1974) described the original model as distinctively avoidance-oriented, in 
that people took health action to avoid diseases rather than because they were drawn by 
positive health reasons. Another key difference between the PMT and HBM is that fear 
is not an important ingredient - a person may be affected simply by noticing personal 
symptoms or receiving additional information via the media. The HBM (see Figure 4) 
prescribes that an individual needs to perceive susceptibility to an at least moderately 
severe disease/condition and also to perceive that taking a specific action would 
diminish the disease's severity or likelihood of occurrence. However, this is mediated by 
perceived barriers including cost, convenience, pain, and embarrassment. Modifying 
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factors such as personal knowledge and demographic differences are also taken into 
account. 
In an example, the HBM postulates that an individual might modify substance 
use behaviours when cues to a significant and likely threat to the person's wellbeing 
becomes evident, such as personally experiencing organ damage or even reading about 
such a possibility in the newspaper. If the threat appears serious enough and that the 
person may be susceptible to it, the person might then be prompted towards reducing or 
terminating substance use after considering barriers to change, such as the effort 
required to make lifestyle changes or having to endure withdrawal symptoms. 
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Figure 4. A visual representation of the Health Belief Model (HBM). 
2.3 Theory of Reasoned Action (TRA) 
Fishbein and Ajzen (1975) were fastidious about defining the Theory of 
Reasoned Action (TRA) components and its scope. As the name would suggest, it 
confines itself to volitional behaviours (Eagly & Chaiken, 1993). The TRA is based on 
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the assumption that humans are rational beings who are strongly influenced by the 
information provided to them. The model (see Figure 5) posits that a voluntary 
behavioural intention is the best predictor of overt behaviour, and that an individual's 
attitudes and subjective norms would form this intention. In the contexts of decisions to 
take illicit drugs for example, the likelihood of an individual intending to use a substance 
would be much greater ifthe person had a positive view of the said drug (positive 
attitude) as well as perceiving the use as socially acceptable by significant others 
(positive subjective norms), and vice-versa. However, for a valid prediction to occur, 
Fishbein and Ajzen asserted that all three variables have to be assessed at an identical 
degree of specificity. For instance, it would only be useful to elicit an individual's 
attitude, subjective norms and behavioural intention within limited contextual 
parameters such as one particular time and setting. 
Attitudes 
Subjective 
Norms 
Behavioural 
Intention 
Behaviour 
Figure 5. A visual representation of the Theory of Reasoned Action (TRA). 
Furthermore, the behavioural intention could only be accurate barring any 
interfering variables from the time it was elicited and the behaviour was expected to 
occur. So while this level of precision in its operational definitions would seemingly 
increase the model's internal validity, it significantly limits its generalisability. 
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2.4 Theory of Planned Behaviour (TPB) 
Ajzen (1991) subsequently developed the Theory of Planned Behaviour (TPB) as 
an extension of the TRA to overcome the original model's limitations in explaining and 
predicting non-volitional behaviours, and this is arguably the most widely known and 
" 
used attitude-behaviour model at this time (Ogden, 2003). The key addition in the TPB 
(see Figure 6) is perceived behavioural control (PBC), which is an individual's sense of 
control or command over performing an action. Ajzen proposed PBC as both a third 
independent determinant of intention, and as a mediating factor between intention and 
actual behaviour. However, the relative influence of each of the three variables -
attitude, subjective norm, and PBC - in determining intention is expected to differ across 
behaviours and situations. Additionally, the TPB postulates that as voluntary control 
over behaviour diminishes the PBC increases in influence. Thus, an individual who 
might be contemplating whether to use substances would be affected by three primary 
factors, i.e. how positively or negatively the substance is regarded by the person 
(attitude), whether the use is approved by the key figures in the person's life (subjective 
norms) as well as much how much perceived control the individual has over whether to 
use the drugs or not (perceived behavioural control). These factors would together 
impact upon the individual's planned intention to use the drugs, which in turn is a good 
predictor of how likely the substances would actually be partaken. Whilst these variables 
are the core components of the TPB, Ajzen (1991) notes that the model is open to 
additional components if they account for significant proportions of intention and/or 
behaviour. 
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Figure 6. A visual representation of the Theory of Planned Behaviour (TPB). 
3 TPB as the apposite foundation for the development and assessment of drug 
education programs 
Empirical PMT studies show conflicting results in regard to the model's utility in 
predicting behavioural intention (Ho, 2000; Milne et al., 2000; Umeh, 2004). A study by 
Ho (2000), applying the PMT model to predict behavioural intention to use condoms in 
248 participants found that the model explained 56% of the variance in behavioural 
intention. However, a replication of the study by Umeh (2004) found that only 7.7% of 
the behavioural intention was accounted for by the PMT variables and hence asserted 
that the model was deficient in explaining the health decision making process. A meta-
analysis by Milne, Sheeran and Orbell (2000) presented modest support for threat- and 
coping-appraisal components of the model in predicting health-related intentions. Self-
efficacy was found to be the most frequently significantly correlated variable with 
behavioural intention across the studies, compared to the three key original variables in 
the model (the magnitude of harmfulness of a depicted event, the likelihood of the event, 
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and the effectiveness of a protective reaction). Whilst intentions had medium-to-strong 
associations with subsequent behaviour, Milne and colleagues suggested that difficulties 
with operationalising variables in the PMA model had possibly led to a limited number 
of studies that had examined the ability of the PMT model framework to understand and 
predict behavioural decisions. 
In regard to the HBM framework, an extensive review by Janz and Becker 
(1984) noted that the umbrella variable of ''perceived barriers", which included "social 
approval" and "self-efficacy", was the most potent component of the HBM in terms of 
significance ratios, which was defined by the researchers as the number of positive and 
significant results (N = 25) divided by the total number of studies (N = 28), at 89%. Janz 
and Becker went on to conclude that the study provided strong empirical grounds for 
corroborating the model in explaining and predicting individuals' health-related 
behaviours. However, Harrison, Mullen and Green (1992) were critical of Janz and 
Becker's (1984) inclusion criteria and use of significance ratios. Harrison et al 
conducted a more statistically rigorous meta-analysis of this data, using strict inclusion 
criteria for studies into the analysis (based on the reliability and validity of measures 
used in the studies, including only 16 of the 14 7 original studies), finding weak effect 
sizes and a lack of homogeneity in key HBM dimensions. Importantly, if variables 
included in the HBM framework were not homogenous, it would be fallacious to make 
any conclusions as to the efficacy of the model because the constructs measured may be 
very different from to study to study. Whilst not rejecting the model outright, Harrison 
and colleagues were very critical about the lack of congruity in the dimensions of the 
HBM, noting that disparity between studies' definitions of key variables results in 
difficulty interpreting and comparing findings. 
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Unlike the PMT and HBM, the TRA and TPB encompass the study of both 
health and non-health related behaviours such as exercising, condom use, leisure 
activities, drink driving and job seeking (Hardeman et al., 2002). As a conceptual 
extension of the TRA, the TPB has been found in various studies to be superior to the 
TRA, and has been accepted in the research community as a natural replacement for it 
(Ajzen, 1991, 2002c; Armitage & Conner, 2001). In an extensive meta-analysis of up to 
185 independent studies, Armitage and Conner (2001) found that over a range of 
activities such as those noted above, TPB variables can account for 39% of the variance 
in intention, 38% for self-reported behaviour and 27% for observed behaviour. 
In the realm of substance use behaviours specifically, there have been little, if 
any, studies involving HBM or PMT. TPB studies in the area, which typically included 
minor extensions or additions in the model, support the model's efficacy in predicting 
both intentions and behaviour (Armitage & Conner, 2001; Conner et al., 1998; 
McMillan & Conner, 2003; Orbell, Blair, Sherlock, & Conner, 2001). In a study on 
illicit substance use amongst students, McMillan and Conner (2003) found that all three 
TPB variables independently correlated with drug use intentions. Together, attitudes, 
subjective norms and PBC accounted for 48% of intentions in MDMA use. A medium-
to-large proportion of the variance in self-reported MDMA use, 40%, was explained by 
intention and PBC. Between legal and illegal substances, Armitage (1999) found 
different prediction power using a slightly modified version of the TPB. With cannabis, 
88% of the variance in intention was explained, whilst for alcohol, it was only 66%. As 
for actual behaviour, the TPB accounted for 60% of the variance for cannabis and only 
17% for alcohol. In Conner, Sherlock and Orbell's (1998) study on MDMA use, TPB 
variables accounted for between 50% and 63% of the variance in intentions. Intentions 
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to use MDMA were found to explain 18% of the variance in MDMA use, although the 
overall equation, incorporating intentions and PBC, which the researchers divided into 
self-efficacy and perceived control over behaviour, accounted for up to 55%. With the 
wealth ofresearch in this area, in addition to its promising predictive power, the TPB 
appears to be a better tool in understanding and predicting substance use than models 
such as the PMT and HBM. As such, the subsequent sections of this review will 
examine the role of each of the TPB components in turn and review their applicability in 
the effects of harm-reduction and fear-based drug education campaigns. 
3.1 Direct and indirect measures 
All psychological TPB variables can be assessed via direct and indirect 
measures, which comprises of global measurements as well as aggregations of relevant 
sub-components (examples and elaborations of direct and indirect measures will be 
explored in more depth in Section 3 .1.2 below), and whilst both approach the variable 
under examination differently, they tap the same constructs and are expected to be 
correlated (Francis et al., 2004). Some studies (e.g. Armitage, 1999; Conner et al., 1998) 
have shown that the efficacy of using direct and indirect assessment of attitudes and 
beliefs varies depending on the behaviour under study, sample population, behavioural 
context, and indeed the researcher's operational <l~finitions of key study variables. 
Certainly, these findings give credence to Ajzen (2002b) and-Francis et al.'s (2004) call 
to include both direct and indirect measures of all components of the TPB model to 
attain a comprehensive explanation of the constructs because although correlated, the 
measures are based on different premises of the fundamental cognitive framework 
(discussed below). 
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3.1.J Attitudes 
The term 'attitude' is arguably one of the most ambiguous terms in the study of 
psychology, where there have reportedly been almost 500 distinct operational definitions 
for that single term (Fishbein & Ajzen, 1972; Lemon, 1973). Whilst there are still 
differences in the manner in which attitude is measured, there has been widespread 
consensus in the scientific community that attitudes are summary evaluations of an 
entity, which comprises of cognitive and affective components (Ajzen & Fishbein, 1977; 
Eagly & Chaiken, 1993; Petty, Wegener, & Fabrigar, 1997). However, there are still 
disagreements as to the weight of these cognitive and affective evaluative components. 
Eagly and Chaiken (1993) propose that neither have any special priority and that their 
respective importance changes depending on the target object. For the TPB however, 
Ajzen (2001) employs the expectancy-value model (Fishbein & Ajzen, 1975, discussed 
below) which assumes that evaluations are primarily the products of cognition. So whilst 
the TPB model acknowledges the influence of affective contributions to attitude, it is 
deemed as only having an incidental effect (Ajzen & Fishbein, 2005). 
In regard to attitudes that are well-formed and explicit, Ajzen (2002a) prescribes 
direct measures as being fairly accurate gauges of this variable. The direct measure of 
attitudes can be elicited by using a set of bipolar evaluative adjective scales, which an 
individual rates in relation to the object under study such as good- bad, 
harmful-beneficial, desirable-undesirable, pleasant-unpleasant, and useful-useless 
using a Likert-type approach. Azjen has found that the evaluative semantic differential 
to be internally consistent and stable across time when adequate numbers of such scales 
are used. Studies on substance use that employed direct measures of attitude have found 
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them to account between 18% and 41 % of intentions (Conner et al., 1998; Orbell et al., 
2001 ). The discrepancy may be due to differences of sample characteristics and/or data 
analyses in the studies, in addition to differences due to the target behaviour under study, 
as noted by Armitage (1999, Section 3.0). 
An alternate means of measuring attitude toward an object is based on the 
expectancy value model of attitudes (Fishbein & Ajzen, 1975). This indirect measure of 
attitudes postulates that people have certain salient beliefs about an object/action and 
that they naturally form positive or negative evaluations of these attributes of the object 
or action. Thus, the model states that the sum of salient belief strength (how much the 
individual considers a belief as true) multiplied by the outcome evaluation (how positive 
or negative the outcome is), known as behavioural belief, is directly proportionate to 
attitude, and therefore can be considered an indirect assessment of attitude. For example, 
the rating of an individual's belief that using MDMA is very likely to cause euphoria, 
can be multiplied by the person's high rating of how positive it is to experiencing 
euphoria, cumulating to a highly positive behavioural belief. This 'belief-based attitude' 
can be used as an adjunct to the direct measure of attitude, as well as an alternative form 
of measurement for target objects that are not salient or socially acceptable, such as 
illicit drug use. Fishbein and Ajzen (1975) caution that such an indirect assessment of 
attitude toward an object or behaviour requires assessment of multiple behavioural 
beliefs, and an examination of the aggregate of these beliefs rather than a single item. 
This is because a single item would be insufficient in representing the complete range of 
behavioural beliefs that one has about an object or behaviour. 
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Figure 7. A visual representation of the expectancy value model of attitude. 
~TPB studies on substance use behaviours have found large correlations between 
the indirect and direct measure of attitude (Armitage, 1999; Conner et al., 1998). More 
importantly, the data collected from behavioural beliefs extends understanding of the 
underlying bases for people's attitudes. For instance, Orbell and colleagues (2001) found 
that MDMA users were more likely affirm positive effects of the drug than non-users. 
However, they found that negative outcome expectancies were endorsed by both groups. 
In another study on MDMA use, the researchers found significantly different belief 
patterns between students and regular club-goers (Conner et al., 1998). These exemplify 
that whilst the attitude variable may be sufficient in accounting for intention, tapping the 
behavioural beliefs constructs can assist in providing a more meaningful interpretation 
of the data. 
3.1.1.1 Attitude ambivalence 
Conventionally, attitude has mostly been conceptualised along a continuum from 
completely negative, to complete indifference, to completely positive. Such a 
formulation would appear to be a straightforward and intuitive construct. However, there 
has been a rise in studies of attitude ambivalence, which is defined as having 
inconsistent beliefs, conflicting emotions or even contradictions between beliefs and 
emotions (Ajzen, 2001; Eagly & Chaiken, 1993). For instance, an individual may enjoy 
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the pleasurable moods of using cannabis, yet experience strong feelings of guilt at the 
same time. Whilst it is possible for specific components of an attitude to be strong, a 
high degree of ambivalence would render the salient attitude at any time relatively 
malleable and unstable (Eagly & Chaiken, 1993; Thompson, Zanna, & Griffin, 1995). 
Thus, attempts to predict behaviour from an ambivalent attitude would logically be 
limited. 
The literature shows that the ambivalence construct is a significant negative 
moderator between attitude and intention, between attitude and behaviour, and also 
between intention and behaviour (Conner et al., 1998; Cooke & Sheeran, 2004; Crano & 
Prislin, 2006). Nonetheless, it has been suggested that when the context of the behaviour 
and attitude are specified precisely, the particular aspect of even an ambivalent attitude 
would become more accessible and salient, increasing the predictive power for at least 
that particular context (Ajzen & Fishbein, 1977; Eagly & Chaiken, 1993; Thompson et 
al., 1995). For instance, whilst a person may be ambivalent about the idea of outlawing 
abortions, if given a very ~pecific context such as what the person might believe about 
the right of a person to have an abortion when the pregnancy is a result of rape, then the 
predictive value of the response would be more representative at least in the said 
context. In sum, it would appear that attitude ambivalence can be an instructive addition 
to the any predictive model (Petty et al., 1997). 
3.1.2 Knowledge 
Whilst behavioural belief is the primary indirect measure for attitude, another 
potentially useful variable to consider is knowledge. Although these appear to be very 
similar concepts within the TPB framework, Ajzen (1991) stated that in relation to 
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attitudes toward a particular behaviour, beliefs are linked to the outcomes or other 
relevant attributes of the behaviour. However, it is implied that an individual's beliefs 
may be merely based on a person's assumptions; whereas knowledge is commonly 
defined as information that is true and based on justifiable evidence. Thus aside from 
being a common measure in the outcome studies of drug campaigns, knowledge about a 
drug's effect may influence behavioural beliefs, and subsequently attitudes, in regard to 
the drug within the framework of the TPB. 
3.1.3 Subjective Norms 
Subjective norms, whichAjzen (1991) describes as the social factor of perceived 
pressure to behave in a certain manner, can be tapped directly by asking the respondent 
as to whether 'important others' approve of a said action (for example, "Most people 
who are important to me think that my smoking cannabis would be undesirable-
desirable"). An indirect measure of subjective norms is attained by multiplying 
normative beliefs (for example, "My friends think I should not use cannabis; Agree-
Disagree") and the motivation to comply (for example, 'In relation to cannabis use, I do 
what my friends think; Agree-Disagree"), which Ajzen postulates will be directly 
proportionate to subjective norms. These normative beliefs have a more narrow term of 
reference, such as th~ approval of specific social groups like family or friends, which is 
then multiplied by the individual's motivation to comply with the perceived social 
pressure from the said referent groups (Ajzen, 2002b ). 
Eagly and Chaiken (1993) however, suggested that there is substantial overlap 
between the construct of attitude and that of subjective norm, highlighting the high 
degree of confounding and multicollinearity between the two constructs in the model 
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when simultaneously run in a regression equation. They offered that the behavioural 
belief and normative belief constructs can be argued to overlap or even be 
interchangeable by merely changing the phrasing of the statements, such as "I have a 
good time with my friends when I am using ecstasy" as compared to "my friends are 
s:upportive of me using ecstasy". It is quite evident that most TPB studies will establish 
significant, positive correlations between subjective norms and attitudes, generally in a 
range between .44 to .66 (e.g. Albarracin, Johnson, Fishbein, & Muellerleile, 2001; 
Orbell et al., 2001; Rivis & Sheeran, 2003; Sheeran, Conner, & Norman, 2001). On the 
other hand, these strong correlations do not necessarily prove multicollinearity. A likely 
concession may be, as Park (2000) projected from his study, that if attitude was split into 
two discrete components, i.e. social and personal, subjective norms would only be 
significantly related to social attitudes but not personal ones. Hence, this issue may be 
resolved by operationally defining the two terms very clearly and discretely, with an 
example of a personal attitude being "using cannabis makes me feel depressed"; and an 
example of a social attitude being "using cannabis makes me argue with my partner". 
In addition to normative beliefs, several other researchers have suggested the 
value of incorporating descriptive norms as an additional social predictor of intention, 
including those involving substance use behaviours (Conner et al., 1998; McMillan & 
Conner, 2003; McMillan, Higgins, & Conner, 2005; Rivis & Sheeran, 2003). A 
descriptive norm solicits the perceived engagement of referent groups in certain 
behaviours, tapping an indirect relation between an action and a referent group's 
approval of it. Thus instead of a more injunctive manner used in identifying subjective 
norms, such as "my friends think I should not smoke", descriptive norms capture the 
indirect nature of social approval via examining the extent of agreement with the 
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statement "most of my friends smoke". In an extensive meta-analysis of the role of 
descriptive norms Rivis and Sheeran (2003) found that the relationships between 
descriptive norms and intention were stronger among younger samples such as school 
children and undergraduate students and for health-risk behaviours as opposed to older, 
non-student samples and health-promoting behaviours. The descriptive norms were 
shown to explain 21 % of variance in the prediction of intention in younger samples and 
23% in health-risk behaviours. 
3.1.4 Perceived Behavioural Control (PBC) 
The addition of perceived behavioural control (PBC) is the primary difference 
between the TPB and TRA. Ajzen (1991) describes PBC as being very similar to the 
construct of self-efficacy, which is an individual's belief of the ease or difficulty in 
executing a particular behaviour. However, PBC is seen as encompassing both the 
concepts of self-efficacy and controllability, which are beliefs about the degree to which 
carrying out an action is under the influence of the individual (Azjen, 2002). Ajzen 
(1991) notes that in lieu of actual control, one's perception of control is the closest 
approximate to it. In a meta-analysis of various health behaviour models including the 
TPB, Webb and Sheeran (2006) found that effects of intention on behaviours were 
positively mediated by both actual control, and PBC. 
Whilst Armitage and Canner's (2001) meta-analysis of 185 studies on the TPB 
showed that the PBC independently predicted intentions and behaviour in a broad range 
of spheres, they questioned the nature and antecedents of the construct. They noted that 
in many TPB studies, PBC has not been operationalised in a consistent manner, leading 
to difficulties in comparing results across studies. This suggested lack of congruence 
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may explain the disparity in the results of the following studies on substance use: In 
Conner and McMillan's (1999, pp.197) study on cannabis use PBC was defined as 
"based upon an evaluation of the power of factors likely to facilitate or inhibit the 
performance of the behaviour, each weighted by their frequency of occurrence". PBC 
which was measured by four direct measure items (e.g. "how much control do you think 
you have over whether or not you use cannabis/marijuana in the next 3 months") was 
found to be significantly correlated with intention only for respondents whose attitudes 
towards the drugs were negative or neutral. In contrast, Umeh and Patel (2004, pp.26) 
operationalised PBC as a construct that "encapsulates beliefs about whether one 
possesses the necessary skills, resources and opportunities to execute the behaviour, and 
the power of these factors to actually facilitate/inhibit the behaviour", and used two 
measures of PBC, those involving the consumption of the substance (Eleven items, e.g. 
"Within the next two months, how much control do you feel you have over taking 
ecstasy?") and obtaining the substance (Three items, e.g. "How confident are you that 
you could get some ecstasy within the next two months?"). Umeh and Patel found that 
for MDMA use behaviours, PBC was only significantly related to intention for 
participants who viewed the substance positively. 
In a study that ranged across different substances, McMillan and Conner (2003) 
retained their original conceptualisation (Conner & McMillan, 1999) of PBC but used 
indirect belief-based measures (the multiplication and averaged of control beliefs, e.g. "I 
am in a bad mood - frequently/infrequently", and power item , e.g. "Being in a bad 
mood makes my taking this drug - more likely/less likely") of PBC instead of direct 
measures and found that PBC was significantly correlated with intention at all levels of 
attitudes for amphetamine and cannabis, but unrelated to intention when attitudes were 
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negative for LSD and MDMA. These examples illustrate the lack of uniformity in the 
operationalisations of the PBC construct across TPB studies, which may make it difficult 
to generalise findings. 
Another plausible reason for the discrepancies is that the type of behaviour - or 
in this case, substance type - in question affects the concept of volitional behaviour 
strongly. For instance, in a study on the use of various substances, Orbell and colleagues 
(2001) divided the PBC construct into PBC over obtaining the substance, as well as PBC 
over consuming the drug. This novel way of using the PBC added 7% each variance to 
the prediction of intentions. It would appear that for substance use behaviours, Or bell 
and colleagues' (2001) operationalisation of PBC taps a larger set of controllability and 
self-efficacy issues within the model. 
3.1.5 Behavioural intentions 
In both TRA and TPB, behavioural intention is seen as the key antecedent 
variable of volitional behaviour. The construct is expected to capture the major driving 
factors that regulate a behaviour (Azjen, 1991). Barring intervening events that may alter 
the intention during the time of measurement and the time of behavioural observation, 
intentions are proposed to be the most practical manner to attain accurate predictors of 
behaviour (Fishbein & Ajzen, 1975). TPB studies on subslam;~ us~ behaviours hav~ 
shown intentions, after mediation by PBC, to significantly correlate with behaviours, 
having medium-to-large effects, explaining between 51 % to 72% of variance in actual 
behaviour (Conner & McMillan, 1999; Johnston & White, 2003). 
As indicated earlier, intention sits within the TPB framework, which is based on 
the assumption that human beings are basically rational creatures that act based on 
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various attitudinal and social beliefs (Azjen, 1991; Eagly & Chaiken, 1993; Fishbein & 
Ajzen, 1975). Behaviours that may be externally perceived as illogical or foolish, may in 
fact be rational albeit based on very short-term, or hidden, payoffs (Reyna & Farley, 
2006). Based on that premise, one can understand why a stated behavioural intention is 
expected to be carried out successfully as PBC increases (Azjen, 1991). Whilst current 
research literature has consistently supported the efficacy of the TPB as a predictor of 
intentions and behaviour (Armitage & Conner, 2001; Conner et al., 1998; McMillan & 
Conner, 2003), Webb and Sheeran's (2006) meta-analysis suggested that the effect size 
of intention on behaviour albeit significant, may be smaller than correlational tests have 
indicated. Their analysis indicated that a medium-to-large change in intention generates 
a small-to-medium change in behaviour. This suggests that there are other significant 
factors that can be considered in addition to intention when attempting to more 
accurately predict or explain behaviour. 
3.1.6 Additional components 
Whilst Ajzen (1991) argued that TPB had to maintain a balance between 
maximising the predictive power of the TPB and parsimony, he welcomed additional 
predictors if they were shown to provide significant variance in intention or behaviour 
above those of the current variablt:s. Since then, many studies have expanded the current 
variables and/or included additional ones, and additional predictors relevant to the 
assessment of the effects of drug education programs are briefly reviewed below. 
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3.1.6.1 Habits and past behaviours 
Habit and past behaviour have been quite common additional variables in TPB 
studies, showing significant moderating effects between the key variables as well as 
explaining additional variance in intentions and/or behaviour (Norman & Conner, 2006; 
Orbell et al., 2001; Webb & Sheeran, 2006). These two variables have very high face 
value, as it is reasonable to understand how an individual who has engaged in a 
behaviour before, or even more so when it is done habitually, is likely to do it again with 
less conscious thought. 
Above the main TPB variables, Orbell and colleagues (2001) found that habit 
explained an extra 2% of variance explained in intention of using MDMA. As a 
moderator in binge drinking behaviour, the frequency of past behaviour was found by 
Norman and Conner (2006) to attenuate the attitude-intention relationship, with attitude 
being a predictor of intention at_= .63 (p <. 001) under high levels of past behaviour,_ 
= .88 (p <. 001) and _ = 1.13 (p <. 001) under medium and low levels of past behaviour 
respectively. In addition, Gibbons and colleagues (1998) also found that previous 
behaviour significantly explained 18% of the variance in behavioural willingness to 
engage in unsafe sex. As such, it would suggest the necessity of controlling for these 
past behaviour and habit in studies on health-risk behaviours, such as with substance use 
behaviours. 
3.1.6.2 Moral norms 
For behaviours that have strong perceived moral or ethical implications such as 
using substances, lying and stealing, moral norms have been proposed as a notable 
variable, explaining small increases in variance of up to five percent of intention 
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(Armitage & Conner, 2001; Azjen, 1991; Conner & McMillan, 1999). Moral norms 
have also been found to be important predictors of smoking intentions for children as 
young as 12 to 13 (McMillan et al., 2005). 
3.1.6.3 Temporal stability 
Aside from additional variables, measuring temporal stability, which is done by 
assessing a variable twice or more over a particular length of time, has been shown to 
significantly improve intention-behaviour consistency (Webb & Sheeran, 2006). 
Conceptually, a consistent and stable intention can be expected to resist contextual 
changes and lessen the effect of other mediating factors, making it a vital feature for the 
prediction of eventual behaviour (Ajzen, 2002b; Webb & Sheeran, 2006). In a meta-
analysis of 44 studies, temporal stability was found to the be the most powerful 
moderating factor between the attitude-behaviour and intention-behaviour associations, 
explaining 14% and 6% of variance respectively (Cooke & Sheeran, 2004). 
3.1.7 Summary 
As discussed in the sections above, it is apparent that understanding and predicting 
substance use behaviours is fairly elaborate and is not as simple as merely measuring 
attitudinal change or recall of public service advertisements. Amongst the other health-
related theoretical paradigms, the TPB puts forward a robust model involving the 
process of several key variables and conditions, which has been shown to be empirically 
supported in illustrating the complexities behind substance use behaviours. 
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3.2 Prototype/Willingness Model (PWM) 
Unfortunately, even with additional predictors, the TPB fundamentally suffers 
from its reliance on an individual's capability of being rational. Ajzen and Fishbein 
(2005) acknowledged that the TPB may be limited in its prediction of behaviour when 
there is a lack of voluntary control, erroneous information, strong affect or while 
intoxicated. Indeed, in a hypothetical scenario where a young individual with little 
experience of a psychoactive substance is offered some in a party of peers who are 
consuming the drug, the TPB may lack substantial power in its prediction of the 
individual's actions. The concept of 'intention' in this scenario would be void because 
there would not have been any premeditated effort on the individual's part to use the 
substance in the first place. Furthermore, intentions have been found to have much 
weaker effects on risk behaviours compared with health-protective ones, when 
performed in social contexts (Webb & Sheeran, 2006). 
An extension or variant of the TPB was thus developed by Gibbons and 
colleagues (1998) to counter this limitation. The Prototype Willingness Model (PWM) 
adopts the TRA's original variables but adds two key predictors, prototype and 
behaviour willingness, which are respectively defined as generalised social images of 
persons who perform certain behaviours and predispositions to engage in an 
opportunistic behaviour. The model posits itself as not contributing greatly to the 
prediction of behaviours that require forethought, but one that does well in predicting 
behaviour that occurs in reaction to unexpected encounters. For instance, the PWM 
studies found that whilst many young people deny having intentions to engage in risky 
behaviours, they are more likely to concede willingness to do so under certain 
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circumstances. Indeed, the model appears to target opportunistic risk behaviours in 
younger people who may have less firm views on certain matters such as trying cannabis 
for the first time; or even adults who may exploit certain situations such as not reporting 
a profiting bank error or cutting in line when no one is watching (Gerrard, Gibbons, 
Stock, Lune, & Cleveland, 2005; Gibbons, Gerrard, Blanton et al., 1998). In such 
situations, the PWM suggests that social context is a key influence or trigger for such 
opportunistic behaviours. In relation to substance use, a study on young people who used 
amphetamines and MDMA found that social and contextual reasons were more 
influential in the prediction of future use in comparison to the actual mood-altering 
psychoactive effects of the substances (Boys et al., 1999). Thus, one can see that while 
the TPB is able to capture a large portion of the important information, an extended TPB 
which includes concepts from the PWM model (Figure 8), may be more comprehensive 
in encompassing the breadth of key variables in understanding drug education 
effectiveness 
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Figure 8. TPB model extended to include PWM variables. 
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3.2.1 Beliavioural Willingness 
Unlike behavioural intention which indicates one's conscious efforts in carrying 
out a particular behaviour, the premise of behaviour willingness is generally one of a 
predisposition to engage in a behaviour ifthe opportunity arises, which one may not 
particularly intend to dynamically pursue in the first place (Gibbons, Gerrard, Blanton et 
al., 1998). Behavioural willingness could thus become a particularly valuable variable in 
studies involving substance use behaviours in young persons who are not regular drug 
users, because they are likely to be exposed to opportunities to use substances in social 
situations rather than to actively plan to use them. Nonetheless, Gibbons, Gerrard, 
Ouellet and Burzette (1998) assert that whilst willingness implies less reflection than 
intention, it is more than a mere spur-of-the-moment decision. Instead, willingness is 
strongly related with a positive inclination and social acceptance. 
In one study of adolescent smoking, intention and willingness have been found to 
be strongly correlated (r = .69) but after accounting for past behaviour, both variables 
explained a significant and independent proportion of variance in actual behaviour: 
willingness contributing 7% of the variance explained and intention 1 % (Gibbons, 
Gerrard, Blanton et al., 1998). When combined, they accounted for 13% of the variance, 
indicating a synergistic effect of the two which was larger than what each of the 
variables could have achieved independently, demonstrating the value of measuring both 
constructs together when studying health risk behaviour. 
3.2.2 Prototype 
Prototypes in the PWM are conceptualised as social images about typical persons 
who perform a certain behaviour, for instance smokers in general, which are measured 
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on bipolar adjective descriptors such as "smart-foolish" or "fun-boring" (Gerrard et al., 
2005). Young individuals with overall favourable images of risk behaviours tend to be 
more likely to be willing to engage in such behaviours, which in turn has a more likely 
chance of eventuating into actual behaviour (Gerrard et al., 2005; Reyna & Farley, 2006; 
Thornton, Gibbons, & Gerrard, 2002). Prototypes have been used successfully in PWM 
studies with samples of college/university students, high school students and pre-
adolescents in a range of opportunistic behaviours such smoking, unprotected sex and 
alcohol use (Blanton et al., 2001; Gerrard et al., 2005; Spijkerman, van den Eijinden, 
Vitale, & Engels, 2004), explaining between 5% and 16% of variance in willingness and 
intention, independently of other TPB variables. 
3.3 Relevance of an extended TPB model in drug education 
By incorporating the key PWM components into the TPB, it is possible to 
synergise the strengths of both models to elucidate the effects of the different models of 
drug education programs (fear based vs. harm reduction) more comprehensively - with 
the TPB assessing the rational component of substance use behaviours, and the PWM 
variables address the social and contextual influences on such behaviours. Furthermore, 
the literature also suggests other additional factors on top of the basic TPB and PWM 
that may be useful in augmenting and complementing the model's explanatory and 
predictive capabilities. 
Whilst different drug education models have divergent goals, the changes they 
aspire to invoke in the recipients would be those that are substantial and sustained. The 
extended TPB model as proposed here (Figure 9) could allow for a more thorough 
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understanding of the exact impacts of the different drug education strategies on the 
various components leading up to substance use behaviours. 
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Figure 9. Proposed extended TPB model for the assessment of the effects of drug 
education programs. 
4 Attitude and Persuasion 
Whilst social cognitive models may help explain and predict behaviours, they do 
not address the process of change in behaviours and the relevant attitudes. Various 
information campaigns have gone awry due to failure to take into consideration the 
different dynamics of persuasion, such as the different interpretation by the recipients 
(Hyman & Sheatsley, 194 7). Given that drug education programs aim to persuade those 
involved to adopt a certain position toward use of drug, it is important to further 
examine the mechanisms involved in this process in order to better determine the 
effectiveness of such drug education efforts. 
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4.1 Elaboration Likelihood Model-The central and peripheral route 
Persuasive messages generally aim to change one's beliefs, attitudes or intentions 
(Fishbein & Ajzen, 1972). Arguably the most prominent paradigm of persuasion today is 
the Elaboration Likelihood Model (ELM) (Crano & Prislin, 2006), which claims that a 
message's persuasiveness and the impact of other mediating factors (e.g. source 
credibility, audience demographics) fundamentally depend on the motivation of the 
audience to process it (Petty & Cacioppo, 1986). The ELM posits that when an 
individual is highly motivated and able to process a message, the 'central route ' is 
utilised. On the other hand, when an individual is unmotivated or unable to process a 
message, the 'peripheral route ' is used instead. In contrast to information processed via 
the central route, which is believed to run on the attentive considerations of reasoning 
which are central to the matter, information processed via the peripheral route is instead 
believed to operate on simple associations or inferences tied to extraneous cues in the 
persuasion context. The model goes on to suggest that mediatory factors, for instance 
source attractiveness or message discrepancies, which may increase a message's 
persuasiveness via one route, could have an opposite influence through the other route, 
for instance using distraction (such as playing a loud background music while presenting 
the message) will increase the persuasiveness of a message if the audience were using 
the peripheral route, but would be counterproductive if the central route was used. 
Whilst the model has a strong empirical base, it serves more as a descriptive or 
predictive model than an explanatory one (Eagly & Chaiken, 1993; Petty & Cacioppo, 
1986). 
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Petty and Cacioppo (1986) state that according to the ELM and studies applying 
this model, attitude change appears to be weaker, more susceptible to change and less 
predictive of behaviour when it is processed via the peripheral route compared to the 
central route. Thus in relation to drug education where the goal is typically to cause 
long-lasting and meaningful attitudinal as well as behavioural shifts, then it is imperative 
that attempts be made to ensure that the audience processes the presented information 
via the central route. 
The model has an exhaustive list of source factors such as credibility, 
attractiveness; message factors such as number of arguments, discrepancy; audience 
factors such as demographic differences, past experience; and other variables that may 
mediate attitudes depending on the context of the persuasion process. For instance, a 
message that has high personal relevance is likely to increase an individual's motivation 
to scrutinise a message's merits, whilst prior knowledge of the subject matter may 
encourage biased examination of the newly presented information. On the other hand, 
source factors and other secondary variables play a more significant role, when 
elaboration likelihood is moderate or low (Petty & Cacioppo, 1986). 
Hence while the ELM may appear unwieldy due to its numerous possible 
combinations of mediating factors, if used strategically and tailored for specific target 
audiences, the model can be a useful tool in increasing persuasiveness. As asserted 
earlier, in a drug education context where the preferred outcome would be substantive 
and enduring attitudinal as well as behavioural changes, influencing recipients to use the 
central route would be more effective than the peripheral route. 
Among the possible steps to increase the likelihood of the audience utilising the 
central route include customising the message to increase personal relevance and the 
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sense of personal responsibility of the audience, as well as using language that is easily 
understood by the recipients. Nonetheless, whilst there is some degree of control in 
attempts to influence the persuasion route is engaged by manipulating the source or 
message variables, personal variables such as tolerance for ambiguity, 
argumentativeness, and prior knowledge may play a more prominent, and overriding 
role (Hale, Mongeau, & Thomas, 1991; Petty & Cacioppo, 1986). 
Fishbein, Hall-Jamieson, Zimmer and von Haeften (2002) studied the perceived 
effectiveness of several anti-drug public service announcements (PSAs) and found that 
out of 30 PSAs, slightly over half were rated by participants as being more effective at 
reducing drug use than a control video about non-drug news production techniques. 
Additionally, 20% of the videos were perceived as being significantly worse than the 
control in their ability to reduce drug use. Thus while the study only assessed the 
viewers' perceived effectiveness and not actual effectiveness in terms of behaviour 
change, the results highlight that not all anti-drug PSAs are made equal. This study 
(Fishbein et al., 2002) found that the factors most highly correlated with perceived 
effectiveness were realism, learning and negative emotional responses. PSAs that 
promoted a "just say no" message were seen as less effective than those that focused 
primarily on the negative outcomes of drug use and those using dramatic representation. 
Although both types present only the negative aspects of drug use, the depth and amount 
of arguments presented differ. The study also found that individuals at highest risk of 
drug use, namely those who did not consider substance use as detrimental or unsafe, 
were the ones that were least likely to view the PSAs as effective overall. The 
researchers argue that ultimately, the effectiveness of anti-drug messages rely heavily on 
the desired behaviour and the target population; asserting that a particular behaviour 
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may be determined primarily by attitude in one population, but by social norms in 
another. Fishbein and colleagues (2002) concluded that preparatory research to 
understand the fundamental variables driving the behaviour in the target population is 
critical to ensure health promotion efforts and interventions succeed. 
4.1.J One-sided vs. two-sided messages 
Amongst persuasion strategies, messages can be delivered with only one side of 
the story or from both perspectives. Findings have shown that overall, the most effective 
messages are two-sided with rebuttal about the discounted side, followed by one-sided 
messages, and that two-sided messages with no refutation are the least powerful in terms 
of persuasiveness (Allen, 1991; Hale et al., 1991). Strength of persuasiveness aside, 
Glasman and Albarracin (2006) found that one-sided information increases attitude 
stability as well as attitude-behaviour correlations. Nonetheless, whilst significant, 
message sidedness generally has relatively small effect sizes in attitude change, likely 
due to other meditational factors about the way that information is processed, as 
suggested by the ELM (Hale et al., 1991). 
Whilst having a relatively small influence, presenting two-sided messages with 
arguments against the opposing side appears to be the most effective way of presenting 
drug education information. In practice, this would mean that information about 
substances could be delivered in a way where both the positives and negatives of drug 
use are exhibited, but the former are actively refuted, without being exaggeratedly so. 
This suggests some sort of a middle point between the harm-reduction and abstinence-
based approaches, where the risks and benefits of drugs are openly discussed, yet using a 
systematic effort to discourage drug use. 
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4.1.2 Reactance to Fear-based Persuasion 
Common key performance indicators that are used in mass media based anti-drug 
campaigns include message reach and recall of the information (Orwin et al., 2006; 
Pennay et al., 2006; Scottish Executive Social Research, 2002). However, these 
measures contribute little in the way of predicting or explaining significant behavioural 
changes (Brown, 2001; Hughes, 2007). If seen from a TPB perspective, recalling a 
message's content may influence one's attitude, but that alone will not necessarily affect 
intention or behaviour. Furthermore, being subjected to a health promotion message may 
increase attitude accessibility (the salience of an attitude in memory) but that does not 
mean acceptance or integration of the message. To the contrary, when bombarded with 
constant and numerous warnings, people may simply get jaded of such messages, or in 
some cases, be affected by 'boomerang effects' or 'psychological reactance', in that the 
exact opposite outcome of those intended by the original message have known to occur 
(Ringold, 2002). 
Fear appeals that trigger strong emotions can be used successfully, if judged to 
be reasonable by the recipient, to displace positive attitudes towards a particular object 
or behaviour (Dillard & Anderson, 2004; Walton, 2006). On the other hand, ifthe 
message is perceived as being overinflated, the audience may judge it to be manipulative 
and actively reject it (Brown, 2001). Eagly and Chaiken (1993) concede that the cause of 
resistance that frequently occurs when persuasion is highly coercive is not yet fully 
understood. However, they offer that there are two major classes of theories that are 
accepted to be bases of such resistance, which are motivational and cognitive. In the 
former, reactance occurs because the ego, self or personal liberty is threatened by 
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change, such as when a person insists on using a particular substance because an order to 
cease use implies a disregard to the person's freewill. The cognitive class of reactance 
posits that certain attitudinal change may present a danger to the stability of numerous 
other cognitions within certain schemas. For instance, if a person whose significant 
others use substances frequently and that person was presented with the assertion that 
'drug users are society's scum', the person may have to reject the notion in order to 
protect the integrity of the significant others cognitively. Empirically, psychological 
reactance has been found to differ significantly by age and gender, with the most 
resistance coming from people between adolescence to early adulthood, and males more 
than females (Bushman & Cantor, 2003; Ringold, 2002). In a study on alcohol 
prevention by Benley and Wu (1991), college students were shown identical information 
on the effects of alcohol in two conditions, with the only difference being the concluding 
statements: in one condition, participants were directed to not use alcohol ('high threat' 
condition) ; in the other, moderation was urged ("low threat" condition). Benley and 
Wu found that dogmatic recommendations were the least effective overall, and was 
simply counter-productive in both intention and behaviour to the highest risk groups. 
-Male heavy drinkers drank significantly more when exposed to the high threat condition 
than the low threat condition. In regard to cannabis use, various types of fear appeals 
such as those that were anti-"hard" drugs; those that claimed that the use of cannabis 
would ultimately lead to harder drugs; and other fear-based anti-drug messages, have 
been shown to produce no effects among a large sample of middle and high school 
students (Yzer, Cappella, Fishbein, Hornik, & Ahem, 2003). The researchers proposed 
that messages that are incongruent with people's personal experiences may ultimately 
backfire. 
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In the context of drug education, this means that the use of fear-based persuasion 
has to be weighed very carefully depending on the goal of the drug education campaign, 
such as considering whether the aim was to reinforce non-using young people's 
unfavourable attitudes towards a particular substance, or encouraging active substance 
using teenagers to stop their drug use. Even if it was judged that it may be efficacious 
for a particular purpose, the degree of fear elicited should be sparingly pitched. That 
said, because most drug education campaigns are usually delivered indiscriminately via 
the mass media, limiting fear-based persuasion may be the optimum way of ensuring 
that the message is conveyed efficiently with minimal risk of being counterproductive. 
4.2 Credibility 
The ELM states that source credibility plays a much more significant role in 
determining persuasiveness when elaboration likelihood is low (Petty & Cacioppo, 
1986). That is to say that when there is little motivation to scrutinise a message in detail, 
a recipient is more likely to be persuaded by someone who appears to be an authority 
figure or has high credibility rather than the actual content of the message, such as when 
a popular musician is featured in a public service ad discouraging drug use, without 
using substantial arguments. By the same token, message content plays a more 
prominent role in persuasion when elaboration likelihood is high, whilst source 
credibility becomes less important. 
In a contemporary context concerning credibility of health promotion 
information on the internet, Hong (2006) found that when participants were asked to 
recommend tobacco cessation websites to friends and relatives, their intention to revisit 
the site was strongly correlated with the site's perceived credibility. Specifically, the 
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dimensions of depth and trust/expertise were found to be significantly linked whilst 
fairness and goodwill were not. However, the study's generalisability was limited in that 
participants were viewing emotionally neutral information instead of potentially 
distressing or controversial information Fairness and goodwill may possibly play a 
more significant role in websites that are based on controversial topics such as substance 
use information. In addition to that, website design and attractiveness are also known to 
have a substantial influence on the intention to revisit websites (Rosen & Purinton, 
2004). Websites that are hard to navigate, difficult to read and/or generally unattractive, 
may simply detract people from the focusing on the content or, as the ELM would 
suggest, reduce persuasiveness for recipients with low elaboration motivation (Petty & 
Cacioppo, 1986). 
Nonetheless, the factor of credibility is muddied by a little understood 
phenomenon known as the sleeper effect. In a classic study by Hovland and Weiss 
(1951-1952), although a perceived credible source managed to change opinions more 
substantially than an untrustworthy source initially, after a time interval of several 
weeks, attitudes were found to have decreased for those who were presented with 
credible sources and an increase with those from the untrustworthy sources. This 
' 
'sleeper effect' appears to be only moderately reliable when the message is remembered 
but the source forgotten (Hovland & Weiss, 1951-1952), especially ifthe source is 
revealed after the message (Eagly & Chaiken, 1993). 
Like the other mediating factors in persuasion, the role and influence of source 
credibility in drug education varies according to contexts and particularly with the 
degree of elaboration likelihood. This suggests that most effective way of presenting 
drug education information would be by providing substantial content and using a 
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credible source, which would then likely be efficacious across the different levels of 
elaboration likelihood. On the other hand, this also means that messages that use only a 
credible source but do not present solid arguments, or vice-versa, may only be 
persuasive for a limited range of audience. 
4.3 Summary 
Like the TPB, the ELM framework suggests that delivering effective drug . 
education programs is far more complex than simply airing dramatic anti-drug 
advertisements via the mass media. It is apparent that there does not appear to be a one-
size-fits-all approach to persuasion, or indeed drug education. A seemingly clear 
conclusion of the ELM literature would be that drug educators must understand the 
target population very well in terms of their demographics, motivations, and cognitive 
abilities amongst other pertinent factors. With a comprehensive understanding of the 
factors comes the ability to shape messages that are a good fit in terms of message 
complexity, message sidedness, emotional arousal and so forth to elicit a positive and 
long-lasting change in the target audience's attitudes and behaviours towards substance 
use. The risk of being unprepared or ill-informed in relation to these key factors may 
render the health promotion effort useless, or even counterproductive. 
Thus while the ELM provides a framework to predict to som~ degree how 
persuasive fear-based drug education programs are as compared to harm-reduction ones, 
when combined with an extended model of the TPB, the results would be able to present 
a comprehensive picture about what impacts two different streams of drug education 
have on particular sample groups in specific contexts. 
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5 Potential weaknesses of the TPB and other social cognition models in the 
prediction of behaviour 
One of the most common criticisms of social cognition research generally, and 
the TPB specifically, is reliance on self-report. Aside from the typical doubt about the 
accuracy of self-reporting, Ogden (2003) proposes that a respondent's cognitions and 
affect may be contaminated or manipulated simply by reflecting upon the questionnaire, 
especially if the target behaviour is unknown and new, for instance asking a person 
whether using condoms reduced sexual pleasure, when the person was not particularly 
aware about it before. Ogden goes on to argue that the responses to these questions 
could also directly influence self-reported behaviour, implying that their future 
behaviour would be affected simply participating in such a study. 
Based on their meta-analytical findings, although Armitage and Conner (2001) 
concede that prediction of self-reported behaviour using the TPB model is usually more 
accurate than for observed behaviour, they submit that the TPB nevertheless has a 
medium to large effect size, explaining approximately 20% of the variance in actual 
behaviour. That said, Webb and Sheeran's (2006) meta-analytical results add a 
surprising element to the argument, finding that when intention was actively 
manipulated, it appeared to impact behaviour that was measured objectively twice as 
much as self-report, d = +0.67 and d = +0.30 respectively. 
In regard to studies about controversial topics, such as sexuality or substance use, 
the question about responding in a socially acceptable manner often occurs. Amongst the 
possible distortion of responses are self-deception and impression management even 
under anonymous conditions (Meston, Heiman, Trapnell, & Paulhus, 1998). Various 
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social desirability scales have been developed and used over the years, but non-TPB 
related studies over large samples have shown little support of their validity or 
practicality (Leite & Beretvas, 2005; Piedmont, McCrae, Riemann, & Angleitner, 2000). 
Thus, the most pragmatic way to minimise social desirability biases in responding may 
still simply be to assure the participants of their anonymity and by assessing as many 
relevant variables as possible to attain a consistent and comprehensive result. 
Whilst the TPB is by no means infallible, it appears to be one of the most 
reliable and sound social cognition models at this time. However, due to its underlying 
assumption of rational processes, the basic TPB model may not be sensitive enough to 
attitudinal or intentional changes in substance use behaviours as a result of a short 
exposure to related health promotion information. An extension of the TPB model by 
incorporating PWM variables may be able to explain and predict substance use 
behaviours among the younger population in particular more robustly. 
6 Conclusion/practical implications 
In a hard hitting commentary about the evaluation of the Australian Illicit Drug 
Diversion Initiative (IDDI), Hughes (2007) contrasted how evidence was used to design 
the program but political concern guided the framing of the initiative, especially in 
avoiding the appearance of condoning illegal substance use. Among the reasons why 
Hughes asserts political objectives as being inferior to evidence-based best practice, are 
untenable expectations and inappropriate evaluation criteria such as 'saving or changing 
lives' rather than reducing harm in relation to drug use. However, the author 
acknowledged the socio-political realities and asserted that a careful balance must be 
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stuck between political considerations and pragmatic evidence- based objectives in such 
endeavours. 
On that note, it is clear that simplistic measurements of message recall and 
knowledge of substance effects, such as those used to evaluate the success of Australia's 
recent NDC, are inadequate to gauge the impact of health promotion media on substance 
use behaviours. In order to evaluate the impact of health promotion dissemination 
satisfactorily, the literature is unequivocal about the need to measure a wider range of 
variables that can predict target behaviours more accurately, such as those incorporated 
within the TPB framework. In addition to that, it is also important to assess other 
pertinent variables which can clarify and explain the driving factors of such behaviours 
in specific target populations, for example, the PWM components, particularly in 
younger target populations. 
Specifically, substance-related health promotion information on the internet 
appears to be a neglected area of research. For a medium which appeals to a broad base 
on young people, who are typically the main target of such health promotion material, it 
is unfortunate that it is not studied in more depth. In an era of evidence based practice, it 
is imperative to examine the effectiveness of this mode of delivery of information in 
detail, particularly given that $32.9 million has been allocated to drug education efforts 
in the 2007-2011 Australian NDC. As the research reviewed above suggests, education 
campaigns that are currently delivered on the internet may very well increase, decrease 
or have no significant impact on the substance use behaviours of those viewing the sites. 
Additionally, as the internet is one of the most popular sources of substance-
related information today (e.g. Boyer, Shannon, & Hibberd, 2005; Brewer, 2003; Falck 
et al., 2004; Matthews & Bruno, 2007), it would be highly beneficial to know what 
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effects these materials have on the audience and how they can be refined for ongoing or 
future substance-related health promotion information on the internet. Thus, in light of 
the discussions in the sections above, it is proposed that using the extended model of the 
TPB detailed in this review would be an effective and comprehensive framework for 
measuring the practical impact of fear-based versus harm-reduction streams of drug 
information on the internet. Ideally, findings derived from such an investigation would 
be both comprehensive and highly predictive of substance use behaviour, therefore 
presenting pragmatic results and minimising the influence political considerations in 
regard to assessing the efficacy of these two approaches to drug education on young 
people via the internet. 
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reduction Drug Websites 
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Abstract 
For many young persons, the internet is a primary source on information regarding 
substances, such as ecstasy (methyelenedioxymethamphetamine, MDMA) and 
gamma-hydroxy-butyrate (GHB), and is increasingly being used by agencies to 
disseminate education massages about drugs. Despite the numerous substance-related 
websites on the internet, very little is known about their impact. An extended model 
of the Theory of Planned Behaviour (TPB) was assembled to assess the practical 
impact of internet-based drug education campaigns, in particular, the differences 
between websites that are based on hann-reduction (i.e. which provide information 
about both positive and negative effects of substances, as well as means to avoid 
harm should people choose to use them) and fear-based (i.e. which primarily use fear 
appeals to discourage people from using substances) materials. To examine this 
question, a laboratory experiment was conducted in which drug-naive participants 
aged between 18 and 25, were randomly assigned to browse through either harm-
reduction or fear-based websites for information on MDMA and GHB in order to 
advise a hypothetical 'friend' who was intending to use these drugs. Short-term 
effects of treatment include sharp increases in knowledge in both site-type 
conditions, and a moderate decrease in attitudes, but increased behavioural 
willingness, to use ofMDMA in the fear-based condition. After two weeks, only 
knowledge gain was sustained, whilst participants reading harm reduction sites 
showed a significant delayed reduction in willingness to use GHB. The findings 
suggest that young persons who have never used MDMA or GHB before, derive 
almost equal benefit from both fear-based and harm reduction websites. Importantly, 
providing harm reduction information did not increase the likelihood that consumers 
would use MDMA, and significantly decreased their likelihood of GHB use. The 
findings also supported the utility of the proposed extended TPB model in empirical 
assessments of drug education websites. 
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1.1 Major drug education philosophies 
At a global level, drug education generally falls into the philosophies of a 
moral/abstinence-based approach to drug policy, which has the primary aim of 
achieving an abstinent population, or pragmatic public-health based approaches, 
based on the precepts of harm-reduction, that aim to reduce the net community level 
of morbidity associated with drug use, including among people who continue to use 
such substances. 
Moral/abstinence approaches to drug education typically apply campaigns 
based on fear arousal. Such fear-based campaigns are established upon the idea that 
fear strongly motivates people to avoid negative consequences by altering their 
attitudes (Rogers, 1975). A fear-based drug education campaign would highlight 
negative facets of substance use to the extent of accentuating extreme but rare events, 
whilst minimising and ignoring any positive effects (see Figure 10 for example). A 
common example would be heralding cannabis as a dangerous 'gateway drug' that 
quickly leads to the use of other 'harder' drugs such as morphine and amphetamines 
(Hall & Lynskey, 2005), but not acknowledging that some find significant pleasure 
in its use (Chambers, Connor, & McElhinney, 2005). 
This approach remains very popular as the primary framework in large 
campaigns such as the National Youth Anti-Drug Media Campaign (NYADMC) in 
the United States (Orwin et al., 2006), which is one the largest campaigns of its kind, 
as well as the National Drug Campaign in Australia (Pennay et al., 2006). However, 
evidence for the success of these fear-based campaigns have been mixed, with 
indications of high exposure and recall by target audiences in both campaigns; but 
little signs of positive behavioural change, and in fact, signs of weaker anti-drug 
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social norms and significantly higher rates of cannabis initiation in youth groups 
after exposure to the NY ADMC (Orwin et al. , 2006). 
Figure 10. Example of online fear-based campaign material from 
www.drugfreeworld.org (Foundation for a Drug-Free World , 2007). 
Harm-Reduction, which is defined as "a policy or programme directed 
towards decreasing adverse health, social and economic consequences of drug use 
even though the user continues to use psychoactive drugs at the present time (Single, 
1995, p.239)", is typically acknowledged as the primary alternative to fear-based 
drug education policy. A typical example of harm-reduction information would 
include discussion about the prevalence of a particular substance, as well as 
descriptions of the different effects of the substance, both positive and negative (see 
Figure 11). Subsequently, strategies to avoid harm should people decide to use the 
substance would also be suggested, for instance, providing tips to avoid or to 
overcome an overdose. Often seen as politically controversial, harm-reduction 
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presents itself as a pragmatic policy that seeks to manage immediate issues but does 
not impose any long-term objective (House of Representatives Standing Committee 
on Family and Human Services, 2007; Single, 1995), and in the last several decades 
has slowly gained more acceptance among policy makers across the globe (e.g. 
Hawks & Lenton, 1995; Home Office, 2006; Ritter & Cameron, 2006). 
ecstasy dangers 
more peo ple die fro m 
peanut alle rgies than 
fro m MDMA 
pi ctu re : m.fil!.Q 
ecstasy effects 
The risk of death from Ecstasy use is 
extremely low. Between 1988 and 1997 
some 50-100 UK deaths have been 
connected to Ecstasy use. The current 
rate is 7 deaths per million users per 
year. More people die fishing or eating 
peanuts. 
The US figures are much lower, only one death 
per million users, largely due to the enduring 
preference for warehouse or outdoor parties 
rather than hot packed-out nightclubs . There is 
also less of a booze culture amongst American 
kids. Most E-related deaths are related to 
alcohol-consumption and over-heating . 
.... top 
overheating 
The most common cause of Ecstacy -related 
death is overheating (hyperthermia). MOMA 
1nterfers with the body's ability to 
thermoregulate itself, allowing the body to 
overheat without discomfort and other warning 
signs, especially when dancinQ for hours in hot 
dubs. 
In a worse case scenario, the body can reach 
extreme temperatures (41-42°C) - a severe 
heatstroke which causes unpredictable and 
often medically-untreatable problems, including 
unstoppable bleeding, liver and kidney failure 
and ultimately death. Not the nicest way to go . 
Most fatalities occur amongst inexperienced 
users, who have not learnt how to read the 
body's response to Ecstasy. 
Drinking alcohol heavily also disrupts your body 
temperature, making Ecstasy-related 
over-heating much easier. Avo id alcohol 
All users should be familiar with safe dancing 
practices . 
MOMA produces intense feelings of 
pleasure, empathy, warmth, and 
hap·piness. It also increases sensitivity 
to music, makes peopte more 
emotionally open, and has a 
stimufating, speedy physical effect. 
When ecstasy is swallowed, the full effect is 
usualty felt within one hour. It starts with 
tingling and little rushes of exhilaration . Some 
people may experience nausea or dizziness 
whire coming up but it quickly passes. 
The effect builds quickly, coming on in waves 
within the first two hours, strengthening with 
each pass. A lightness of mood and relaxation 
gives way to waves of physical pleasure, 
euphoria, openness and empathy to others 
around you. The awareness of touch is 
strongly heightened. The muscles relax. 
The peak arrives and then the effects last 4-6 
hours, with a gradual tapering come-down in 
the last two. 
Jaw clenching and "clamping" is a common 
side-effect of E and many people get relief by 
chewing on dummies or gum, smoking 
cigarettes or sucking lollies. 
Figure 11. Example of online harm-reduction campaign material from 
www.thegooddrugsguide.com (The Good Drugs Guide, 2008). 
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1.2 Understanding the impact of drug education campaigns by use of an 
extended Theory of Planned Behaviour model 
The efficacy of drug education campaigns are not easily gauged as different 
stakeholders often use different criteria. Midford (2007) notes that key outcome 
measures that are not objective and behaviour-dependent can be susceptible to 
political and moral influences, which are usually unsupported empirically. Hawthorne 
(2001) argues that whilst there might be disagreements between advocates and 
researchers about what the key criteria should be, it would be ill-advised to disregard 
public health measures of substance [ mis ]use, such as the change in actual substance 
use behaviour, prevalence of drug-related diseases, accidents and/or fatalities. 
Nonetheless, it might not always be feasible, or indeed possible, to assess actual 
behavioural changes due solely to the exposure to drug education. Thus, a 
compromise may sometimes be necessary to take the stead of behavioural indicators. 
This noted, insufficient and/or superficial measures such as attitude change, 
which have been shown to have indirect and complex links with behaviour (Cooke & 
Sheeran, 2004; Glasman & Albarracin, 2006), have commonly been used as a 
measure of success of campaigns. Solely measuring attitudinal change for instance, is 
grossly insufficient to forecast or indeed proclaim any behavioural changes. There is a 
substantial literature empirically demonstrating that many variables mediate the link 
between attitudes and behaviours. From these, several social cognition theories have 
been demonstrated to usefully explain and predict behaviour in a health-related 
context, among the more prominent are the Protection Motivation Theory (PMT), the 
Health Behaviour Model (HBM), the Theory of Reasoned action (TRA), the Theory 
of Planned Behaviour (TPB) and the Prototype/Willingness Model (PWM) (Azjen, 
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1991; Gibbons, Gerrard, Blanton, & Russell, 1998; Harrison, Mullen, & Green, 1992; 
Milne, Sheeran, & Orbell, 2000). 
It would appear prudent to evaluate the outcomes or indeed successes of drug 
education campaigns based on an appropriate behavioural model that would ideally be 
able to predict and explain substance use behaviours in lieu of measuring actual 
behavioural changes. Moreover, the said model may then also be used prospectively 
in formulating health promotion materials to target key variables that are likely to 
affect behavioural change (Ogden, 2003; Webb & Sheeran, 2006). However, with the 
numerous behavioural models found in the literature, it can be an onerous task to 
identify one that suits the needs of studying a specific behaviour, in a particular 
context. Whilst, it would be misguided to assume that there is a perfect model that can 
explain and predict behaviours under all circumstances without fail, it would be vital 
to establish one that is suitable for the proposed purpose. 
Unlike the PMT and HBM, which are fairly limited to health-related 
behaviours such as taking flu vaccinations and performing breast cancer screening, 
the TRA and TPB have been found applicable towards a myriad of behaviours 
including exercising, condom use, leisure activities, drink driving and job seeking 
(Hardeman et al., 2002). The TRA is derived from the premise that humans are 
rational beings who are strongly shaped by the information provided to them 
(Fishbein & Ajzen, 1975). The model posits that a voluntary behavioural intention is 
the best predictor of overt behaviour, and that an individual's attitudes and subjective 
norms would form this intention. In the context of using psychoactive substances for 
instance, the probability of someone intending to use a substance would be high if the 
person had a positive view of the drug as well as perceiving the use as socially 
acceptable by significant others. 
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Two decades after its inception, Ajzen (1991) proposed an expanded TRA, 
named the Theory of Planned Behaviour (TPB), by including another major factor 
known as perceived behavioural control (PBC), which is an individual's sense of 
control or command over performing an action, to overcome the original model's 
shortcomings in explaining and predicting non-volitional behaviours. These three 
factors - attitude, subjective norms and PBC - were proposed to together influence an 
individual's intention to carry out a particular behaviour, which in turn was 
hypothesised to be a good predictor of how likely it is that the actual behaviour will 
be executed. The TPB has been accepted in the research community as a natural 
replacement for the original model after being found to be superior to the TRA in 
numerous studies, and is arguably the most commonly used attitude-behaviour model 
to date (Ajzen, 1991, 2002b; Armitage & Conner, 2001; Ogden, 2003). 
Attitudes 
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Norms 
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Behavioural 
r.nntrnl 
Behavioural 
Intention 
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Figure 12. A visual representation of the Theory of Planned Behaviour (TPB). 
In an extensive meta-analysis of 185 independent studies, Armitage and 
Conner (2001) found that the TPB model could account for 39% of the variance in 
intention, 38% for self-reported behaviour and 27% for observed behaviour over a 
range of target behaviours. TPB studies in the area of substance use behaviours, which 
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typically included minor extensions or additions in the model, support the model's 
efficacy in predicting medium-to-large proportion of the variance in intentions and 
behaviour, ranging from 17% to 88% depending on the population and the target 
substance (Armitage & Conner, 2001; Conner, Sherlock, & Orbell, 1998; McMillan & 
Conner, 2003; Orbell, Blair, Sherlock, & Conner, 2001). 
Whilst the literature suggests that the original TPB model would be sufficient 
as a theoretical framework to base the efficacy of substance-education campaigns, 
large numbers of TPB studies that have incorporated additional variables in various 
settings, including in the prediction of substance use, demonstrate that there are 
potential ways of improving the predictive power of the TPB model. As the model 
grows and evolves, it becomes ever more important to clarify the operationalisations 
of the key variables as well as the methods of eliciting them. 
Ajzen (2002) and Francis et al.'s (2004) proposed that the key variables of the 
model can be elicited via both direct (global measurements) and indirect measures 
(aggregations of relevant sub-components) to provide a more comprehensive 
assessment of the construct. Although direct and indirect measures are highly 
correlated, they are based on different premises of the fundamental cognitive 
framework. Furthermore, the efficacy of the direct and indirect measures is dependent 
on various factors such as the target behaviour, social desirability biases, sample 
population, context and operational definitions of key study variables (Armitage, 
1999; Conner, Sherlock, & Orbell, 1998). For instance, if attempting to gauge 
people's attitudes towards immigrants, the indirect way of measuring attitude, would 
firstly involve asking respondents about the perceived impact of immigrants in the 
society. Secondly, they would be asked about the pros and cons about these impacts. 
This indirect manner of eliciting people's views may sometimes provide additional 
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information over simply asking people directly about their attitudes towards 
immigrants. 
Whilst applying more comprehensive assessment approaches may be helpful 
in improving predictive power of the TPB model, it is more crucial that the variables 
measured match the specific target action as well as context in order to achieve strong 
correlations and internal reliability (Ajzen & Fishbein, 1977; Eagly & Chaiken, 1993). 
For instance, ifthere was a study on the smoking cessation in cars with young 
children was being conducted, a general attitudinal question such as "how appropriate 
is smoking?" would be insufficient. The question would need to be highly detailed 
such as "how appropriate is smoking in a car in the presence of young children?" The 
same context and specificity would then need to be applied to other variables. 
Attitudes are generally accepted to be summary evaluations of a target object 
or behaviour, which comprise of cognitive and affective components (Ajzen & 
Fishbein, 1977; Eagly & Chaiken, 1993; Petty, Wegener, & Fabrigar, 1997). 
Nonetheless, the TPB deems that these evaluations are principally the products of 
cognition (Ajzen, 2001) and the proposed indirect measures of attitudes, i.e. 
behavioural beliefs, which is the product of outcome evaluations (e.g. "having slow 
reaction time is very undesirable") by salient belief strengths (e.g. "using cannabis 
will slow my reaction time"), primarily taps cognitive aspects of attitude, leaving the 
affective component of attitude largely unassessed. 
Moreover, attitude has, for the most part, been conceived as existing along a 
bipolar spectrum of completely negative to completely positive. However, a high 
degree of ambivalence, defined as having inconsistent beliefs, conflicting emotions or 
opposing thoughts and affect (Ajzen, 2001; Eagly & Chaiken, 1993), would cause the 
salient attitude to be relatively malleable and unstable even if specific components of 
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an attitude are strong (Eagly & Chaiken, 1993; Thompson, Zanna, & Griffin, 1995). 
For instance, if an individual really enjoys using cannabis but at the same time 
believes very strongly that is it inappropriate to use it, the individual may be easily 
swayed either way depending on time and circumstances. Thus, measuring 
ambivalence in addition to attitudes proper would likely assist in elucidating the role 
of attitudes in a behavioural model (Petty et al., 1997). 
In regard to attitude, as it is defined within the TPB, knowledge may appear 
very similar to the concept of behavioural beliefs. Ajzen (1991) stated that in relation 
to attitudes toward a particular behaviour, beliefs are linked to the outcomes or other 
relevant attributes of the behaviour. However, it is implied that an individual's beliefs 
may be merely based on a person's assumptions; whereas knowledge is defined as 
information that is true and based on verifiable evidence. Thus, aside from being a 
common measure in the outcome studies of drug campaigns, knowledge about a 
drug's effect may also influence behavioural beliefs (as a component of attitude) 
regarding the drug within the framework of the TPB. 
Ajzen (1991) represents subjective norms in the TPB as the social element of 
perceived pressure to behave, for example, such as whether significant others approve 
of using alcohol regularly. In addition to direct and indirect measures of subjective 
norms, descriptive norms - defined as the proportion of an individual's social circle 
that perform the target behaviour - which captures the indirect relation between a 
behaviour and the referent group's approval of it, have been showed to a useful 
additional social predictor of intention, including in studies examining substance use 
behaviours (Conner et al., 1998; McMillan & Conner, 2003; McMillan, Higgins, & 
Conner, 2005; Rivis & Sheeran, 2003). Moral norms, defined as the perceived moral 
correctness of a certain behaviour, have also been proposed as a meaningful variable 
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in behaviours that have high perceived moral or ethical implications such as cheating, 
shoplifting, and substance use, explaining small increases in variance of up to five 
percent of intention (Armitage & Conner, 2001; Azjen, 1991; Conner & McMillan, 
1999). 
Perceived behavioural control (PBC) is inclusive of self-efficacy, which is the 
assumed controllability and degree of ease or difficulty in performing a particular 
behaviour, namely beliefs about the amount of influence the individual has in carrying 
out an action (Azjen, 1991, 2002). In a study on MDMA use, Orbell and colleagues 
(2001) divided PBC into two components; PBC over obtaining (PBC-obtain) the 
substance, as well as PBC over consuming the drug (PBC-take ), which each added 
7% of unique variance to the prediction of intentions. This suggests that, for substance 
use behaviours, Orbell and colleagues' operationalisation of PBC may evoke a 
broader set of controllability and self-efficacy effects within the model. This may due 
to the fact that the difficulty in substance use is not only limited to the use of it, but 
also due to its illicit nature, such substances are generally difficult to attain, which 
subsequently influences the likelihood of subsequent use. 
In the TPB, behavioural intention is the antecedent variable of volitional 
behaviour which is expected to encapsulate the primary factors that direct a behaviour 
(Azjen, 1991). TPB studies on substance use behaviours have shown that intentions 
explain between 51 % to 72% of variance in actual behaviour after mediation by PBC 
(Conner & McMillan, 1999; Johnston & White, 2003). However, Webb and Sheeran's 
(2006) meta-analysis found that a medium-to-large change in intention only generates 
a small-to-medium change in behaviour, suggesting that the effect size of intention on 
behaviour may be smaller than correlational tests have represented. Nonetheless, it 
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would appear that behavioural intention would be a crucial factor to measure in an 
evaluation of any drug education campaigns. 
Whilst empirically shown to be fairly robust, the TPB is handicapped in 
certain contexts due to its fundamental premise that individuals are rational beings. To 
elaborate, Ajzen and Fishbein (2005) concede the that the TPB may be limited where 
there exists erroneous information, strong affect, intoxication or a lack of voluntary 
control. Moreover, intentions have been found to be less predictive of risk behaviours 
as compared with health-protective ones when performed in social contexts (Webb & 
Sheeran, 2006). Gibbons and colleagues (1998) have since developed an extension or 
variant of the TPB known as the Prototype/Willingness Model (PWM) which adopts 
the TRA's original variables but adds two key predictors, namely prototype and 
behaviour willingness, to fill this gap. The PWM is proposed as a model that is best 
suited for predicting behaviour that occurs in reaction to opportune events. In studies 
of health risk behaviour among young persons, it has been shown to explain between 
one and seven percent of the variance in behaviour after past behaviour and 
behavioural intention have been taken into account (Gibbons, Gerrard, Blanton, & 
Russell, 1998; Gibbons, Gerrard, Ouellette, & Burzette, 1998; Rivis & Sheeran, 
2003b). By integrating the strengths of both the PWM and TPB, a combined model 
may be superior for understanding the effects of different models of drug education: 
while the TPB would theoretically tap the rational component of substance use 
behaviours, the PWM variables could additionally assess the social and contextual 
influences on these acts. 
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Figure 13. Theory of Planned Behaviour model enhanced to include variables from 
the Prototype/Willingness Model. 
In the PWM, behavioural willingness is understood to be an inclination to 
engage in a particular behaviour at an opportune moment, which one may not 
particularly seek out (Gibbons, Gerrard, Blanton et al., 1998). The difference between 
behavioural willingness and behavioural intentions is that the former is more strongly 
related to positive predispositions and social acceptance, as opposed to the more 
active decision of the latter (Gibbons, Gerrard, Ouellette et al., 1998). For instance, a 
high behavioural intention in regard to substance use would be reflected in an instance 
where someone actively planned to smoke cannabis during the weekend, whereas in 
the case of high behavioural willingness, the person may not actively plan to do so, 
but during a night out with friends, is likely to take opportunities to use cannabis if 
they arise. 
Another novel variable that is proposed in the PWM is prototype, which is 
conceptualised as a collection of social images of typical persons who carry out a 
particular behaviour, and is measured on bipolar adjective descriptors such as 
"responsible-irresponsible" or "unpopular-popular" (Gerrard, Gibbons, Stock, Lune, 
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& Cleveland, 2005). Positive prototypes of people performing risk behaviours tend to 
be associated with an increased willingness to engage in such behaviours, which 
subsequently predict a higher likelihood of actual behaviour (Gerrard et al., 2005; 
Reyna & Farley, 2006; Thornton, Gibbons, & Gerrard, 2002). 
Among several other variables that have been commonly added to TPB studies 
in health-related areas are habit and past behaviour which have been found to be 
significant moderators in the model, as well as explaining additional variance in 
intentions, willingness and behaviour (Gibbons, Gerrard, Blanton et al., 1998; 
Norman & Conner, 2006; Orbell et al., 2001; Webb & Sheeran, 2006), suggesting that 
these variables have to be controlled for, or manipulated. Another useful consideration 
is the temporal stability of key variables, namely assessing the constancy of the said 
scores over several time intervals. This is important as consistent and stable 
components have been shown to exhibit more resistance to contextual changes and 
other mediating factors, thus increasing its predictive power (Ajzen, 2002; Webb & 
Sheeran, 2006). Similarly, ifthe model's key constructs are found to fluctuate 
significantly over time, behaviour predictability based on the model would be 
severely compromised (Webb & Sheeran, 2006). 
As discussed in the literature above, it is important for drug education 
campaigns to be assessed objectively and empirically in terms of their efficacy in 
affecting behavioural outcomes. However, due to various constraints, measuring 
actual behavioural changes may not be feasible in practical situations. On the other 
hand, measuring superficial variables such as recall do not suffice for the assessment 
of outcome either. Fortunately, social cognition models like the TPB have been shown 
to be successful in bridging this gap between validity and practicality. The numerous 
TPB studies as discussed above have strongly suggested that incorporating additional 
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predictors to the basic TPB model would be advantageous for application in the area 
of substance use. This study proposes that a literature-based extension of the TPB 
model would be a more comprehensive manner of understanding and measuring the 
efficacy of drug education materials. The proposed model is depicted in Figure 14 
below. 
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Figure 14. Proposed extended TPB model for the assessment of the effects of drug 
education programs. 
1.3 The Elaboration Likelihood Model of persuasion 
The proposed extended TPB model implies that changing a person's substance 
use behaviour via drug education necessarily requires a change in at least of one of the 
basic constructs of knowledge, attitudes, norms, perceived behavioural control and 
ultimately, intention and/or willingness. Persuasive messages are generally designed 
to change the recipient's beliefs, attitudes or intentions (Fishbein & Ajzen, 1972), and 
possibly the most notable persuasion paradigm is the Elaboration Likelihood Model 
(ELM) (Crano & Prislin, 2006). 
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The ELM asserts that a message's persuasiveness fundamentally depends on 
the motivation and capacity of the audience to process it, and is operationalised as 
elaboration likelihood (Petty & Cacioppo, 1986).The model suggests that when 
elaboration likelihood is high, i.e. when an individual is highly motivated and able to 
process a message, a proposed 'central route' of information processing is utilised. 
When elaboration likelihood is low, i.e. when an individual is umnotivated and/or 
unable to process a message, a 'peripheral route' is used instead. Petty and Cacioppo 
(1986) state that according to the ELM, attitude change appears to be stronger, longer 
lived and more predictive of behaviour when educational messages are processed via 
the central route as compared to the peripheral route. Thus, if the goal of drug 
education campaigns is to produce significant attitudinal and behavioural shifts, then 
it is critical to ensure that the materials are processed through the central route. 
The ELM has an exhaustive list of source factors such as credibility, 
attractiveness; message factors such as number of arguments, discrepancy; audience 
factors such as demographic differences, past experience; and other variables that may 
mediate attitudes depending on the context of the persuasion process. In particular, 
source factors and other secondary variables play a more significant role however, 
when elaboration likelihood is moderate or low (Petty & Cacioppo, 1986). 
A distinctive characteristic of fear-based drug-education materials is the 
extreme use of single-sided messages that predominantly, or even solely, describe 
these substances negatively. As the name implies, they attempt to elicit fear so as to 
discourage the audience from using these substances. Harm-reduction materials on the 
other hand, tend to present a more comprehensive view of drugs, including both 
negatives and the positives, and do not place particular value judgements on either. 
Several studies have shown that whilst having a relatively small influence, the most 
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effective persuasive messages are two-sided with rebuttal about the discounted side, 
followed by one-sided messages, and that two-sided messages with no refutation are 
the least powerful (e.g. Allen, 1991; Hale, Mongeau, & Thomas, 1991). This would 
imply that fear-based materials could be found as more persuasive than harm-
reduction materials as the former is one-sided, whilst the latter is two-sided with no 
refutation. 
The ELM however, elaborates the topic further by noting the interactions of 
message-sided with audience motivation (Petty et al., 1997), whereby when highly 
motivated to process the information, only argument quality influences intentions. On 
the other hand, under low motivation, two-sided messages with rebuttal draw more 
favourable intentions but argument quality has less influence. Under moderate 
motivation conditions, comparative messages tend to elicit more favourable scrutiny 
than non-comparative ones. This would suggest that if disseminating drug education 
indiscriminately via the mass media to audiences who may or may not be motivated to 
process the materials (i.e. generally under low to moderate levels of motivation to 
process the information), information about both the positives and negatives of drug 
use should ideally be presented, but with either moderate discounting of the positives 
effects, or restrained emphasis of the negative effects. 
Fear appeals that trigger strong emotions can be a persuasive tool to displace 
positive attitudes towards a particular object or behaviour if judged to be reasonable 
by the audience (Dillard & Anderson, 2004; Walton, 2006). However, if a persuasive 
message is perceived as being grossly exaggerated, especially to the extent of eliciting 
fear, the recipient may find it manipulative and actively dismiss it (Brown, 2001 ). The 
rejection of persuasive messages, also known as psychological reactance, has been 
found to be more common with people aged between adolescence to early adulthood -
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the prime target of drug education campaigns, and also with males more than females 
(Bushman & Cantor, 2003; Ringold, 2002). 
The ELM asserts that source credibility plays a more significant role in 
affecting persuasiveness when elaboration likelihood is low (Petty & Cacioppo, 
1986). When it is high, credibility plays a far smaller role because the content and 
merits of a message are perceived as more important than the credentials of the 
source. This suggests that in key target audiences, such as teenagers who may not be 
particularly interested in seeking drug-related information, they may be more 
accepting of information if they perceive the source as credible, for example, an older 
friend whom they think is streetwise and will tell them the bare facts; or declared 
'experts' in the field, such as doctors or drug researchers. 
In a non-ELM related study, Hong (2006) found that the intention to revisit 
tobacco cessation websites was strongly correlated with the sites' perceived 
credibility. In Hong's study, the dimensions of depth and trust/expertise were found to 
be significantly linked to intention whilst fairness and goodwill were not. The latter 
two dimensions may possibly play a more significant role in websites that are based 
on controversial topics such as substance use information. In relation to harm-
reduction and fear-based drug education campaigns, if credibility was operationalised 
as per Hong's study, it could help clarify how audiences perceive them. 
Hypothetically, one could argue that credibility comes from perceived authority, and 
fear-based materials could attain credibility by presenting 'expert' opinions. However, 
harm-reduction materials could also be arguably more credible because they are more 
transparent and present more complete and accurate information. Nonetheless, in 
addition to credibility of health promotion materials on the internet, website design 
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and attractiveness is also found to have a substantial influence on the intention to 
revisit websites (Rosen & Purinton, 2004). 
Overall, these frameworks suggest that there are many subtleties in drug 
education and that a tailored approach is very important. The literature would 
certainly suggest that drug educators must understand their target population well in 
matters including like demographics, motivations and cognitive abilities. While the 
extended model of the TPB might be helpful in explaining and predicting the 
pathways to actual behaviour, the ELM's theoretical framework of persuasion might 
be used to illustrate and better understand the impacts of the two different streams of 
drug education on particular sample groups, in specific contexts. 
1.4 The internet as a primary source of information on substances for young 
persons 
Whilst there is much research on the impact of community-based or 
nationwide anti-drug programs, many youth attain substance-related information 
through other means - and the internet is one such information pathway which has 
gained much popularity and impact in recent times. 
A study (Brewer, 2003) on both "club drug" users (consumers of drugs such as 
MDMA, methamphetamine, ketamine or gamma-hytlroxy-butyrate) and non-club 
drug users from an American university showed that 89 out of the 117 participants 
have searched for club drug information on the internet before. A survey ofMDMA 
users in a United States metropolitan city by Falck, Carlson, Wang and Siegal (2004) 
showed that among various sources of substance-related information, 'non-
government drug websites' (which were primarily harm-reduction based) ranked 
second only to friends as most important, although these websites were rated lower 
than drug use treatment programs and physicians in terms of perceived accuracy. 
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Interestingly, these non-government websites were rated higher than governmental 
sources (which were primarily fear-based) in both importance and accuracy by these 
participants. Furthermore, four times as many of the MDMA user sample visited the 
non-government drug websites as they did government web sites. 
An ongoing study of the trends of MDMA and other related drugs in various 
Australian states (Matthews & Bruno, 2006, 2007) found that a significant proportion 
(45% in 2005, 36% in 2006 and 46% in 2007) of the frequent MDMA users 
interviewed reported having recently searched the internet for information on MDMA 
or other similar drugs. Out of 12 websites listed in the survey, the three most popular 
websites were harm-reduction websites (i.e. www.pillreports.com, www.erowid.com, 
and www.bluelight.com). 
A qualitative study by Boyer, Shannon and Hibberd (2005) on 12 youths 
involved in treatment for substance use problems at health centres found that all of 
had used the internet to gain information about psychoactive substances before, and 
whilst 10 preferred non-government websites (primary harm-reduction based), only 2 
accessed government anti-drug sites and/or general medical sites. All of these 
adolescents had modified 'their consumption behaviours after reviewing this 
information; however such responses were extremely variable, ranging from 
discontinuation of use of a particular drug, initiation into use of new drugs, to using 
this information to reduce the health risks associated with the consumption of 
particular drugs. These cases suggest that information about illicit drugs on the 
internet will not necessarily lead to an increased likelihood of use of particular drugs, 
but may also lead to increases in health-protective behaviours amongst consumers. 
Overall, these qualitative and quantitative studies overwhelmingly suggest that 
existing substance consumers tend not to use fear-based websites, and are far more 
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responsive to harm-reduction websites. Nonetheless, it remains mostly untested as to 
how drug-naive participants (individuals who have never used the target substances 
before) would react to these two different types of websites. They may respond in a 
similar manner to substance users and seemingly disregard fear-based information, or 
may indeed respond favourably to them because the message is congruent with their 
current attitudes and behaviours (Hyman & Sheatsley, 1947). 
Besides gauging the preferences of audiences towards either harm-reduction or 
fear-based websites, it would also be important to examine how drug education 
websites affect the recipients. Brewer (2003) conducted a post-test only study (N = 
117) where participants (comprising of both users and non-users of 'club drugs') in an 
experimental group were given a scenario whereby a very close friend had started 
using 'club drugs' such as MDMA as well as methamphetamine, and they were then 
asked to search the internet for information on these drugs. The experimental group 
was given 40 minutes to search online club drug information via several search 
engines, whilst the control group were asked to search for information on genetically 
modified foods. The results indicated that for drug-naive participants, searching 
increased knowledge and made attitudes toward the target substances less negative 
relative to the control condition. Brewer proposed that non-users were probably more 
accepting of new views because they were likely to still be forming their opinions on 
a health behaviour that was relatively new for them. 
Whilst Brewer's results (2003) showed that internet searching increased 
knowledge as well as attitudinal 'permissiveness' towards club drug use, it found that 
it did not affect 'attitudes towards future use' (a variable presented by the researcher 
as a form of behavioural intention). A possible explanation of these mixed outcomes 
may be that the study did not account for the complex association between reported 
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attitude and actual behaviour as discussed earlier in the social cognition models. 
Arguing from a TPB perspective, attitudinal items are simply not sufficient to predict 
behaviour, and furthermore items used in the study appeared to lack contextual 
specificity between each other as prescribed in the model, i.e. the items were of a 
general nature and was not set with a specific context or timeframe, such as "Using 
club drugs would be a good experience" and "The side effects of club drugs are only a 
minor nuisance" (cf. Ajzen & Fishbein, 1977; Eagly & Chaiken, 1993). In addition, 
due to Brewer's post-test only design, difficulties exist in discerning the existence of 
baseline differences in terms of attitudes and knowledge about the target drugs 
between experimental and control groups, as well the temporal stability of the 
identified effects on knowledge and attitudes. 
1.5 MDMA and GHB: Two very different 'club drugs' 
Across Western countries over the last two decades, the use of MDMA 
(methyelenedioxymethamphetamine, 'Ecstasy') and related drugs such as ketamine 
and GHB (gamma-hydroxy-butyrate) appear to have increased (Degenhardt, 
Copeland, & Dillon, 2005). Due to the growing presence of these substances at dance 
events and parties, this cluster of drugs are commonly referred to as "club drugs", 
"party drugs" or "designer drugs". Although there have always been difficulties in 
drawing strong conclusions about drugs' effects in general due to individual 
differences and methodological issues (Britt & McCance-Katz, 2005), research on 
these club drugs have been outpaced by the growth in their popularity and use 
(Maxwell, 2005). 
Among the club drugs, MDMA is among the most popular due its availability 
and reputation (Australian Institute of Health and Welfare, 2005; Degenhardt et al., 
2005; Maxwell, 2005). MDMA can be found in tablet or capsule form and is usually 
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taken orally, but is also sometimes crushed into powder form for snorting or injection. 
Acutely, MDMA primarily affects serotonin neurotransmission but is also known to 
affect noradrenergic, dopaminergic, and cholinergic activity (Britt & McCance-Katz, 
2005). Among the common desired effects ofMDMA use are feelings of empathy, 
increased energy, enhanced sociability, psychomotor drive, self-confidence, sense of 
well-being, positive mood, and heightened sensory awareness, whilst negative effects 
such as anxiety, bruxism, difficulty concentrating, disturbance of balance, 
hypertension and hyperthermia have been reported (Britt & McCance-Katz, 2005; B. 
White et al., 2006). 
When compared with MDMA and the other club drugs, GHB is less well 
studied with most of the data originating from health services data sets, due to high 
levels of morbidity linked to its use (Degenhardt et al., 2005). GHB was initially used 
for legal medical purposes but began to be sold illegally due to its psychoactive 
effects. It is usually sold in liquid form and its effects are very similar to alcohol, 
causing feelings of euphoria, relaxation, anxiety reduction, sleep induction and 
increased libido. Unwanted effects such as dizziness, confusion, agitation, 
unconsciousness, vomiting, tremors, physical dependence, as well as central nervous 
system and respiratory depression are also associated with GHB use (Britt & 
McCance-Katz, 2005; B. White et al., 2006). 
Most notably, Degenhardt, Darke and Dillon (2003) found that in a survey of 
76 GHB users, slightly over half of the sample had overdosed at least once, while a 
third had overdosed three times or more. Accidental GHB overdosing is very 
dangerous and has a high potential to be fatal when coupled with vomiting, which 
may cause choking in one's vomit while unconscious. The commonly regarded 
reasons for such high levels of overdosing among GHB users are due to the difficulty 
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in gauging the actual dosage of a vial of GHB, as well as a very narrow range between 
an effective dosage and an overdose. 
In relation to the utility of the TPB across different drug types, McMillan and 
Conner (2003) asserted that the TPB was effective in predicting the intention and use 
of four different substances - LSD (Lysergic acid diethylamide), amphetamine, 
cannabis, and MDMA. However, the fmdings indicated different relationships 
strengths between the model's components with behavioural intention as well as with 
actual behaviour. The predictive power of the model on actual behaviour also varied 
by drug type, with intention and PBC explaining up to 26% of variance for LSD use, 
40% for MDMA use, 46% of variance for amphetamine use, and 70% for cannabis 
use. Whilst not explicitly mentioned by the researchers, it would appear that the 
predictive power of the model corresponds closely with the relative popularity of 
these drugs; with LSD being one of the least used substances in recent times, followed 
by amphetamines and MDMA which are both relatively equal in use prevalence, and 
finally cannabis, which is the most widely used illicit drug (Australian Institute of 
Health and Welfare, 2005). Whilst this would imply that the extended TPB model 
would have different level of efficacies in regard to MDMA and GHB which differs 
both in popularity as well health risks, it would be interesting to note if, and how, the 
effects of harm reduction and fear-based information would interact with these two 
different drug types. 
1.6 Aims of the current study 
Meta-analyses (e.g. Armitage & Conner, 2001; Webb & Sheeran, 2006) of 
social cognition models, including TPB and PWM, support the notion that a 
reasonable prediction of behaviour is attainable by using these models. This literature 
demonstrates that in addition to the pivotal behavioural antecedents such as intention 
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and willingness, other core components of the models such as attitudes, subjective 
norms, and PBC, should be assessed in order to predict behaviour more accurately. 
Additionally, the TPB has been shown to benefit from the inclusion of 
additional variables for the prediction of health-related behaviours as discussed in the 
sections above. Whilst limiting the TPB to the three main variables to maintain 
parsimony, Ajzen (1991, pp. 199) clarified "that the TPB is in principle, open to the 
inclusion of additional predictors if it can be shown that they capture a significant 
proportion of the variance in intention or behaviour". 
Thus, this study has two principal goals. The first is to establish a pragmatic 
and comprehensive model, primarily based on the TPB, upon which the practical 
impact of internet-based drug education campaigns can be assessed. Secondly, this 
study aims to empirically assess the efficacy of the two divergent drug-related health 
education website types, i.e. harm-reduction and fear-based strategies. 
In regard to the first aim, the current study hypothesises that additional 
variables of descriptive norms, moral norms, knowledge and the division of PBC into 
the obtaining and consuming of the substance, would explain additional variance in 
behavioural intention above and beyond the three main predictors in the original TPB 
(Conner et al., 1998; McMillan & Conner, 2003; McMillan, Higgins, & Conner, 
2005; Orbell et al., 2001; Rivis & Sheeran, 2003a). Furthermore, whilst behavioural 
willingness is a different construct to behavioural intention, they share common 
relationships wi!h the primary predictors to some degree (Gibbons, Gerrard, Ouellette 
et al., 1998). It is thus hypothesised that the additional variables would explain 
additional variance in behavioural willingness as well. 
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H.1 Additional variables of descriptive norms, moral norms, knowledge and the 
division of PBC to PBC-obtain and PBC-take would explain additional variance 
in behavioural intention and in behavioural willingness over the variance 
explained by the three predictors, namely attitudes, subjective norms and PBC, 
used in the TPB. 
The target sample's age group of young adults is within the age range which is 
most likely to exhibit psychological reactance (Bushman & Cantor, 2003; Ringold, 
2002). Furthermore, due to the controversial nature of drug education and most young 
persons prior exposure to other fear-based campaigns, it is hypothesised that most 
participants would perceive fear-based websites as being glaringly exaggerated and 
manipulative; thus actively dismissing it (Brown, 2001 ), and hence, finding the hann-
reduction websites significantly more credible than the fear-based ones. 
H2. Hann-reduction websites will be perceived as significantly more credible 
than fear-based websites. 
As 'club drugs' are one of the most popular drugs among the youth today 
(Koesters, Rogers, & Rajasingham, 2002; Maxwell, 2005), websites providing health 
education about MDMA would be a natural area to examine. However, due to the 
perception ofMDMA as a far more common as well as relatively safe drug 
(Degenhardt et al., 2005; Nutt, King, Saulsbury, & Blakemore, 2007), it might also be 
useful to examine ifthere would be any significant difference in these health 
promotion campaigns on a different drug that is both uncommon and higher in risk 
such as the GHB (Degenhardt et al., 2003). 
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With the literature suggesting that the efficacy of drug education may vary 
tremendously depending on context as well as participant variables, this study will 
focus on a common target audience group of such campaigns, namely young persons 
who have not used certain substances before (e.g. Paglia & Room, 1999; D. White & 
Pitts, 1998). This would control for several possible variables, namely past behaviour 
and habit, as well as age. Furthermore, to control for possible differences in the ease 
of website navigation and attractiveness, selected existing harm-reduction as well as 
fear-based websites will be presented in a standardised format to maintain 
consistency. 
In order to activate the central route of persuasion as per the ELM, a short 
experimental scenario will be presented to participants where they have been asked by 
a close friend to find more information about two particular drugs, MDMA and GHB, 
because the friend was deciding whether or not to try them (see Procedure for the 
precise scenario). It is hoped that this scenario would be sufficient to invoke personal 
relevance and motivation to use the central route of persuasion. 
The dissemination of substance-related information has commonly been shown to 
have effects on participants' knowledge and attitudes (e.g. Brewer, 2003; Pennay et 
al., 2006). However, the TPB and PWM posit that the persuasive material needs to 
change behavioural intention and/or willingness to have any meaningful impact on 
behaviour (Ajzen, 1991; Gibbons, Gerrard, Blanton et al., 1998). Some non-intemet-
based drug education campaigns (e.g. McBride, Farringdon, Midford, Meuleners, & 
Phillips, 2004; Orwin et al., 2006) have shown changes in substance use behaviour 
post-campaign in either direction, which infers, based on the extended model of the 
TPB, intention and/or willingness were also significantly affected. The same findings 
could be extrapolated to online campaigns, thus suggesting that website-based 
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information on substance use could also have effects on the recipients' intentions and 
willingness, as well as their predecessor variable, attitude. 
It is hypothesised that participants viewing fear-based websites would be more 
aware about the negative effects of MDMA and GHB, accounting for a statistically 
significant but small increase in knowledge for both drugs because the information 
presented would be fairly limited (i.e. they would have increased knowledge about 
negative but not positive effects). However, due to a potential lack of credibility and 
perceived exaggeration of the one-sided information, it is hypothesised that there will 
be a reverse effect of persuasion due to psychological reactance, as suggested by 
Ashton (1999) as well as Eagly and Chaiken (1993), for those in the fear-based group, 
which would significantly increase attitude scores to be more positive in regard to use 
of both MDMA and GHB. in light of the large moderating effects of past behaviour 
on the key TPB variables as well as its direct influence on intention, willingness and 
behaviour (Gibbons, Gerrard, Blanton et al., 1998; Norman & Conner, 2006; Orbell et 
al., 2001; Webb & Sheeran, 2006), it is hypothesised that that there will be a 
significant increase in behavioural intention and behavioural willingness, although 
only of small magnitudes due to the sample's salient characteristic of never having 
used either of these drugs before. 
H3a. After exposure to fear-based websites, there will be a significant increase in 
MDMA-related attitudes, related knowledge, behavioural intention and 
behavioural willingness. 
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H3b. After exposure to fear-based websites, there will be a significant increase in 
GHB-related attitudes, knowledge, behavioural intention and behavioural 
willingness. 
It is hypothesised that knowledge about both drugs would increase 
substantially after viewing harm-reduction websites because of the comprehensive, 
two-sided information provided in these sites. It is also hypothesised that participants 
viewing harm reduction websites will have significantly increased (more positive) 
attitudes towards MDMA after being more aware of the positive effects of MDMA 
use detailed in the websites (for example, feelings of well-being, confidence, euphoria 
and social closeness), as was demonstrated by the Brewer (2003) study. However, as 
GHB use is associated with substantially greater health risks (Britt & McCance-Katz, 
2005; Degenhardt et al., 2003), it is hypothesised that participants in the harm-
reduction group would notice this contrast between the two drugs and be more acutely 
aware of the dangers of GHB use, leading to a significant decrease in attitudes 
towards GHB after viewing the websites. 
Given the sample's salient characteristic of never having used either of these 
drugs before, it is hypothesised viewing harm-reduction websites would have 
significant but small effects on behavioural intention and behaviour willingness. 
Specifically, it is hypothesised that that behavioural intention and willingness toward 
MDMA use will increase (following Brewer, 2003), whilst behavioural intention and 
willingness toward GHB use will decrease after treatment. 
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H4a. After exposure to harm-reduction websites, there will be a significant 
increase in MDMA-related knowledge, attitude, behavioural willingness and 
behavioural intention. 
H4b. After exposure to harm-reduction websites, there will be a significant 
increase in GHB-related knowledge, but a significant decrease in GHB-related 
attitude, behavioural willingness and behavioural intention. 
Method 
I. 7 Participants 
A total of 80 undergraduate students at an Australian university participated in 
the study. Most of the participants, who were enrolled in introductory psychology 
units, received course credit for participating whilst those who were not enrolled in 
the units were reimbursed $10 for their participation. There were three inclusion 
criteria for the study, which were being between 18-25 years of age, ability to surf the 
internet and never having used ecstasy or GHB before. The sample comprised of 62 
(78%) females and 18 (23%) males. The mean age of participants was 20 years (SD = 
1.74, range: 18-25). 
1.8 Procedure 
Participants were recruited and allocated to groups in a counterbalanced 
manner to view one of two types of website (either fear-based or harm reduction) at a 
computer laboratory for a total of one hour to complete the first phase of the study. 
This initially involved completing written assessments of demographics and all 
baseline dependent variables (Appendix 1 ). Participants were then presented with a 
written scenario stating:-
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A very close friend is thinking about trying ecstasy (MDMA) and GHB. You 
have agreed to look online to find out more information about these 
substances because you have a faster broadband access to the internet. Your 
close friend would really appreciate your help to find out as much as you 
can about ecstasy and GHB. 
Participants were then asked to browse through a pre-determined list of three websites 
for approximately 25 minutes in total. Subsequently, they completed a post-test 
survey (Appendix 2) and were instructed to complete and submit a follow-up survey 
in two weeks time (Appendix 3). Both the post-test and follow-up survey assessed 
solely the variables of knowledge, attitudes, behavioural intention and behavioural 
willingness. For the purpose of confidentiality and to track the participants across the 
three questionnaires, a unique code identifier was recorded on the questionnaires. 
1.9 Materials and Measures 
1. 9.1 Drug education websites 
The six websites presented in the study had MDMA and GHB related content 
extracted from selected internet websites (updated as of April I i 11 2007) and was 
placed on standardised website formats to control for website design and 
attractiveness (Rosen & Purinton, 2004). In order to select the websites used in this 
process, a group of 10 postgraduate students in psychology independently rated 19 
'live' drug education websites as to their degree of fit with the approach of harm 
reduction or of fear-based information. From this process, the six websites with the 
most uniform assessment in either category were used to provide content for the 
websites used in the experiment. 
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The three websites selected for the fear-based group were from 
www.theantidrug.org, www.drugs.health.gov.au and www.drugstory.org. The three 
websites used for the harm-reduction group were from www.ravesafe.org, 
www.torontovibe.com and www.buzzcode.org. Website extracts are provided in 
Appendix 4. Efforts were made to balance the amount of information presented in 
each website type, however, due to its nature of presenting only limited, one-sided 
information, fear-based sites tended to be briefer than harm reduction sites. 
1.9.2 Assessment of Extended TPB Model Variables 
Seven-point Likert scales, with scores ranging from 1 to 7, were used to assess 
each of the constructs unless otherwise specified. Measures of behavioural intention, 
behavioural willingness, perceived behavioural control, direct measures of attitudes 
and subjective norms were operationalised in the time frame of "the next 2 months"; 
whilst descriptive norms used the timeframe of "the last 6 months", as this would a 
better representation of the factor. In contrast, the assessments of prototypes, 
knowledge, website credibility, moral norms, indirect measures of attitude and 
subjective norms had no specific time frame, because they were independent of time 
and would appear illogical if phrased in that manner. 
The measures were presented in two major sections, the first in regard to 
MDMA, whilst the next in regard to GHB, in each of the three surveys. The pre-test 
survey included covariates such as subjective norms, descriptive norms, PBC and 
prototypes that were assessed solely at pre-test, because the websites are presumed to 
have no impact on these factors. Questions assessing Website credibility (adapted 
from Hong, 2006) were presented only in the post-test, after participants' exposure to 
the websites. TPB measures (attitudes, subjective norms, perceived behavioural 
control and behavioural intention) were created based on the detailed guidelines 
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provided in two TPB questionnaire construction manuals (Ajzen, 2002; Francis et al., 
2004). Items for additional TPB variables were derived from relevant studies, as 
described individually below. Psychometric properties of the survey questions are 
provided in Table 1 below. 
1.9.3 Knowledge 
For the knowledge variable, a large number of facts about MDMA and GHB, 
which could be responded to using true or false statements, were derived from various 
reference sources. Any statements of fact that were controversial (i.e. not consistent 
across all reference sources) were removed from the question pool. The questions 
were then presented to 10 independent psychology postgraduates to answer and their 
difficulty levels were rated depending on the number of correct responses scored. The 
items were counterbalanced in terms of difficulty, and 15 true/false questions for both 
MDMA and GHB were presented in each of the three surveys (pre-test, post-test and 
follow-up). Ten identical questions were repeated in each of the surveys in 
randomised order, and there were five additional unique questions in each of the pre-
test, post-test and follow-up surveys, matched for difficulty. In each survey, 
participants were asked to indicate whether they believed the statements to be 'true', 
'false' or 'do not know'. Only correct responses were scored, and high scores 
indicated accurate knowledge about the said substances. 
1.9.4 Attitude and attitude ambivalence 
Attitudes were measured directly and indirectly. In conjunction with the 
Griffin formula (Costrarelli & Colloca, 2007; Thompson, Zanna, & Griffin, 1995) of 
assessing attitude ambivalence, direct measures of attitudes involved using 4-point 
unipolar split-semantic differential scales that measured positive and negative 
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evaluations separately on three levels: cognitively, affectively and overall. In each of 
the three interval points, participants were presented with two sets of the said scales, 
namely two positive sets and two negative sets (for example, "Considering only the 
positive aspects of using ecstasy in the next 2 months, and ignoring the negatives ... " 
[positive] or "Considering only the negative aspects of using ecstasy in the next 2 
months, and ignoring the positives ... " [negative]). Ambivalence was tabulated as per 
the Griffin formula which was (P+N)/2 - IP-NI, i.e. the polarisation of the positive (P) 
and negative (N) judgements, minus the absolute difference between the two. Higher 
scores, which indicate higher attitudinal ambivalence toward the substances, are 
independent of the attitudinal strength. 
The indirect measure of attitudes, termed as 'behavioural beliefs', was 
assessed through multiplying participants' ratings of 16 outcome evaluation items 
(e.g. Having mood swings would be Bad-Good) by their complementary salient belief 
strengths about the effects of a target drug (e.g. Using ecstasy is Unlikely-Likely to 
cause mood swings). The outcome evaluation items were scored using scales of-3 to 
+3. Positive scores are indicative of favourable behavioural belief toward the 
substance, whilst negative scores are indicative of unfavourable behavioural belief 
toward the substance. 
1.9.5 Subjective norms 
There were three direct measures of subjective norms per drug. Additionally, 
indirect measures of subjective norms were assessed through multiplying normative 
beliefs (e.g. My close friends think I should take ecstasy; Strongly disagree-Strongly 
agree) by motivation to comply (e.g. With regard to ecstasy I want to do what my 
close friends think I should; Strongly disagree-Strongly agree) in regard to four 
reference groups (close friends, family, partners, and health experts). The normative 
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belief items as well as direct measure of subjective norms were scored using scales of 
-3 to +3. Positive scores are indicative of perceived acceptance of use of the substance 
among key referent groups, whilst negative scores are indicative of perceived 
rejection of use of the substance among key referent groups. 
1.9. 6 Descriptive and moral norms 
Descriptive norms of participant's close friends', partners', and family 
members' use of the target substance were also collected (e.g. In the last six months, 
how much GHB have your family members/relatives used?). Descriptive norm items 
were scored using scales of-3 to +3. Positive scores are indicative of higher rate of 
the substance use among key referent groups, whilst negative scores are indicati,ve of 
lower rate of use of the substance among key referent groups. Moral norms 
(McMillan & Conner, 2003) were measured with a single item for each drug, where a 
higher score indicates stronger moral objection to drug use. 
1.9. 7 Perceived behavioural control 
Information in regard to two types of Perceived Behavioural Control (PBC) 
were gathered for each drug; PBC over obtaining the drugs (PBC-obtain), as well as 
PBC over using the drugs (PBC-take) (Orbell et al., 2001). Three items were 
presented for each construct with high scores indicating strong perceived behaviour 
control. 
1. 9. 8 Prototypes 
Prototypes of typical persons using MDMA and GHB were assessed through 
Likert-type ratings using seven bipolar scales: Responsible-Irresponsible, Self-
confident-Insecure, Assertive-Unassertive, Confused-Clearheaded, Popular-
Unpopular, Immature-Mature, Sophisticated-Unsophisticated (adapted from Gerrard 
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et al., 2005). Prototype items were scored using scales of -3 to +3. Positive scores are 
indicative of favourable views of persons using the substances, whilst negative scores 
are indicative of unfavourable views of persons using the substances. 
1.9.9 Behavioural Intention 
Behavioural intention was assessed using a single item in each of the pre-test, 
post-test and follow-up questionnaires for each target drug type. There was also one 
additional novel item in the post-survey interval which directly asked the participants' 
perception of how their intention to use the substances has changed after reviewing 
the websites, from More unlikely to use, to No change, and More likely to use, which 
had a score of -3, 0 and +3 on the scale respectively. Positive scores are indicative of 
perceived increase in intention to use the substances after the websites, whilst 
negative scores are indicative of a perceived intention reduction. 
1.9.10 Behaviour willingness 
Behaviour willingness was measured with two items (adapted from Gibbons, 
Gerrard, Blanton et al., 1998) in each of the pre-test, post-test and follow-up 
questionnaires for each drug type. The first type of willingness item used was 
"Suppose you were with some friends and one of them offered you some GHB. How 
likely is it that you would do each of the following. Take it and try? Unlikely-Likely. 
Decline offer? Unlikely-Likely. 
The second willingness item type was presented in a scenario format, e.g. 
"After discussing the information about ecstasy from the websites with your good 
friend, s/he decides to try one. Your good friend says that s/he would really like you 
to try it with him/her.' Try it with your good friend? Yes/No. How difficult was it for 
you to make that decision? Difficult-Easy." If the response to the offer was "no", then 
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the score for difficulty in making the decision would be reversed as an indication as a 
lower level of willingness. If the response was "yes" to the offer, then a straight 
scoring of the subsequent response would be used as indication of higher willingness. 
1.9.11 Website credibility 
Website credibility was measured in four dimensions using Likert-style scales, 
namely fairness, depth, goodwill and trust/expertise, based on previous scales 
developed by Hong (2006). Each dimension was assessed by three items, which were 
presented in a counterbalanced fashion. Example items for the respective dimensions 
include: "The sites provide information that is neutral" [fairness]; "The sites do not 
provide in-depth information" [depth]; "The sites have my interests at heart" 
[goodwill]; "The sites appear to be a leader in its area of specialty" [trust/expertise]. 
High scores indicate higher levels of perceived credibility of the websites. 
1.10 Design 
Overall, the study employed a 2 (Site-type: Fear-based, Harm Reduction) x 2 
(Substance type: MDMA, GHB) x 3 (Time: Pre-test, Post-test, 2-week Follow-up test) 
three-way mixed ANOV A. Site-type was a between-subjects factor, whilst substance 
type and time were within-subjects factors. Dependent variables included measures of 
knowledge about the target drugs, attitudes toward use of the drugs, behavioural 
intentions and behavioural willingness toward substance use as well as perceptions of 
credibility of viewed sites. Perceived behavioural control (PBC), attitude ambivalence 
toward use of the examined drugs, subjective norms, moral norms and prototypes 
were also assessed as potential covariates. 
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1.11 Data Analysis 
Missing values in the data were filled by the groups' (i.e. by site-type) median 
values. Three participants (i.e. one from the harm-reduction group and two from the 
fear-based group) failed to submit their follow-up surveys, and the data was treated as 
missing values (118 missing values per absent follow-up survey). In the harm 
reduction group, there were 502 missing values out of a total of 16880 (2.97%), and in 
the fear-based group, there were 458 missing values out of a total of 16458 (2.78%). 
One participant was excluded from further analysis due to missing responses in key 
outcome variables (a total of 40 missing values). The final analysis had a total of 79 
participants, with 40 being in the harm reduction group, and 39 in the fear-based 
group. 
The indirect measure of subjective norms as well as descriptive norms in 
regard to the referent group of "partner" [i.e. significant other] was found to have 
elicited a very poor response rate of only 50%, as participants were advised to not 
respond to this question if they were not currently in a romantic relationship, and was 
thus excluded from further analyses. 
As shown in Table 1, there was a wide spread of knowledge scores for 
MDMA and GHB, within the parameters of a normal distribution. The three sub-
components - cognitive, affective and overall - of attitude ambivalence had medium-
to-high correlations with each other, justifying combining them into a single 
aggregate of attitude ambivalence. Similarly, the three sub-components of the direct 
measure of attitude were combined into an aggregate of direct measure of attitude in 
order to simplify data analysis and interpretation. These aggregated scales possessed 
strong internal consistency, with Cronbach a ranging between 0.87 and 0.90. 
96 
Table 1 
Properties of the Developed Questionnaire at Pre-Test 
Dependent Variable 
Knowledge 
N of items per drug 
type 
15 
e.g. Muscle tension is a common effect of using [ecstasy/GHB]. True I False I Don't Know 
MDMA 
Min/Max 
Mean (SD) (Possible range) 
5.96 (2.7) 0/12 (0 I 15) 
GHB 
Cronbach Min/Max Cronbach 
a Mean(SD) (Possible range) a 
4.54 (3.1) 0 I 12 
nfa/\ (O I 15) 0.78 
Attitudes 
-18/13 -18/2 
Directmeasures 12 -9.77 C6·9) (-18/18) 0.90 -ll.3&(5.9) (-18/18) 0.87 
e.g. Considering only the positive aspects of using ecstasy in the next 2 months, and ignoring the negatives, what is your evaluation of ecstasy? Not at all good-Extremely good; Not at all en;oyable-Extremely enjoyable; Not at all beneficzal-
Extremel bene zcial 
Attitude Ambivalence 
Indirect measures 16 -56.11 (52.5) 
-152 I 63 
(-336 I 336) 0.80 
e.g. (a) Getting arrested would be Bad-Good; multiplied by (b) Using ectasy m the next 2 months would get me arrested; Unlikely-Likely. 
Combined 28 -65.89 (56.0) 
6 4.68 (5.7) 
-162 I 52 
(-354 I 354) 
-3 I 18 
(-3 I 24) 
0.81 
0.87 
-66.94 (52.7) 
-78.32 (55.1) 
3.58 (5.6) 
-295 I 64 
(-336 I 336) 
-306 I 55 
(-354 I 354) 
-3 I 16 
(-3 I 24) 
e.g. Considermg only the negative aspects of using GHB in the next 2 months, and ignoring the positives, what is your evaluation of ecstasy? Not at all bad-Extremely bad; Not at all unenjoyable-Extremely unenjoyable; Not at all hannful-Extremely harmfal. 
-7.91 (2.5) -9 I 3 -9 I 0 (-9 I 9) 0.87 -8·57 (1.4) (-9 I 9) Subjective norms Direct measures 3 
e.g. Most people who are !Illportant to me think that I should not-I should use ecstasy in the next 2 months. 
Indirect measures t 3 -36.59 (15.9) 
-63 I -3 
(-63 I 63) 0.41 -42.43 (18.5) 
-63 I 3 
(-63 I 63) 
e.g (a) My family members/relatives think I should take ecstasy Strongly disagree-Strong agree; multiplied by (b) With regard to ecstasy, I want to do what my family members/relatives think I should; Strongly disagree-Strong agree. 
-44.51 (16.5) -72 I -12 -72 I -6 (-72/72) 0.38 -51.00(18.8) (-72/72) Combined 6 
Descriptive norms 2 -5.l 0 (1.3) 
e.g. In the last six months about what proportion of your close friends have used ecstasy? None-All 
Moral norm 
4.77 (2.2) 
e.g. It would be morally wrong for me to use GHB. Strongly disagree-Strong agree. 
Prototype 7 -6.18 (6.3) 
e.g. Granted that all not all people are alike, my image of the typical person who uses GHB is Responsible-Irresponsible. 
PBC Take 3 19.43 (3.4) 
-6 I 0 
(-6 I 6) 
117 
(l I 7) 
-21I8 
(-21I21) 
4 I 21 
(3 I 21) 
e.g. If a friend offered me ecstasy in the next 2 months and I wanted to refuse, 1t would be Difficult-Easy. 
Obtain 3 9.82 (6.2) 
e.g For me to get hold ofGHB m the next 2 months would be Difficult-Easy 
Behavioural lntent10n 1.23 (0.72) 
e g. I do not plan to use GHB in the next 2 months Strongly drsagree-Strong agree. 
Behavioural Willingness 2 3 48 (2.59) 
3 I 21 
(3 I 21) 
1/5 
(1I7) 
2/14 
(2114) 
0.37 -5.91 (0.3) 
n/a# 4.97 (2.1) 
'v-- 0.68 -8.54 (6.6) 
0.78 20.32 (2.3) 
0.92 7.08 (4.5) 
n/a# 1.37 (1.36) 
0.76 3.03 (2.16) 
e.g Suppose you were with some friends and one of them offered you some GHB How likely 1s It that you would do each of the followmg. Take 1t and try? Unbkely-Lzke(v .. Declme offer? U11likely-L1kely 
Note Skewness was operationalised as a skew score that was at least three times the standard error of skew (i.e. y1 > 0.81) 
#single item only; /\categorical response vanable; t not mcluded in further analyses; 
-6 I -4 
(-6 I 6) 
117 
(I I 7) 
-2117 
(-21I21) 
6 I 21 
(3 I 21) 
3 I 21 
(3 I 21) 
l I 7 
(I I 7) 
2/9 
(2114) 
0.59 
0.61 
0.88 
0.74 
0.57 
0.48 
-0.04 
0.75 
0.67 
0.90 
0.46 
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The direct measure of attitude was then subsequently summed with the 
indirect measure of attitude into an aggregated measure of attitudes as preliminary 
analyses found medium-to-high correlations between the direct and indirect 
measures. The sum of the attitude scores maintained acceptable reliability scores for 
MDMA (a= .81) and GHB (a= .61) to justify aggregation. The attitude aggregate 
for MDMA had a lower mean as well as minimum range than GHB, possibly 
explaining to some extent the higher scale reliability score of attitudes for MDMA 
over GHB. 
The indirect measure of subjective norms had unsatisfactory alpha scores for 
MDMA (a = .41) and GHB (a = .57). Furthermore, the indirect measure was found 
only to have a low correlation with the direct measure in MDMA (r = .25, p = .025), 
and no correlation with the direct measure in reference to GHB use (r = .20, p = 
.079). These indicated that these measures of subjective norms should not be 
aggregated together (Ajzen, 2002; Francis et al., 2004), and the decision was made to 
exclude the indirect measure from further analysis in order to protect the integrity of 
the model, whilst maintaining parsimony. A key TPB study on ecstasy use by Orbell 
and colleagues (2001) used only two direct measure of subjective norms and no 
indirect measure, providing precedent for such a decision. 
As for descriptive norms, the low internal consistency of scores for MDMA 
(a = .37) and GHB (a = -.04) can be explained due to the two items measuring 
distinctly different referent groups, namely family members and close friends who 
may clearly have different perspectives in relation to substance use. Responses on 
these scales were further compounded by floor effects, with extremely low variance 
in responses producing an inverted J-shaped distribution of scores. This scale was 
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used in further analyses because of the variable's importance in the model as well as 
because the responses were generally expected due to the sample characteristics. 
The single moral norm item had a substantially negative skew for both 
MDMA (y1 = -0.89) and GHB (Y1 = -1.03), indicating that more of the sample held 
that it was morally wrong to use either drugs. Prototypes achieved acceptable internal 
consistency for MDMA (a= .68) and GHB (a= .75), and although the scores 
indicated that participants generally held more negative prototypes toward people 
that use either drugs, there were no substantial skews in the prototype responses. 
The items assessing PBC-take had satisfactory internal consistency for 
MDMA (a = . 78) and GHB (a = .67), but scores were very heavily left-skewed for 
both MDMA (y1 = -3.09), and GHB (Yr= -4.38), indicating ceiling effects. The scores 
suggest that almost all participants in this sample believed that they had very strong 
control over the consumption of both MDMA and GHB. The assessments of PBC-
obtain had high internal consistency for both drug types with Cronbach alpha values 
of0.90 and 0.92 for MDMA and GHB respectively. However, PBC-obtain was 
heavily skewed in regard to GHB (Yr= 0.87), but not in regard to MDMA (Yr= 0.52). 
This suggested that a significant proportion of the sample believed that it was 
difficult to obtain GHB even if they wanted to. 
The single behavioural intention item for both MDMA (Yr= 4.16) and GHB 
(Yr= 3.81) was heavily right-skewed 3.81, as well as indicated floor effects for both 
drugs. This meant that at baseline, the overwhelming majority in the sample had no 
intentions to use either drugs in the next two months. Behavioural willingness also 
had substantial right skews for both MDMA (Y1=1.98) and GHB (yr= 1.96). 
Furthermore, the mean score for the GHB condition had a smaller amount of 
variation with a more apparent floor effect in comparison to responses in relation to 
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MDMA. This could explain the unsatisfactory scale internal consistency for 
behavioural willingness in relation to in GHB (a = .46), but not in MDMA (a = . 76). 
As highlighted, a large number of scales elicited skewed responses from the 
sample. These skews were expected as representative of a drug-naYve sample (see 
Discussion), and did not necessarily imply that the scales were inadequate. 
Table 2 
Means, Standard Deviations and Cronbach Alphas by Website Credibility 
Dimensions 
N of items Mean(SD) Min/Max Cronbach a 
Fairness 3 12.91 (3.7) 3 I 21 
Depth 3 14.20 (3.7) 4 I 21 
Goodwill 3 15.89 (3.5) 3 I 21 
Trust/Expertise 3 12.75 (3.5) 3 /20 
Total 12 55.75 (11.2) 19 I 82 
As shown in Table 2, with the exception to the Trust/Expertise dimension, 
internal consistency assessments for all other website credibility dimensions in this 
study were consistent with those of the original study that these were derived from 
(Hong, 2006). The low internal consistency for the "trust/expertise" dimension may 
suggest a bifactorial nature of these items, as reflected by the label for this variable. 
Results 
1.12 Relationships between variables in the proposed extended TPB Model 
0.62 
0.71 
0.73 
0.53 
0.83 
In relation to MDMA use, almost all correlations between key variables 
achieved significance as predicted by the proposed extended TPB model (Figure 15). 
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Even after moderation by attitude ambivalence, attitudes had medium-to-large 
correlations with behavioural intention (r = .32,p = .004) and willingness (r = .52,p 
< .001). Subjective norms (direct) were significantly correlated with behavioural 
intention (r = .62,p < .001) and willingness (r = .47,p < .001) at moderate levels, 
whilst descriptive norms was also moderately correlated with intention (r = .50, p < 
.001) but smaller correlation with willingness (r = .31,p = .006). 
Prototype had small but significant correlations with intention (r = .25,p = 
.027) and willingness (r = .32,p = .004). PBC-obtain had moderate correlations with 
both behavioural intention (r = .45,p < .001) and willingness (r = .41,p < .001), 
whilst PBC-take only had a smaller, and negative correlation with intention (r = -.22, 
p = .047). Moral norms also had negative correlations with intention (r = -.40,p < 
.001) and willingness (r = -.34,p = .002). 
Variables that did not reach significance in correlations as predicted were 
between knowledge and attitudes, and between PBC-take and behavioural 
willingness. The lack of an identifiable relationship between knowledge and attitudes 
may reflect their operationalisation in this study: the constructs were assessed in such 
a way that whilst attitude scores were directional in terms of positive or negative 
towards the substance, knowledge scores were not similarly value-laden, and simply 
reflected the depth and accuracy of knowledge about a target substance. Thus this 
finding suggests that whilst knowledge may theoretically influence attitudes, a higher 
or lower knowledge score may not necessarily imply attitudinal direction or strength, 
i.e. an individual who has extensive knowledge about a said substance may equally 
be as likely to be positive or negative towards a said drug. Similarly, a person who 
has very strong attitudinal views ofMDMA may or may not necessarily know a lot 
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of the drug. Nonetheless, the reviewed TPB studies did not include knowledge as a 
factor, and thus this supposition cannot be affirmed without further systematic study. 
Interestingly, PBC-take, which, of the two PBC assessments included in this 
study, is the most consistent with the original operationalisation of PBC (e.g. Conner 
& McMillan, 1999), had lower correlations with the behavioural intention and 
willingness to use MDMA as compared to PBC-obtain. This provides evidence that 
underscores the importance of including PBC-obtain in drug-related TPB studies. 
Another important finding is that the moderate correlation ofr = .54,p < .001 
between behavioural intention and behavioural willingness indicates that while these 
variables share some variance, they can justifiably be considered distinctly different 
constructs. 
Interestingly, there were many unpredicted statistically significant, albeit 
small in magnitude, correlations found between the variables in the proposed 
extended TPB model in relation to MDMA use as seen in Figure 16. Interestingly, 
knowledge was found to correlate with a number of the other variables, including 
intention directly, instead of indirectly via attitudes as inferred from the TPB model 
(Ajzen, 1991). Moreover, the low to moderate correlations between the normative 
variables, i.e. subjective norms, descriptive norms, moral norms and prototype 
suggest that whilst these factors are thematically similar, they are distinct constructs. 
PBC-obtain and PBC-take for MDMA use were not significantly correlated, 
implying that both were distinctly different constructs. Of particular note, PBC-
obtain and moral norms were shown to have significant correlations of moderate 
magnitude with many of the other variables. This suggests that these variables could 
be valuable additions in drug-related TPB studies. 
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In comparison to MDMA use, there were far fewer significant correlations 
between the model's key variables in relation to GHB use, as shown in Figure 17. 
Among those which were statistically significant, they were only of small magnitude, 
i.e. between attitudes and behavioural willingness, r = .28,p = .011; subjective 
norms (direct) and behavioural intention, r = .26,p = .022, subjective norms (direct) 
and willingness, r = .27,p = .015; descriptive norms and intention, r = .26,p = .023; 
moral norms and behavioural intention, r = -.27,p = .015; prototype and behavioural 
willingness, r = .22,p = .050; PBC-take and intention, r = -.27,p = .016. These low 
magnitude correlations may be due to floor effect of scores across most GHB 
variables (for example, 91 % of the sample reported no intention to use GHB at 
baseline), as a reflection of GHB' s relative obscurity in comparison with the well-
known MDMA. This suggests that the model may have less predictive power in less-
known drugs as compared to more well-known ones. 
As shown in Figure 18, there were similarly fewer extra correlations between 
the model's components in relation to GHB use in comparison to MDMA use. 
Furthermore, the finding provides additional support for the treatment of PBC-take 
and PBC-obtain as distinct variables. Similarly, it supports the independence of the 
different normative constructs, such as subjective norms, descriptive norms, moral 
norms and prototype. 
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Figure 15. Correlations between key variables in the proposed extended TPB model in relation to MDMA use. 
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Figure 16. Additional significant correlations between variables in the proposed extended TPB model in relation to MDMA use. 
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Figure 18. Additional significant correlations between variables in the proposed extended TPB model with GHB use. 
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Using hierarchical regression models to predict behavioural intention and 
behavioural willingness separately, in relation to MDMA and GHB use, predictor 
variables were entered in two steps; where the original variables of the TPB model 
was entered in the first step (attitudes, subjective norms-direct and PBC-take) and all 
the other additional variables (descriptive norms, PBC-obtain, knowledge, moral 
norms and prototype) were included in the second step. It should be noted that of the 
two assessments of PBC used in the current study, PBC-take was used in Step 1 
because it was most representative of the manner in which PBC is defined in TPB 
literature. 
As presented in Table 3, both the original and extended TPB models 
performed much better in explaining the variances in behavioural intention and 
willingness for MDMA as compared to GHB. Whilst the models explained between 
41 % to 68% of the variances for behavioural intention and willingness in reference to 
MDMA use, only 17% to 36% of the variances in behavioural intention and 
willingness were explained in reference to GHB use. As a whole, the additional 
variables were shown to increase the variances explained by 2% to 5% above the 
original TPB model for MDMA use, and by 5% to 18% for GHB use. This suggests 
that, while still only explaining a minority of variance in behavioural intention or 
willingness, the additional variables may be able to increase the sensitivity of the 
model in drugs which are less commonly used. It should also be noted that the 
components appear to have different strength relationships with behavioural intention 
and willingness as represented by their beta scores, reinforcing that behavioural 
intention and willingness are distinct constructs. 
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Table 3 
Hierarchical Regression of Pre-Test Behavioural Intention and Behavioural Willingness onto Extended TPB Model Variables {Or MDMA and GHB 
MDMA 
GHB 
Attitudes 
Subjective norms (direct) 
PBC (take) 
Descriptive norms 
PBC (obtain) 
Knowledge 
Moral norms 
Prototype 
ModelF 
ModelR2 
Attitudes 
Subjective norms (direct) 
PBC (take) 
Descriptive norms 
PBC (obtain) 
Knowledge 
Moral norms 
Prototype 
ModelF 
ModelR2 
Behavioural Intention 
Step 1 Step 2 
Original TPB model Extended TPB model 
0.03 0.21 
0.80*** 
0.11 
48.58*** 
0.66 
-0.08 
0.11 
-0.35** 
5.26** 
0.17 
0.75*** 
0.08 
0.06 
0.01 
0.11 
0.02 
0.02 
18.24*** 
0.68 
0.02 
-0.20 
0.21 
-0.32** 
0.39** 
-0.18 
0.12 
-0.17 
-0.02 
4.87*** 
0.36 
Behavioural Willingness 
Step 1 Step 2 
Original TPB model Extended TPB model 
0.46*** 0.44*** 
0.29** 0.21 
-0.03 -0.02 
17.48*** 
0.41 
0.34** 
0.02 
-0.29* 
7.17*** 
0.22 
-0.01 
0.11 
-0.04 
0.08 
0.24* 
7.50*** 
0.46 
0.05 
0.35** 
-0.05 
-0.31 * 
-0.09 
0.20 
-0.10 
0.03 
0.04 
3.31 ** 
0.27 
R2 chan e 0.18 0.05 
Note. Moderating effects of attitude ambivalence were not included in the regression models or in subsequent analyses due to experimental power limitations. 
*p < .05, **p < .01, ***p < .001 
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In relation to MDMA use, subjective norms (f3 = 0.75,p < .001) contributed 
the largest share of prediction to intention, with some assistance from attitudes (f3 = 
0.21,p = .80) and knowledge (f3 = 0.11,p = .19). The other factors such as PBC-take, 
descriptive norms, PBC-obtain, moral norm and prototype had a beta of no more than 
0.10 each in this situation (p = .30,p = .58,p = .93,p = .83,p = .78 respectively). 
For behavioural willingness toward MDMA use however, the relationship 
strengths of the variables were very different. Attitudes (f3 = 0.44,p < .001) was 
strongest, followed by prototype (f3 = 0.24,p = .025), subjective norms ({3 = 0.21,p = 
.062) and PBC-obtain ({3 = 0.11, p = .036). PBC-take, descriptive norms, knowledge 
and moral norms had beta scores ofless than 0.10 each (p = .80,p = .95,p = .68 and 
p = .53 respectively). 
The pattern of relationship strengths was yet again different in relation to 
GHB use, with a wider spread of beta scores for behavioural intention. Descriptive 
norms ({3 = 0.39,p = .001) contributed most of the explanation, followed closely by 
PBC-take ({3 = -0.32,p = .008), and then attitudes ({3 = -0.20,p = .085). The other 
factors, such as subjective norms (f3 = 0.21,p = .12), PBC-obtain ({3 = -0.18,p = .10), 
moral norm ({3 = -0.17,p = .12), and knowledge ({3 = 0.12, p = .25), collectively 
assisted as well the improvement in the prediction of behavioural intention for GHB 
above the original TPB model (from 17% of variance explained to 36% in this 
measure). Prototype however, only had a very small beta score of -0.02 (p = .83). 
In regard to behavioural willingness for GHB use, attitudes ({3 = 0.35,p = 
.004) had the strongest relationship followed by PBC-take ({3 = -0.31,-p = .014), and 
PBC-obtain (f3 = 0.20, p = .086). The other variables such as knowledge, subjective 
norms, descriptive norms, moral norms and prototype did not appear to assist as 
much in explaining additional variance. 
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This finding supports HI, whereby the additional variables of knowledge, 
descriptive norms, moral norms, prototype, and the division of PBC to PBC-obtain 
and PBC-take were shown to explain additional variance in behavioural intention and 
behavioural willingness, in relation to both MDMA and GHB. 
However, there were substantial variations in the beta scores of the model's 
variables between drug type and outcome variable. For instance, while PBC-obtain 
had moderate contributions to the prediction of behavioural intention and 
willingness, it was never found to be statistically significant. Similarly, knowledge 
and moral norms did not appear to significantly provide unique contributions in any 
of the regressions. In comparison, prototype significantly explained variance in 
behavioural willingness to use MDMA, yet gave non-significant and insubstantial 
explanations in the other regressions. Interestingly, no single variable from either the 
original or extended model was found to significantly provide unique contributions 
in all the regressions. These findings suggest that no single variable can be strongly 
recommended to be kept in, or left out, of the proposed model. 
1.13 Differences in perceived credibility between harm reduction and fear-
based websites 
As shown in Table 4, there were no significant differences between harm 
reduction and fear-based websites in the dimensions of perceived fairness, depth, 
trust/expertise and total credibility. However, there was a significant difference 
between the site types in the dimension of goodwill F(I, 77) = 9 .48, p = .003, where 
the fear-based websites were perceived as displaying more goodwill than harm 
reduction sites with a difference of moderate magnitude (Cohen's d = +0.69). There 
was also a notable trend that was almost significant, in the dimension of 
trust/expertise between the site-types, F(l,77) = 3.73,p = .057, where the fear-based 
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sites were again perceived as having more trust/expertise than harm reduction sites at 
d = +0.44. It is likely that with an increased sample size, the result would have 
achieved statistical significance. 
Table 4 
Mean Scores and Standard Deviations of Website Credibility Scores between Site-
Type 
Harm Fear-Based Mean d(HR-FB) 
Reduction difference 
HR-FB 
Fairness 13.2 (3.3) 12.6 (4.0) +0.6 -0.16 
Depth 14.5 (3.1) 13.9 (4.3) +0.6 -0.16 
Goodwill 14.8 (3.9) 17.1 (2.6) -2.3** +0.69** 
Trust I Expertise 12.0 (3.5) 13.5 (3.4) -1.5 +0.44 
Total Credibility 54.4 (11.9) 57.l (10.4) -2.7 +0.24 
Note. Higher scores indicate stronger perceived credibility. Possible range is 3-21 per dimension, and 
12-84 for total credibility. 
*p < .05, **p < .01 
The finding did not support H2 and showed that harm reduction websites 
were in fact not perceived by the sample as significantly more credible than fear-
based websites overall, and may in fact be seen as less credible in certain 
dimensions. 
1.14 The effects of viewing drug-education websites on key outcome variables 
Table 5 summarises the findings of three-way ANOVA examining the effects 
of sitetype (harm reduction; fear-based) for the two different drugs (MDMA, GHB) 
over three points in time (baseline, immediately following the task, two weeks after 
the task) on the key outcome variables of knowledge, attitudes, behavioural intention 
and willingness. Hyunh-Feldt adjustments were applied to all analyses involving the 
variable of Time. There was a strong main effect of site-type for all of these variables 
(p < .001), with the fear-based group having higher scores than the harm reduction 
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group in all key outcome variables aside from intention. For knowledge, the fear-
based condition had a mean score of 7.55 (SD = 0.26) and the harm reduction 
condition had a mean score of7.46 (SD = 0.25); the mean scores of attitudes in the 
fear-based condition was -73.77 (SD = 7.54) and was -79.46 (SD = 7.44) in the harm 
reduction condition; the fear-based condition had a mean score of 3 .48 (SD = 0.27) 
for behavioural willingness, and the harm reduction condition had a mean score of 
2.86 (flD = 0.26); but for behavioural intention, participants in the fear-based group 
reported an average score of 1.24 (SD = 0.10) whilst the harm reduction group 
reported an average score of 1.31 (SD = 0.09). 
There were also significant main effects of time for knowledge F(2,154) = 
113.62,p < .001 and behavioural willingness F(l,77) = 289.25,p < .001, but none 
for attitudes and behavioural intention. As the main effects of time indicate temporal 
stability in the constructs, the findings suggest that attitudes and behavioural 
intention did not significantly alter over time whilst knowledge and behavioural 
willingness did; in comparison with pre-test scores, knowledge increased greatly 
after exposure and was sustained after two weeks, whilst behavioural willingness 
increased at post-test, but reversed after two weeks. Nonetheless, there were no 
significant interaction effects between time and site-type across all variables, 
suggesting that exposure to drug education websites, regardless of site-type, affected 
both knowledge and behavioural willingness. 
The main effect of drug type was significant across three of the four 
variables: for knowledge, F(I,77) = 12.03,p = .001; attitudes, F(l,77) = 20.15,p < 
.001; and behavioural willingness F(l,77) = 17.22,p < .001, where scores were all 
higher for MDMA than for GHB. However, there was no significant difference in 
intention between both drugs, F(l,77) = 1.77,p = .26. This suggests that, overall, in 
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comparison to GHB, participants knew more about MDMA (GHB, M = 7 .16, SD = 
0.20; MDMA, M = 7.85, SD = 0.21), had less negative attitudes towards MDMA 
(GHB, M= -82.09, SD = 5.26; MDMA, M= -71.14, SD = 5.61), were more willing 
to use MDMA (GHB, M = 2.78, SD = 0.15; MDMA, M = 3.56, SD = 0.26), but had 
equally no intentions of using MDMA or GHB (GHB, M = 1.22, SD = 0.07; 
MDMA, M = 1.33, SD = 0.08). 
However, these main effects found for drug type were tempered by higher 
order effects. While there were no significant interaction effects between drug type 
and site-type for knowledge and behavioural intention, there was a significant 
interaction between drug type and site type for attitudes: F(l,77) = 4.03,p = .048; 
and a trend just short of significance for such an interaction for behavioural 
willingness at F(l,77) = 3.75,p = .057, with observed power= .481. There were also 
significant interaction effects between drug-type and time for knowledge: F(2,144) = 
4.67,p = .013; and willingness: F(2,145) = 4.48,p = .015, but none in attitudes and 
intention. 
A three-way interaction was also apparent for knowledge: F(2,144) = 5.18,p 
= .008, but not for the other three variables. To clarify this effect, a series of break-
down analyses revealed an interaction between site-type and time in regard to 
knowledge about MDMA: F(2,154) = 6.75,p = 0.002; but not for GHB: F(2,153) = 
0.50,p = .61. As detailed in analyses below (Table 6), the significant two-way 
interaction reflected a greater improvement in knowledge among participants 
viewing harm reduction websites than those that viewed fear based websites. 
In addition to that, to clarify the statistically significant two-way interactions 
for attitude and behavioural willingness as shown in Table 5, which were not 
contextualised by a higher-order effect, a series of break-down analyses were 
conducted. 
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Table 5 
Main Effects and Interaction Effects of Site-Type, Drug Type and Time by Dependent Variables of Knowledge, Attitudes, Behavioural Intention 
and Behavioural Willingness 
Dependent Variable 
Knowledge Attitudes Behavioural Intention Behavioural Willingness 
Sitetype F(l,77) = 1745.99*** F(l,77) = 209.22*** F(l,77) = 367.52*** F(l,77) = 289.25*** 
Time F(2,154) = 113.62*** F(2,154) = 2.12 F(2,154) = 1.31 F(2,154) = 5.36** 
Time * Sitetype F(2,154) = 0.66 F(2,151) = 1.62 F(2,153) = 2.29 F(2,146) = 0.97 
Drug Type F(l,77) = 12.03** F(l,77) = 20.15*** F(l,77) = 1.77 F(l,77) = 17.22*** 
Drug Type * Sitetype F(l,77) = 1.71 F(l,77) = 4.03* F(l,77) = 2.34 F(l,77) = 3.75t 
Time * Drugtype F(2,144) = 4.67* F(2, 125) = 0.28 F(l,109) = 2.30 F(2,145) = 4.48* 
Time * Drugtype * Sitetype F(2,144) = 5.18** F(2, 125) = 0.58 F(l,109) = 0.29 F(2,145) = 1.74 
*p < .05, **p < .01, ***p < .001, tp = .057 
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A two-way ANOV A of site-type (harm reduction; fear-based) over the three 
points in time (baseline, immediately following the task, two weeks after the task) by 
drug type found that main effect of site-type was significant for attitudes toward 
MDMA F(l,77) = 160.78,p < .001 (harm reduction, M = -76.43, SD = 7.88; fear-
based, M = -65.86, SD = 7.99), as well as attitudes toward GHB F(l,77) = 244.09 ,p 
< .001 (harm reduction, M = -82.48, SD = 7.38; fear-based, M = -81.69, SD = 7.48). 
Similarly, there were significant main effects of site type on behavioural willingness 
to use MDMAF(l,77) =195.44,p < .001 (harm reduction, M = 3.07, SD = 0.36; 
fear-based, M = 4.05, SD = 0.36) and GHB F(l,77) = 345.74,p < .001 (harm 
reduction, M = 2.65, SD = 0.21; fear-based, M = 2.91, SD = 0.21). These main 
effects of site-type suggested that participants in the harm reduction sites had overall 
lower scores on attitudes and behavioural willingness in regard to both substances, as 
compared to fear-based websites. 
There were also significant main effects.oftime on knowledge about MDMA, 
F(2,154) = 79.72,p < .001 (baseline, M = 5.97, SD = 0.30; post-test, M = 9.25, SD = 
0.19; follow-up, M = 8.32, SD = 0.28) as well as on knowledge about GHB, F(2,153) 
= 66.96,p < .001 (baseline, M = 4.54, SD = 0.35; post-test, M = 8.89, SD = 0.24; 
follow-up, M = 8.06, SD = 0.32). The findings show a sharp increase in knowledge 
about both drugs after intervention, which appeared largely sustained two weeks later 
during follow-up. 
Initial screening of data revealed some significant baseline differences in 
knowledge and behavioural intention in regard to MDMA, which may have 
undermined the potential to identify the hypothesised higher order effects. Analysis 
of covariance revealed no interactions between site-type and time after controlling 
for these baseline differences in regard to knowledge or behavioural intention in 
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regard to MDMA F(l,76) = 0.12,p = .73; F(l,76) = 0.42,p = .52 respectively, 
producing no change to the effects identified prior to baseline adjustment. 
Despite the absence of identified three-way interactions for variables other 
than knowledge, analyses of cell means (Table 6) were conducted in order to clarify 
the main effects oftime and provide more explicit detail of the individual effects of 
each site-type for both drug types, as this would provide practical direction as to the 
effect of site-type drug education websites on these key variables. As such, the 
analyses in Table 6 below are more practically relevant to guiding applications in 
formal evaluations of the effects of such internet-based drug education campaigns. 
Harm reduction websites were shown to significantly increase knowledge 
about both MDMA, F(2,78) = 67.79,p < .001 and GHB, F(2,71) = 25.48,p < .001. 
Cohen's d was used to measure effect size for these changes and harm reduction sites 
produced substantial short term effects on increasing knowledge about MDMA (d = 
+2.04) at immediately after treatment, importantly this effect was still substantial 
after a two-week follow-up (d = + 1.22). The initial, short-term effect of viewing 
harm-reduction websites on knowledge about GHB was not as large, d = + 1.4 7, but 
at follow-up, it was at a similar level of d = + 1.19. These results strongly suggest 
that exposure to harm reduction sites increase knowledge on drugs dramatically, and 
that these changes were largely sustained. 
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Table 6 
Mean Scores, Standard Deviations, Main Effects and Effect Sizes of Site Type by Drug Type and Time 
Pre a Post-b Follow-upc F Post-hoe d(pre-post) d(pre-follow) 
Hann 
a<b*** 
Reduction MDMA Knowledge 5.3 (2.2) 9.5 (1.9) 8.3 (2.7) 67.79*** a<c*** +2.04 +1.22 b>c** 
Attitude -77.0 (55.8) -77.0 (62.4) -75.3 (61.3) 0.04 0.00 +0.03 
Intention 1.1 (0.2) 1.3 (1.1) 1.5 (1.4) 2.74 +0.25 +0.40 
Willingness 3.2 (2.4) 3.3 (2.5) 2.8 (1.8) 1.75 +0.04 -0.19 
GHB Knowledge 4.8 (3.1) 8.8 (2.3) 8.2 (2.6) 25.48*** a<b*** +l.47 +l.19 
a<c*** 
Attitude -81.9 (50.9) -84.2 (59.7) -81.4 (60.2) 0.1 -0.04 +0.01 
Intention 1.4 (1.4) 1.2 (0.8) 1.4 (1.3) 0.56 -0.18 0.00 
Willingness 3.0 (2.2) 2.8 (1.9) 2.3 (0.8) 3.37* a>c* -0.10 -0.42 
a<b*** 
Fear-Based MDMA Knowledge 6.7 (3.0) 9.0 (1.4) 8.3 (2.3) 19.65*** a<c*** +o.98 +0.60 
b>c* 
Attitude -54.5 (54.5) -76.4 (54.6) -66.7 (54.9) 3.43* a>b* -0.40 -0.22 
Intention 1.4 (1.0) 1.2 (0.6) 1.4 (1.3) 0.67 -0.24 0.00 
Willingness 3.7 (2.7) 4.8 (3.5) 3.6 (2.3) 5.39** a>b* +0.35 -0.04 b>c** 
GHB Knowledge 4.3 (3.1) 9.0 (1.8) 8.0 (3.1) 44.37*** a<b*** +l.85 +l.19 
a<c*** 
Attitude -74.6 (59.5) -91.4 (46.1) -79.1 (48.8) 1.94 -0.32 -0.08 
Intention 1.4 (1.3) 1.0 (0.0) 1.0 (0.0) 2.77 -0.37t -0.37t 
Willingness 3.1 (2.2) 3.1 (2.3) 2.5 (1.1) 1.59 0.00 -0.35 
*p < .05, **p < .01, ***p < .001 
tnue to floor effect, sample-wide SD was used, i.e. pre= (1.4), post= (0.6), follow-up= (0.9) 
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While there were no effects of viewing harm-reduction websites on 
behavioural willingness to use MDMA, F(l,66) = 1.75,p = .19, d = -0.19; 
participants were significantly less willing to use GHB after viewing such sites: 
F(2,71) = 3.37,p = .044. The change in behavioural willingness was interesting in 
that post-hoe paired samples t-tests indicated that there was no significant change 
immediately after treatment, d = -0.1; but at follow-up, behavioural willingness had 
dropped significantly with an effect size of d = -0.42. 
There was a non-significant trend of increasing intention to use MDMA after 
exposure to harm reduction websites, F(l,63) = 2.74,p = .083. Whilst the trend did 
not achieve statistical significance, the effect sizes from baseline of d = +0.25 at 
post-test and d = +0.40 at follow-up suggest that these are effects of moderate 
magnitude and may merit further consideration. In contrast, there was no effect on 
intention to use GHB F(2,59) = 0.56, p = .53, with participants generally not 
intending to use the drug at baseline or post-test. 
Of note, there were no significant effects of exposure to harm reduction sites 
on attitude toward either MDMA or GHB, with participants maintaining a generally 
negative attitude toward both drugs. 
The results thus only partially supported H4a, where after viewing the harm-
reduction websites, there was a significant increase in MDMA-related knowledge but 
no significant changes in attitude or behavioural willingness. There was however, a 
moderate trend of increase in intention that did not achieve significance. H4b was 
also only partially supported, where there was a significant increase in knowledge 
about GHB together with a significant decrease in behavioural willingness (apparent 
only at follow-up) to use the drug after treatment in the harm reduction condition. 
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However, no significant changes in attitude or behavioural intention toward GHB use 
were observed. 
Fear-based websites were also shown to significantly improve knowledge in 
regard to both MDMA, F(2,7l) = 19.65,p < .001 and GHB, F(2,76) = 44.37,p < 
.001. There was a larger effect size of exposure to fear-based sites on knowledge 
over time in relation to GHB, d = + 1.85 in comparison to baseline at post-test and d 
= + 1.19 at follow-up, than for MDMA, d = +0.98 at post-test and d = +0.60 at 
follow-up. 
Additionally, fear-based sites significantly affected attitudes toward MDMA, 
F(2,73) = 3.43,p = .040, as well as behavioural willingness toward using the drug, 
F(2,76) = 5.39,p = .006. Interestingly, these effects were in the opposite direction. 
Post-hoe paired samples t-tests showed that these effects were only significant in the 
short term, with statistically significant increases between baseline and post-test 
which were not retained at follow-up. Exposure to fear-based sites produced a more 
negative attitude toward ecstasy in comparison to baseline at post-test, d = -0.40, but 
not in follow-up, d = -0.22. While trends were in a similar direction in regard to 
attitudes toward GHB, these were not statistically significant. 
The effect on MDMA willingness however was pronounced in the other 
direction to attitudes, namely where immediately after treatment to fear-based sites, 
participants significantly increased their willingness to use MDMA by d = +0.35, 
however after two-weeks this had returned to baseline levels (d = -0.04). This pattern 
of change in MDMA behavioural willingness may imply psychological reactance 
(see Discussion) to the fear-based sites immediately after exposure, but that the 
reactance was short-lived. There were no statistically significant effects of viewing 
fear-based sites in relation to willingness to use GHB. 
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There was a very low degree of willingness to use either MDMA or GHB 
among participants at baseline (Table 1 ), and there were no statistically significant 
changes to this following viewing of fear-based websites. This noted, viewing fear-
based websites reduced intention to use GHB at the trend range of significance, 
F(l,38) = 2.77,p = 0.10. Whilst the trend did not achieve statistical significance, 
there were small effect sizes of d = -0.37 at post-test, retained at follow-up, and, 
notably, all participants in this group reported the lowest level of intention to use 
GHB. 
H3a was partially supported by the findings whereby exposure to fear-based 
websites significantly increased MDMA-related behavioural willingness (although 
only short-term) and knowledge as hypothesised. However, the significant short-term 
decrease in attitudes toward MDMA use as well as no change in intention was 
contrary to the hypothesis. Similarly, H3b was only partially supported with only a 
significant increase in knowledge about GHB after treatment in the fear-based 
condition as hypothesised, whilst there were no significant changes in attitudes, 
intention or willingness. Furthermore, there was a moderate but non-significant trend 
of decrease in behavioural intention and willingness toward GHB use at follow-up 
that was contrary to the hypothesis. 
In addition to these main fmdings, when participants were asked directly 
about the perceived effect of viewing the websites on their intentions to use the target 
substances, there was a significant difference between the drug types F(I,77) = 4.74, 
p = .033, with participants perceiving themselves as having a reduction in intention 
to use GHB by a marginal mean score of-1.82 (SD = 0.15), as compared to -1.54 
(SD = 0.16)for MDMA use (out of a possible range of-3 to +3). There were 
however, no significant main effect of site-type F(I, 77) = 0.22, p = .64 (with a 
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marginal mean score of -1. 7 5 in the harm reduction condition vs. -1.62 in the fear-
based condition); and no interaction effects between site-type and drug type, F(l,77) 
= 0.05,p = .82. Participants in both site-type conditions significantly perceived 
themselves as being less likely to use both drugs after viewing the websites, with 
one-sample t-tests for: harm reduction condition and MDMA with t(39) = -6.79,p < 
.001, (M = -1.63, SD = 1.5); harm reduction and GHB with t(39) = -8.47,p < .001 
(M= -1.88, SD = 1.4); fear-based group and MDMA with t(38) = -7.05,p < .001 (M 
= -1.46, SD = 1.3); as well as fear-based group and GHB with t(38) = -8.59,p < .001 
(M = -1.77, SD = 1.3). This suggests that drug-naive audiences believe that drug 
education websites, both fear-based and harm reduction, have a deterrent effect of 
substance use intentions. 
Discussion 
There were two key aims of the current study. Firstly, to establish a pragmatic 
and comprehensive TPB-based model that could be used to assess the practical 
impact of drug education campaigns, including those through the medium of the 
internet. Secondly, the study aimed to subsequently use the proposed model to 
compare the efficacy of fear-based and harm reduction-based drug education 
websites in changing drug-related health behaviours. 
1.15 The efficacy of the extended TPB model 
In order to evaluate the utility and adequacy of any drug-education approach, 
it is crucial to assess pragmatic outcome measures such as behavioural indicators 
(Hawthorne, 2001; Midford, 2007). However, this is sometimes impractical or 
unfeasible in reality due to limitations in resources and ethical challenges. In lieu of 
measuring actual behaviour, intention and willingness have been proposed as strong 
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predictors of substance use behaviour. Specifically, behavioural intention has been 
shown to explain between 51 % and 72% of variance in actual substance use 
behaviours after mediation by PBC (Conner & McMillan, 1999; Johnston & White, 
2003). Furthermore, behavioural willingness has been shown to explain additional 
variances of between 1 % to 7% in health risk behaviours, after behavioural intention 
and past behaviour have been accounted for (Gibbons, Gerrard, Blanton et al., 1998; 
Gibbons, Gerrard, Ouellette et al., 1998). These suggest the value of measuring as 
well as predicting these variables in the evaluation of drug education interventions. 
In this study, the range of variances explained in the substance use intention 
and willingness by the original TPB components varied quite substantially from 
moderate (17%) to large (66%). For MDMA, a drug used by approximately 22% of 
Australians in the 20-29 age group (Australian Institute of Health and Welfare, 
2005), the original TPB components explained an adequate amount of variance in 
behavioural intention and willingness to use the drug ( 66% and 41 % of variance 
explained respectively). By contrast, in regard to the less prevalent drug GHB, the 
TPB variables were less adequate in predicting intention and willingness, explaining 
17% and 22% of variance in these measures respectively. Whilst the results are 
within the range of variance explained in other TPB studies (Armitage & Conner, 
2001; Rivis & Sheeran, 2003a), this suggests that the efficacy of the TPB model for 
predicting behaviour is dependent on substance type. 
The inclusion of the extra variables into this theoretical framework was 
successful in explaining 2% to 18% additional variance beyond that from traditional 
TPB predictors in behavioural intention and an additional 5% variance in behavioural 
willingness. This improvement was modest for MDMA (a 2% variance increase, to a 
total of 68% of variance in behavioural intention). In contrast, this was more 
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substantial for GHB, doubling the amount of variance explained by TPB parameters 
alone (by 18% to 36%). The disparity may be due to GHB's relative obscurity, 
indicating that an individual's behavioural intention may be notably influenced by 
additional factors such as descriptive norms, PBC-obtain, knowledge and moral 
norms, in addition to well-recognised factors such as attitude, subjective norm and 
PBC-take, when a drug is not well-known. On the other hand, in regard to 
behavioural willingness, the additional variables explained 5% additional variance in 
willingness beyond TPB variables for both drugs (to a total of 46% of variance 
explained in willingness to use MDMA and 27% for GHB). 
The results that show both the original TPB model and the extended TPB 
model explaining more variance in behaviour intention and willingness to use 
MDMA as compared to GHB is congruent with Conner and McMillan's (2003) 
findings on the TPB's efficacy across four substance types; whereby the predictive 
power of the model appeared to correspond with the relative popularity of these 
drugs (i.e. explaining up to 26% of variance for LSD use, 40% for MDMA use, 46% 
of variance for amphetamine use, and 70% for cannabis use). It is possible that a 
similar effect could be elicited by using the drug education websites as a means to 
increase awareness about the target substances, and thus causing the participants' 
responses in relation to the model's variables to become firmer and more defined. 
This might subsequently lead to an increase in the model's explanatory and 
predictive power after treatment. However, due to the study's design, not all 
variables were measured at all time intervals, and this supposition could not be 
tested. 
Ajzen (1991) acknowledged that the TPB was open to the inclusion of 
additional variables, but emphasised that parsimony in measurement should remain a 
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key consideration. The findings of the current study suggest that there is some 
justification to include additional variables in studies that are intent on scrutinising 
the precise interactions of these different factors in influencing behavioural intention 
and willingness of substance use. That said, given that the increase in explanatory 
power comes at the expense of parsimony and additional participation burden, the 
findings of the current study suggest that the use of additional factors beyond TPB 
variables may be of most value when used in studies about substances that are not 
well known, such as GHB. 
However, the present results make it difficult to provide general statements 
about which of the additional - or indeed which of the original TPB variables - was 
useful or not. As seen in Table 3, all individual variables fluctuated in their 
independent explanatory power quite dramatically by drug type and dependent 
variable. For example, when the extended TPB model was entered in the hierarchical 
regression, subjective norms showed a large beta score(~= 0.75,p < .001) in the 
prediction of intention toward MDMA use; moderate beta scores for intention toward 
GHB (~ = 0.21,p = .12) and behavioural willingness toward MDMA use(~= 0.21,p 
= .062); but only a small beta score in willingness toward GHB use(~= -0.05,p = 
.71). The other components also had very different relationship strengths in each 
scenario. 
Among the highlights were PBC-obtain, which was not found to be 
statistically significant on its own, yet made moderate contributions in the extended 
model to the prediction of behavioural intention toward GHB use, as well as 
behavioural willingness to use both MDMA and GHB. Knowledge and moral norms 
likewise did not appear to provide unique contributions in any of the regressions. In 
contrast, prototype significantly explained variance in behavioural willingness to use 
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MDMA, but played a negligible role in the other regressions. Interestingly, no single 
variable from either the original or extended model was found to significantly 
provide unique contributions in all the regressions. These findings suggest that no 
single variable can be strongly recommended to be kept in, or left out, of the 
proposed model. However, as seen in the findings, it should be considered that the 
attenuated range in responses from a drug-na'ive sample due to the skewed responses 
and floor effects may have reduced potential correlations in the model. A wider 
distribution of scores from a sample that was recruited from a broader population 
may possibly increase the relationship strengths between the model's components 
and subsequently, the predictive power of the model. 
Nonetheless, the implications of this finding would be that future research in 
this area would ideally conduct a pilot study using the extended TPB model in its 
entirety, and subsequently examine only the most predictive variables in the main 
study. If that process is not feasible at a practical level, then a broad recommendation 
based on the results would be that the original TPB model is sufficient for use in 
assessing education effects on intentions to use more widely known drugs like 
MDMA, whilst the more detailed extended model is most appropriate when 
assessing more obscure drugs such as GHB. 
1.16 Differences in perceived credibility between harm reduction and fear-based 
site-type 
In regard to website credibility, there appeared to be minimal differences 
between the harm reduction and fear-based site types, in contrast to the hypothesis 
that harm reduction sites would be perceived as more credible than fear-based 
websites. The results showed that for drug-na'ive audiences, fear-based sites appeared 
moderately more credible than the harm reduction websites in the dimension of 
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goodwill (d = 0.69,p = .003). The inclusion criteria required all participants to have 
never used MDMA or GHB before, and this was reflected in their baseline results of 
overwhelmingly negative attitudes, norms, intentions and willingness towards 
MDMA or GHB use. It could thus be inferred that fear-based sites presented 
information that were more congruent to their original beliefs as compared to the 
harm reduction sites and that their perception of the presented content as well as the 
credibility of the website was influenced by their predisposition (Hyman & 
Sheatsley, 1947), i.e. that drug-naive audiences might find fear-based websites more 
favourable because it presents information and/or views that are similar to their own. 
However, Hong's (2006) study found that in regard to the credibility of health 
promotion information on the internet, intention to revisit tobacco cessation sites was 
not significantly linked to the dimension of goodwill but instead to its perceived 
depth and trust/expertise, variables that did not differ between the website types in 
this study. Whilst the identified difference in perceived goodwill may not impact on 
participants' behavioural intention directly, it may still have affected the other key 
outcome variables in the model. 
In light of the ELM' s assertion that source factors such as credibility play a 
more significant role when elaboration likelihood is moderate or low (Petty & 
Cacioppo, 1986), this suggests if the study was successful in increasing elaboration 
likelihood by presenting the personalised scenario (see Procedure) to participants, the 
differences in credibility might not be a significant factor in the efficacy of the drug 
education websites. On the other hand, if that attempt was not successful, and 
participations maintain a low or moderate level of elaboration likelihood, then the 
differences in perceived credibility may have had more substantial effects on 
behavioural intention and/or willingness, namely suggesting that participants might 
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have been slightly more persuaded by the fear-based websites than the harm 
reduction websites. 
1.17 The effects of viewing drug education websites on key outcome variables 
Whilst interpreting the results, it is important to bear in mind that the 
independent variable levels of site-type (i.e. harm reduction and fear-based) were not 
orthogonal because they were chosen based on the grounds of being the two most 
common approaches to drug education. To clarify, whilst fear-based websites have a 
clear agenda towards halting substance use, harm reduction websites do not promote 
substance use, but merely provide information about the pros and cons of substance 
use and suggest methods to reduce the likelihood of harm if a person does consume a 
drug. This lack of orthogonality between the site-type may have thus been reflected 
in more similarities in the results than differences. 
Overall, the results suggest that exposure to the internet-based drug education 
materials had varying effects on key outcome variables of the extended TPB model. 
The most conspicuous post-treatment change was the large increases in knowledge 
about both drugs, which were mostly sustained after a two-week follow-up. 
Specifically, viewing harm reduction sites produced approximately twice the amount 
of increase in knowledge about MDMA (d = +2.04) than did the fear-based sites (d = 
+0.98), and this difference was maintained at follow-up (d = + 1.22 vs. d = +0.60). 
For GHB, both site-types produced comparable effects on knowledge. In terms of 
effects on knowledge, the results suggest that the information on GHB were fairly 
similar across the harm reduction and fear-based websites. However, it appears that 
for MDMA content, harm reduction websites had more comprehensive information 
and/or the approach of presenting two-sided information was more effectively in 
increasing knowledge. It is also possible that the amount of information presented in 
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the websites could be a significant confounding variable in relation to knowledge 
gain or indeed across all variables as well, that is to say if fear-based websites 
provided as much information, albeit negatively laden, as harm reduction websites, 
that might have lead to an equal increase in knowledge about the substances. 
On a similar token, the questions assessing knowledge incorporated in the 
current study were not balanced in terms of negative and positive aspects of the 
target substance, and such an approach would have provided more clarification as to 
the different effects of the two site-types on these items. Nonetheless, it is interesting 
to note that most of the knowledge items were about the negative aspects of drug use, 
yet participants who viewed the harm reduction website had a greater increase in 
knowledge for MDMA in comparison to participants in the fear-based condition. 
This suggests that either the greater quantity of information on the harm-reduction 
websites may have produced this differential knowledge gain (despite the fact that 
both groups had an equal amount of time to read the websites) and/or that harm 
reduction websites presented information in a manner that was more absorbable to 
participants. 
Exposure to harm reduction websites did not significantly affect attitudes 
towards either drug. In the fear-based condition, there were also no significant 
changes in attitudes toward GHB, but a short-term increase in negative attitudes 
toward MDMA (d = -0.40) was found. This drop in attitudes toward MDMA 
appeared to have attenuated over the two weeks (d = -0.22). A suggestion by Hyman 
and Sheatsley (1947) that people interpret and distort information differently based 
on their prior attitudes is worth considering in light of this finding, as it implies that 
drug education websites are ineffective tools in changing pre-conceived attitudes 
toward drugs. This suggests that there should be reconsideration about measuring 
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attitudes as a primary, or sole, outcome variable in drug education campaigns 
because whilst it remains a popular measure in drug education campaigns evaluations 
(e.g. Orwin et al., 2006; Pennay et al., 2006), the findings suggest that attitudes may 
not be sensitive to the effects of this type of interventions. 
Whilst it may be logical to presume that knowledge about a substance 
informs ones' attitudes towards it, the large increase in knowledge but lack of change 
in attitudes in both site-type conditions indicate that the amount and type of 
knowledge do not lead to significant changes in attitudes. As attitudes comprise of 
affective and cognitive components (Ajzen & Fishbein, 1977; Eagly & Chaiken, 
1993; Petty et al., 1997), it is possible to suppose that knowledge may have very little 
influence over the former and only a small influence over the latter. Nonetheless, the 
overall implication is that whilst knowledge gain appears to be another popular 
measure in drug education campaign evaluations (Hughes, 2007; Snyder, 2007), it 
may be more valuable as an indicator of success to harm-reduction campaigns due to 
their goals of increasing the recipients' awareness of the different effects of 
substances, as well ways to reduce harm in relation to their use. On the other hand, as 
the findings suggest that knowledge gain does not appear to be a meaningful 
indicator of change in substance-related attitudes or abstinent behaviour as aspired 
for by fear-based campaigns, it diminishes the utility of gauging knowledge in 
evaluations of such campaigns. 
There was a non-significant but moderate increase in behavioural intention 
toward ecstasy use (d = +0.25 at post-test; and d= +0.40 at follow-up) after visiting 
the harm reduction websites. In the fear-based condition, there was no change in 
behavioural intention to use MDMA after treatment but there was a non-significant 
but moderate decrease in intention for GHB (d = -0.37). This non-significance could 
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likely be explained by the heavily right-skewed baseline which was compounded by 
a floor effect, as the participants in the group were unanimous in their responses of 
not wanting to use GHB. 
When participants were asked directly about what they perceived the overall 
impact of viewing the websites were on their intentions to use the substances, most 
participants reported themselves as being less likely to use both drugs. There was no 
significant difference between the site-type on participants' perception of 
behavioural intention change and their seemingly unanimous response suggests that 
drug education websites generally reinforce drug-narve participants' unfavourable 
perceptions of substances, regardless of whether one-sided or two-sided information 
is provided. Whilst one-sided messages, as per fear-based websites, have been 
demonstrated to be more powerful than two-sided messages without refutation, as 
per harm reduction websites (Allen, 1991; Hale et al., 1991), the findings indicate 
that this is not a significant factor in affecting behavioural intention for a drug-naYve 
sample. Ultimately, the finding suggests that drug-naYve audiences perceive both 
fear-based and harm reduction drug education websites as having deterrent effects on 
substance use intentions. Nonetheless, it should be noted this measure was a novel 
item to gauge the participants' direct views of the websites' effect, but that a 
perceived decrease in behavioural intention may not necessarily render as an actual 
decrease in intention. 
The effect of exposure to the websites on behavioural willingness was more 
complex, with varying short-term and long-term effects. There was no significant 
change in behavioural willingness to use GHB immediately after treatment in the 
harm reduction condition ( d = -0 .10), but a delayed effect was evident when 
behavioural willingness dropped significantly at follow-up (d = -0.42). There was 
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also a similar but non-significant trend in the fear-based condition where there was 
no change at post-test (d = 0.00), but a reduction in willingness scores occurred at 
follow-up (d = -0.35). This finding is very interesting because of its counterintuitive 
premise. Whilst this suggests that both types of drug education websites have 
delayed effects in reducing behavioural willingness toward GHB, the exact 
mechanism for this phenomenon remains unclear. Whilst the hierarchical regression 
(see Table 3) indicated that the three largest predictors of behavioural willingness in 
GHB use are attitudes, PBC-take and PBC-obtain, it is unlikely that attitudes would 
have caused this shift because attitude scores returned to baseline at follow-up 
instead of decreasing in tandem with behavioural willingness. This then suggests that 
viewing drug education websites either directly caused a delayed decrease in 
behavioural willingness toward GHB use, and/or that there was indirect effect from a 
change in either or both of the two variations of PBC (which was not assessed at 
follow-up due to its assumed temporal stability). This complex finding underlines the 
potential utility of measuring change in other components in the extended TPB 
model, in addition to knowledge, attitudes, behavioural intention and willingness, at 
all time intervals in future studies to better evaluate the dynamics of drug education. 
In contrast, there were no significant effects on intention toward MDMA use 
in the harm reduction condition. However, exposure to the fear-based sites caused 
participants to significantly increase their willingness to use MDMA (d = +0.35) 
immediately after treatment, but at two-week's follow-up, the behavioural 
willingness returned to baseline (d = -0.04), possibly implying short-lived 
psychological reactance, i.e. that there was a shift towards the opposite direction in 
willingness to use MDMA because the information presented by the fear-based 
websites were seen as being exaggerated and manipulative (Ashton, 1999; Brown, 
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2001). Whilst this finding would be consistent with H3a, it was not in concordance 
with the other changes in the key outcome variables, which suggest that this 
phenomenon was not necessarily an instance of psychological reactance. 
An alternative explanation for initial short-term increase in behavioural 
willingness would that be that prototype, which was found to be significant predictor 
(~ = 0.24,p = .025) of willingness in MDMA use, might have been affected after 
viewing the fear-based websites, subsequently influencing behavioural willingness. 
If this was true, then it would mean that viewing the fear-based websites caused 
participants to have a more favourable impression of MDMA users, possibly due to 
the implicit connotation that MDMA is a very popular drug used by many youths, 
which then influenced them to be more willing to use MDMA for a short duration of 
time. However, because changes in prototype scores were not measured at post-test 
and follow-up, this conjecture cannot be ascertained. 
The study's overall results were partially congruent with a similar 
experiment by Brewer (2003), where drug-naive participants were found to have 
increased knowledge and less negative attitudes toward the target substances, but no 
change in attitudes towards future use after searching for substance-related 
information on the internet. Differences between the studies' designs and 
operationalisations of key outcome variables could account for the disparity in 
attitudinal change. Nonetheless, the mutual finding of knowledge increase but lack of 
change in behavioural intention ( operationalised as "attitudes towards future use" in 
Brewer's study with some variation) clearly supports the notion that exposure to drug 
education websites have strong effects on knowledge and minimal effects on 
intention. 
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A possible reason for the lack of identifiable changes on attitude or intention 
was that the design did not provide sufficiently long or sufficiently frequent 
exposures to the information in the treatment groups. It is possible that reinforcing 
the message over several time intervals and/or for longer periods of time may be 
necessary in order to produce sustained changes. However, in a naturalistic context, 
exposure to websites typiCally requires individuals' voluntary intention to remain and 
return to the site, unlike public-service announcements on television or radio. This 
implies that generally, online-based drug education should be expected to be used for 
short-term information provision only, rather than a primary arm of health 
behavioural change. 
It is possible that with the exception of behavioural willingness in MDMA 
use, fear-based websites did not increase attitudes, behavioural intention and 
behavioural willingness as hypothesised because reactance towards the websites, 
which would be crucial to the production of effects in the direction hypothesised, 
would have needed to be caused by a significant lack of credibility; for example by 
the fear-based site being perceived by the viewers as presenting the negative aspects 
of the drugs unreasonably, to the point of being discredited (Dillard & Anderson, 
2004; Walton, 2006). Since both site-types were equally seen as credible (as 
presented in Table 4), the premise of reactance in relation to the fear-based websites 
and the subsequent hypotheses (i.e. H3a and H3b) were likely undermined. 
Moreover, the sample's gender imbalance, where 77.2% were female, could 
have possibly reduced the sample's overall reactance because reactance is found to 
be significantly more common with men rather than women (Bensley & Wu, 1991; 
Bushman, 1998; Piedmont, McCrae, Riemann, & Angleitner, 2000; Ringold, 2002). 
Nonetheless, the results suggest that for this sample, fear-based websites were 
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generally seen as fair, possessing goodwill, trust, expertise and a reasonable depth of 
information. Subsequently, the fear appeals appeared to be effective in significantly 
deflating attitudes and willingness towards MDMA (Brown, 2001; Bushman, 1998), 
but only in the immediate short term. Nonetheless, it should be noted that the short-
term increase in behavioural willingness to use MDMA - in contrast to the more 
negative attitude toward the drug - after viewing the fear-based websites alluded to 
psychological reactance, warranting scrutiny in future studies to examine the 
reliability of this phenomenon as well as the reason for this increase, which appeared 
to be dissonant to the other key outcome variables. 
As a whole, the findings suggest that drug education websites are excellent 
sources for increasing knowledge about JVIDMA and GHB, but have minimal long-
term effects on attitudes, behavioural intention and willingness toward their use. In 
addition to the increase in knowledge, the only long-term effect that was significant 
during follow-up was the reduction of behavioural willingness toward GHB use in 
the harm reduction group. It is interesting to note the effect because whilst harm 
reduction websites do not have a primary intention of dissuading audiences from 
using these substances, such as the fear-based websites, they generated similar 
results, and was in fact more effective in lowering willingness to use GHB 
Furthermore, an ELM-based explanation for the overall results may be that in 
spite of using the personalised scenario in the study to increase participants' 
motivation and sense of personal relevance, the elaboration likelihood of the 
participants were generally low to moderate, thus engaging the peripheral route of 
processing, rendering any effect of persuasion on the part of drug education websites 
weak and short-lived (Petty & Cacioppo, 1986). It could be argued that in reality, if 
an individual chooses to visit these sites on their own volition, motivation would be 
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higher, and there would be stronger and more persevering changes to their attitudes, 
intention and/or willingness. 
Nonetheless, perhaps the concept of 'persuasion' in this context only applies 
to the fear-based approach because it has an agenda of convincing the target audience 
of the benefits of abstinence; whereas the harm reduction approach has no agenda in 
that regard, and only seeks to infonn. Indeed, iflong-term effects were used as the 
primary yardstick of effectiveness in terms of achieving their respective agendas, 
then the results would indicate that both approaches 'succeeded' because those in the 
fear-based conditions maintained their rejection in terms of intention and willingness 
to use the substances, whilst those in the harm-reduction condition had large gains in 
the specific substance-related knowledge. 
Moreover, the results also vindicate the hann-reduction approach by refuting 
the argument that harm reduction drug education materials condoned and promoted 
drug use. The results showed that after viewing the harm reduction websites, there 
were no significant increase in the likelihood of viewers using the drugs from 
baseline, and was in fact significantly reduced willingness to use GHB at follow-up, 
undermining the premise of using fear-based websites. 
1.18 Limitations/Future studies 
As highlighted in the discussion above, it would appear that one key 
recommendation from the current study would be to measure the other factors in the 
proposed model aside from knowledge, attitudes, behavioural intention and 
behavioural willingness, as outcome variables throughout over time, rather than 
simply as covariates at baseline. Whilst it was presumed that the PBC variables and 
normative factors like prototype and subjective norms, were stable and resistant to 
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the effects of viewing drug education websites, the findings suggest that they are 
worth examining to better understand the effects of the interventions. 
The amount of information between the site-types was a potentially major 
confounding variable that was not possible to eliminate. Due to their fundamental 
characteristics in presenting one-sided information in the fear-based condition, and 
two-sided information in the harm reduction condition, the amount and 
comprehensiveness of information presented could not be equalised for the purposes 
of this study. Whilst the disparity in amount of information presented would be a 
weakness in an experimental study of the effects of persuasion (Petty & Cacioppo, 
1986), it is also a natural reflection of their differences. This study attempted to 
minimise this potential limitation by allowing participants in both site-type 
conditions the same amount of time to view the websites. Nonetheless, future 
researchers could opt to create the websites rather than to adapt them from existing 
websites to control their length; or use amount of information as an independent 
variable. 
The issue of credibility in this study might have been muted due to the 
between-subjects design in terms of site-type. Whilst using a within-subjects design 
for site type, where participants examined both harm reduction and fear-based sites, 
would have been more naturalistic, it would have confounded the interpretation of 
the individual impact of the site-types after intervention. Thus this exploratory study 
hoped to have laid the groundwork for subsequent studies by using a more limited 
and controlled design. It is recommended that participants be presented with both 
harm reduction and fear-based conditions to determine if the perceived level of 
credibility of the respective websites would be more strongly affected after being 
presented with contrasting viewpoints in future studies. Firstly, doing so would be 
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more realistic, as a person searching on the internet for substance-related information 
will typically be exposed to both hann reduction and fear-based websites. Secondly, 
this would probably heighten their awareness of the inherent intents and biasness of 
the said websites. Thus, when the contrast between the site-type becomes so blatant, 
the participants' rating of credibility for fear-based websites may decrease more 
substantially because of its apparent bias in not acknowledging any of the opposing 
views (Allen, 1991). 
The current study recruited only drug-naive participants for two main 
reasons, firstly as young drug-naive participants are targets of the primary prevention 
focus of fear-based education (e.g. Paglia & Room, 1999; D. White & Pitts, 1998); 
and secondly to control for effects of past behaviour and habit (Gibbons, Gerrard, 
Blanton et al., 1998; Norman & Conner, 2006; Orbell et al., 2001; Webb & Sheeran, 
2006). Whilst this assists with the interpretation of the results, future studies should 
to be extended to participants who have used, and/or are current users of these 
MDMA and/or GHB. Furthermore, a sample with a better gender balance as well as 
those in different age groups may display different levels of psychological reactance 
(Bensley & Wu, 1991; Bushman, 1998; Piedmont et al., 2000; Ringold, 2002), 
possibly generating different results in the key outcome variables. Extending the 
study by systematically studying these factors would be assist in understanding the 
complexities of the drug education websites' effects, as well as be crucial ingredients 
in the ability to generalise the efficacy of these websites to beyond a drug-naive 
sample to the general community. 
In terms of elaboration likelihood, this study attempted to increase m9tivation 
and personal relevance by presenting participants with a scenario where they were 
asked by a close friend to find more infonnation about the drugs because the friend 
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was deciding whether or not to try them, in hopes of triggering the central route of 
persuasion. The central route was preferred over the peripheral route because only 
the former is likely to make any substantial and long-lasting change to attitudes or 
behaviours (Petty & Cacioppo, 1986). Nonetheless, the actual elaboration likelihood 
was not measured in the study as it was presented by the authors as a form of meta-
construct that was not particularly open to measurement, but was able to be 
controlled by manipulating the presented scenarios to participants. Specifically, an 
assessment of elaboration likelihood would entail measuring participants' motivation 
and ability to process the presented information, which would be methodologically 
difficult as well as possibly tainted by demand characteristics and "good subject" 
tendencies (McBurney, 2001 ), i.e. that participants might respond in a manner to 
appear as being motivated and able to process the information in the study regardless 
of actual responses. In lieu of measuring elaboration likelihood, it might be 
interesting to examine how using different scenarios to manipulate varying levels of 
elaboration likelihood, would impact on the effectiveness of the drug education 
websites in future studies. 
In relation to the measures used in the current study, increasing the number of 
comparable behavioural intention and behavioural willingness items used could 
possibly increase the reliability and sensitivity to change to these measures. Whilst 
the floor and ceilings effects in certain variables were expected from a drug-naive 
sample, there were also concerns about the participants responding a socially 
desirable manner due to the controversial and illicit nature of the study's subject. 
However, the decision was made to not include the use of social desirability scales in 
the study as their utility have been significantly questioned (Leite & Beretvas, 2005; 
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Piedmont et al., 2000) and efforts were made to assure participants of their individual 
anonymity in responses to attain accurate responses. 
1.19 Conclusion/practical implications 
The implications of the results may be far reaching as a majority of young 
persons who use club drugs, as well those who do not, view and use the internet as an 
important source of information for these substances (Brewer, 2003; Falck et al., 
2004). 
The current study suggests that young persons who do not use substances and 
already have negative attitudes, norms, and low intentions and willingness to use 
these substances, derive almost equal benefit from both fear-based and harm 
reduction websites. The most apparent effect of viewing these drug education 
websites would be the sustained increases in knowledge about the said drugs, and 
also some short-term effects on attitudes, behavioural intention and willingness 
toward their use. Aside from the knowledge increase, the long-term effects on these 
key outcome variables were not evident aside from a follow-up reduction in 
willingness toward GHB use for participants in the harm reduction condition. This 
implies that overall, online-based drug education should only be expected to be used 
a good source for information provision rather than a primary mode of changing 
substance use behaviours. 
In comparison with the other traditional media formats such as television or 
radio, where exposure to drug education materials is passive, visiting drug education 
related websites requires an individual to actively to visit and read it. If people 
generally only seek information that is congruent with their original beliefs as 
suggested by Hyman and Sheatsley (1947), then young persons who are current or 
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prospective users of such substances may be unfavourable toward fear-based 
websites and simply avoid such websites in the first place. 
Hence, whilst fear-based websites may be useful only to non-users, harm-
reduction websites may be found useful to both users and non-users. This is 
underscored in a survey of young persons managed for substance use problems 
(Boyer et al., 2005), where it was found that they primarily sought information from 
harm-reduction drug websites, which led 8 out of 12 of these individuals to adopt 
health-protective behaviours. While this supposition that participants may modify 
substance use behaviours to avoid harm after viewing drug education websites is 
beyond the scope of the current study due its drug-naive sample, it may have potent 
implications for lar~e_ sc~le substance-related health promotion efforts, namely 
national drug education campaigns that are disseminated to the population at large. 
Nonetheless, the results strongly undermine the argument that only the fear-based 
approach is appropriate as the means of drug education because the harm-reduction 
approach allegedly condones and promotes drug use. The results demonstrated there 
were no significant increase in the likelihood of viewers using the drugs from 
baseline, and was in fact significantly reduced willingness to use GHB at follow-up, 
viewing the harm reduction websites. 
As noted, the value of the different streams of drug education is very complex 
and contextual. The scope of this study was intentionally limited in terms of its 
generalisability, due to its primary goal of establishing a pilot mechanism that is able 
to empirically assess the effects of drug education websites. Moreover, Webb and 
Sheeran's (2006) meta-analysis on behaviour change methods found that 
interventions that were based on the TRA/TPB produced among the largest changes 
in intention and behaviour, especially if the interventions promoted stability in 
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intention together with valence change. Whilst critical of the conceptual basis of 
social cognition models, Ogden's (2003) meta-analysis also found that models like 
the TPB were useful at a pragmatic level in developing interventions for health-
related behaviours. This implies that the findings of this study might not only be 
useful in evaluating the impact of drug-education websites, but could be used to 
design interventions as well, namely using the model as a guide to target 
interventions on specific components that are found to have strong influences on 
behavioural intention and/or willingness. 
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Appendix 1: Survey at Pre-test 
1. 
11. 
12. 
15, 
Section A: The following questions aim to examine your knowledge about GHB and Ecstasy. Please respond TRUE or FALSE 
to the following statements for both Ecstasy and GHB. However, please respond DK (Don't Know) to any statements that you 
are very unsure about. 
[Ecstasy/GHB) is commonly associated with reports of 
drink spiking. 
It is possible to be 'psycliological]y ad~icted'to _ 
[ecstasy/GHB]. _ · 
Users feel less socially inhibited when on 
[ecstasy/GHB]. 
Ecstasy 
(circle one answer from here) 
TRUE FALSE DK 
TRUE FALSE 
TRUE FALSE DK 
GHB 
(circle one answer from here) 
TRUE FALSE DK 
TRUE · FALSE DK 
TRUE FALSE DK 
Section B: Please evaluate how good or bad ALL of the following outcomes would be to you in general 
Having a wider network of friends would be 2 3 4 5 6 7 
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Section C: This section asks you about your responses in relation to ecstasy IMDMAl. Please answer all of the following items as 
honestly and accurately as you can: 
1. How many times do you think it is likely for you to use ecstasy over the next 2 months? 
(a) Never 
(b) Once 
(c) Twice 
(d) Three times 
(e) Four times 
(f) Five times 
(g) More than five times 
2. Considering only the positive aspects of using ecstasy in the next 2 months, and ignoring the negatives, what is your 
evaluation of ecstasy? Please rate all,.;o~f-":t~hi!-e ..,fo..,l..,lo;.;w;;.i;.;ng,,.~it,..e~m-.s'-_.,..~~..,..,~~'"""~"::""'=-. 
3 -
Q\jite 'QOOd 
1 2 
not at all enjoyable slightly enjoyable 
3 
quite enjoyable 
4 
extremely enjoyable 
3. Not taking ecstasy in the next 2 months would be 
1 2 3 4 5 
difficult 
4. If I wanted to get some ecstasy in the next 2 months, it would be 
1 2 3 4 5 
difficult 
6 
6 
7 
easy 
7 
easy 
5. If I take ecstasy in the next 2 months, most people who are important to me would 
1 2 3 4 5 6 7 
disapprove approve 
7. Granted that not all people are alike, my image of the typical person who uses ecstasy is: 
(Please rate all of the following items) 
responsible 
self-i:on 1dent 
assertive 
3 4 5 
•4 
-5 
2 3 4 5 6 
7 
7 
7 
7 
irresponsible 
unassertive 
. clearf\eaaed 
unpopular 
· mature 
unsophisticated 
8. If a friend offered you ecstasy in the next 2 months in the following places, in which setting would you probably accept the 
offer? (Tick as many or as few as apply) 
§ Friend's home Live music event 
Private party 
§ Pub Raves I Nightclub I Dance parties 
Your home 
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9. For me to get hold of ecstasy in the next 2 months would be 
2 3 4 5 6 7 
difficult easy 
10. If a friend offered me ecstasy in the next 2 months and I wanted to refuse, it would be 
1 2 3 4 5 6 7 
difficult easy 
11. In the last six months about what proportion of your close friends have used ecstasy? 
w ~ ~ ~ oo ro ~ 
none half all 
12. My close friends think I should take ecstasy 
2 3 4 5 6 7 
strongly disagree strongly agree 
13. With regard to ecstasy I want to do what my close friends think I should 
2 3 4 
strongly disagree 
5 6 7 
strongly agree 
14. In the last six months how much ecstasy has your partner used? (if not currently in a relationship, please skip this question) 
(a) Never 
(b) Once 
(c) Twice 
(d) Three times 
(e) Four times 
(f) Five times 
(g) More than five times 
15. My partner thinks I should not take ecstasy (if not currently in a relationship, please skip this question) 
1 2 3 4 5 6 7 
strongly disagree strongly agree 
16. With regard to ecstasy, I want to do what my partner thinks I should (if not currently in a relationship, please skip this question) 
1 2 3 4 5 6 7 
strongly disagree strongly agree 
17. In the last six months about what proportion of your family members/relatives have used ecstasy? 
(a) (b) (c) (d) (e) (f) (g) 
none half all 
18. My family members/relatives think I should take ecstasy. 
1 2 3 4 5 6 7 
strongly disagree strongly agree 
19. With regard to ecstasy, I want to do what my family members/relatives think I should. 
1 2 3 4 5 6 7 
strongly disagree strongly agree 
20. Health experts think I should not take ecstasy 
2 3 4 5 6 7 
strongly disagree strongly agree 
21. With regard to ecstasy, I want to do what health experts think I should 
2 3 4 5 6 7 
strongly disagree strongly agree 
22. Considering only the positive aspects of using ecstasy in the next 2 months, and ignoring the negatives, what 
Is our evaluation of ecstas ? Please rate all of the following Items) 
. ,, '--~~-....... ~~....-..................... _,,, 
-: 1- 2 3 
not at all safe 
· slightly positive quite 'positive 
2 
slightly safe 
3 
quite safe 
4 
extremely safe 
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23. If I was in a situation where I was offered some ecstasy in the next 2 months, I would be willing to use it. 
1 2 3 4 5 6 7 
strongly disagree 
24. Most people who are important to me think that... 
1 2 3 4 5 6 
I should not 
... use ecstasy in the next 2 months. 
25. I do not plan to use ecstasy in the next 2 months 
1 2 3 4 5 6 
strongly disagree 
26. It would be morally wrong for me to use ecstasy 
1 2 3 4 5 6 
strongly disagree 
27. For me to decide whether I wanted to use ecstasy or not in the next 2 months is 
1 2 3 4 5 6 
difficult 
28. How sure are you that you could get some ecstasy in the next 2 months if you wanted to? 
1 2 3 4 5 6 
extremely unsure 
strongly agree 
7 
I should 
7 
strongly agree 
7 
strongly agree 
7 
easy 
7 
extremely sure 
29. Suppose you were with some friends and one of them offered you some ecstasy. How likely is it that you would do each of the 
following? 
Take it and try it 
Decline offer 
1 
unlikely 
1 
unlikely 
2 3 
2 3 
4 5 
4 5 
6 
6 
7 
likely 
7 
likely 
30. Considering only the negative aspects of using ecstasy in the next 2 months, and ignoring the positives, what is your evaluation of 
ecstasy? (Please rate all of the following items) 
1 4 
not at all unenjoyable extremely unenjoyable 
31. Most people who are important to me think that my taking of ecstasy in the next 2 months would be 
1 2 3 4 5 6 7 
undesirable desirable 
32. How often do you intend to use ecstasy over the next 2 months? 
(a) Never 
(b) Once 
(c) Twice 
(d) Three times 
(e) Four times 
(t) Five times 
(g) More than five times 
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33. Please rate your preferred responses for each of the following statements. 
Using ecstasy in the next 2 months would: 
unlikely 
1 2 
2 
Lead to a wider network of friends 2 
3 . 4 
3 4 
3 4 
4 
4 
3 4 
3 4 
3 4 
3 4 
like I 
5 6 7 
5 6 7 
5 6 7 
5 6 7 
-5 6 7 
5 6 7 
5 6 7 
" 
6 7 
6 7 
5 6 7 
6 7 
6 7 
6 7 
6 
5 6 7 
Section D: This section asks you about your responses in relation to GHB. Please answer all of the following items as honestly and 
accurately as you can: 
1. How many times do you think it is likely for you to use GHB over the next 2 months? 
(a) Never 
(b) Once 
(c) Twice 
(d) Three times 
(e) Four times 
(f) Five times 
(g) More than five times 
2 3 
not at all enjoyable slightly enjoyable quite enjoyable 
3. Not taking GHB in the next 2 months would be 
1 2 3 4 5 
difficult 
4. If I wanted to get some GHB In the next 2 months, it would be 
1 2 3 4 5 
difficult 
6 
6 
4 
extremely enjoyable 
7 
easy 
7 
easy 
5. If I take GHB in the next 2 months, most people who are important to me would 
1 2 3 4 5 6 7 
disapprove approve 
6. Considering only the negative aspects of using GHB in the next 2 months, and ignoring the positives, what is your evaluation 
of GHB? (Please rate all of the following items) 
. 1 .. · . ... 2 
slightly nega_tive , 
2 
not at all dangerous slightly dangerous 
3 .. 
quite negative 
3 
quite dangerous 
4 . 
extremely negative 
4 
extremely dangerous 
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7. Granted that not all people are alike, my image of the typical person who uses GHB is: 
(Please rate all of the following items) 
responsible 1 2 3 4 5 6 
self-confjdent· ' . -1 5 6 
assertive 5 6 
confused 6 
popular 1 6 
.Jrnm9ture 11 -. 1 _ 6 
sophisticated 2 3 4 5 6 
7 irresponsible 
7 insecure 
7 unassertive 
7 
7 unpopular 
7 ' mature 
7 unsophisticated 
8. If a friend offered you GHB in the next 2 months in the following places, in which setting would you probably accept the 
offer? (Tick as many or as few as apply) 
§ Friend's home Live music event 
Private party 
§ Pub Raves I Nightclub I Dance parties 
Your home 
9. For me to get hold of GHB in the next 2 months would be 
1 2 3 4 5 
difficult 
6 7 
easy 
10. If a friend offered me GHB in the next 2 months and I wanted to refuse, it would be 
1 2 3 4 5 6 7 
difficult easy 
11. In the last six months about what proportion of your close friends have used GHB? 
(a) (b) (c) (d) (e) (f) (g) 
none half all 
12. My close friends think I should take GHB 
2 3 4 5 6 
strongly disagree 
13. With regard to GHB I want to do what my close friends think I should 
2 3 4 5 6 
strongly disagree 
7 
strongly agree 
7 
strongly agree 
14. In the last six months how much GHB has your partner used? (if not currently in a relationship, please skip this question) 
(a) Never 
(b) Once 
(c) Twice 
(d) Three times 
(e) Four times 
(f) Five times 
(g) More than five times 
15. My partner thinks I should not take GHB (if not currently in a relationship, please skip this question) 
1 2 3 4 5 6 7 
strongly disagree strongly agree 
16. With regard to GHB, I want to do what my partner thinks I should (if not currently in a relationship, please skip this question) 
1 2 3 4 5 6 7 
strongly disagree strongly agree 
17. In the last six months about what proportion of your family members/relatives have used GHB? 
(a) (b) (c) (d) (e) (f) (g) 
none half all 
18. My family members/relatives think I should take GHB. 
1 2 3 4 5 6 7 
strongly disagree strongly agree 
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19. With regard to GHB, I want to do what my family members/relatives think I should. 
2 3 4 5 6 7 
strongly disagree strongly agree 
20. Health experts think I should not take GHB 
2 3 4 5 6 7 
strongly disagree strongly agree 
21. With regard to GHB, I want to do what health experts think I should 
2 3 4 5 6 7 
strongly disagree strongly agree 
22. Considering onlv the positive aspects of using GHB in the next 2 months, and ignoring the negatives, what 
is our evaluation of GHB? (Please rate all--'o,.,.f..,th.,,.e_fi~o_ll_o_w'""in~..,.g•i•te,..m.-s., ..... ____ ....,.,..~----
1 3 . 
not at all safe 
2 
slightly safe 
' quite positive . 
3 
quite safe 
~ 4 
extremely positive 
4 
extremely safe 
' 4 
extremely pleasant 
23. If I was in a situation where I was offered some GHB in the next 2 months, I would be willing to use it. 
1 2 3 4 5 6 7 
strongly disagree strongly agree 
24. Most people who are important to me think that.. . 
1 2 3 4 
I should not 
.. . use GHB in the next 2 months. 
25. I do not plan to use GHB In the next 2 months 
1 2 3 4 
strongly disagree 
26. It would be morally wrong for me to use GHB 
1 2 3 4 
strongly disagree 
27. For me to decide whether I wanted to use GHB or not In the next 2 months is 
1 
difficult 
2 3 4 
5 
5 
5 
5 
28. How sure are you that you could get some GHB in the next 2 months if you wanted to? 
1 2 3 4 5 
extremely unsure 
6 
6 
6 
6 
6 
7 
I should 
7 
strongly agree 
7 
strongly agree 
7 
easy 
7 
extremely sure 
29. Suppose you were with some friends and one of them offered you some GHB. How likely is it that you would do each of the 
following? 
Take It and try it 
2 3 
unlikely 
Decline offer 
2 3 
unlikely 
4 5 
4 5 
6 
6 
7 
likely 
7 
likely 
30. Considering onlv the negative aspects of using GHB in the next 2 months, and ignoring the positives, what is your evaluation of 
GHB? Please rate all of the following-.l_te_m_s,.,....,....,.. _ _,,,, _ __..,..,.....,, ___________ _ 
: 1 . 2 
not at all bad slightly bad 
1 2 
not at all unenjoyable slightly unenjoyable 
3 
quite bad 
3 
quite unenjoyable 
3 
quite harmful 
4 
extremely bad 
4 
extremely unenjoyabie 
4 
extremely harmful 
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31. Most people who are important to me think that my taking of GHB in the next 2 months would be 
1 2 3 4 5 6 7 
undesirable desirable 
32. How often do you intend to use GHB over the next 2 months? 
(a) Never 
(b) Once 
(c) Twice 
(d) Three times 
(e) Four times 
(f) Five times 
(g) More than five times 
33. Please rate your preferred responses for each of the following statements. 
Using GHB in the next 2 months would: 
unlikely likely 
2, 3 4 ·s 6 7 
2 3 4 5 6 7 
2 3 4 5 6 7 
2 3 4 5 6 7 
2 3 4 5 6 7 
2 3 4 5 6 7 
2 3 4 5 6 7 
2 3 4 5 6 7 
2 3 4 5 6 7 
2 3 4 5 6 7 
2 3, 4 5 0 7 
2 3 4 5 6 7 
2 3 - 4 5 5, 7 
2 4 5 6 7 
4 5 6 7 
Lead to a wider network of friends 2 3 4 5 6 7 
155 
Appendix 2: Survey at Post-test 
Section A: The following questions aim to examine vour knowledge about GHB and Ecstasv. Please respond TRUE or FALSE 
to the following statements for both Ecstasy and GHB. However. please respond DK !Don't Know) to any statements that you 
are veN unsure about. 
Ecstasy GHB 
(circle one answer from here) (circle one answer from here) 
1. [Ecstasy/GHB) has very similar effects to alcohol. TRUE FALSE DK TRUE FALSE DK 
3. 
Muscle tension is a comrrion effect of using 
[ecstasy/GHB]. 
Unintentionally falling into a temporary comatose state 
is quite common with [ecstasy/GHB] use. 
" 
TRUE FALSE 
TRUE FALSE 
DK 
DK 
" i TRUE 
TRUE 
FALSE DK 
FALSE DK 
r 4. Overdose is unlikely on [ecstasy/GHB]. TRUE FALSE DK . t TRUE FALSE DK ! 
-, 
5. [Ecstasy/GHB] can cause physical addiction. 
l People usually report only mild or no headaches the 6· .K • day after using [ecstasy/GHB]. ,,, 
7. 
t 8. 
9. 
~ 10. 
Users feel less socially inhibited when on 
[ecstasy/GHB]. 
There have been reports ofwat~r poisoning from .;11e , 
drinking too rinich water while using [ecstasy/GHBJ. , 
Small amounts of the [ecstasy/GHB] chemical is 
produced as a result of fermentation . 
[Ecstasy/GHB] is used among bodybuilders and 
athletes as pEirformance enhancers. • 
11 . [Ecstasy/GHB] raises body temperature. 
TRUE 
TRUE 
TRUE 
TRUE 
TRUE 
\I TRUE 
TRUE 
l Dehydration is a v.e_rv. c~mmoo-when you use "' '"'~"' t ,.,.T_RUE~ f 12· Tecstasv/Gf:lBl >:_ ,,. ,, t. ···~ 
13_ One of the main problems with [ecstasy/GHB] is determining its purity. TRUE 
[ 14 One of_t~e .. ~ain problems with [ecstasy/GHB] is· ~d~ ,,. TRUE l ,, · i;; determmma its dosage levels.'! · · · 
It is possible to be psychologically addicted to 15
· [ecstasy/GHB]. TRUE 
FALSE DK 
FALSE DK 
FALSE DK 
li'ALSE . 1' 
FALSE DK 
FALSE DK 
FALSE DK 
FALSE DK 
FALSE DK 
FALSE DK 
FALSE DK 
I 
I 
I 
; 
TRUE 
TRUE 
TRUE 
TRUE 
TRUE 
TRUE 
TRUE 
TRUE 
.. 
TRUE 
TRUE _..., 
TRUE 
Section B: Please evaluate how good or bad ALL of the following outcomes would be to you in general 
bad 
1 . 
Having a wider network of friends would be 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
3 
3 
3 
, 3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
4 
4.. . 
4 
4 
4 
4 
4 
4 
4 
4 
4 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
FALSE 
FALSE 
FALSE 
FALSE 
FALSE 
FALSE 
FALSE 
': • E 
FALSE 
FALSE 
FALSE 
FALSE 
7 
7 
7 
7 
7 
7 
7 
7 
7 
7 
7 
7 
DK 
DK 
DK 
bk ! 
DK 
; 
DK 
DK 
DK 
.-
DK 
DK 
"' 
DK 
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Section C: This section asks you about your responses in relation to ecstasy (MOMA). Please answer all of the following items as 
honestly and accurately as you can: 
1. Considering only the positive aspects of using ecstasy in the next 2 months, and ignoring the negatives, what is your 
evaluation of ecstasy? Please rate all of the following ite"!s)_,_ _________ _ 
1 ~ 2 . 3 4 
not at ali" good slightly good quite good extremely good 
2 
not at all enjoyable slightly enjoyable 
~ 1 
not a't all oeneficial 
3 
quite enjoyable 
". 3 
quite beneficial 
4 
extremely enjoyable 
4 
extremely beneficial 
2. After discussing the information about ecstasy from the websites with your good friend, s/he decides to try one. Your good friend 
says that slhe would really like you to try it with him/her. 
Try it with your good friend? 
Yes I No (Please circle your response) 
How difficult was It for you to make that decision? 
1 
difficult 
2 3 4 5 6 7 
easy 
3. Considering only the negative aspects of using ecstasy in the next 2 months, and ignoring the positives, what is your 
evaluation of ecstasy? (Please rate all of the fo/lowing<...;..;ite...,m.....;;;s,__~-~----------
1 "' F 3 4 
not at an negative quite negative extremely negative 
. 
2 3 4 
not at all dangerous slightly dangerous quite dangerous extremely dangerous 
2 • 3 4 
slightly, unpleasant quite unpleasant extremely unpleasant 
4. In which of the following settings would you intend to use ecstasy in the next 2 months? (Tick as many or as few as 
apply) § Friend's home Live music event 
Private party 
§ Pub Raves I Nightclub I Dance parties 
Your home 
5. If a friend offered you ecstasy in the next 2 months in the following places, in which setting would you probably accept 
the offer? (Tick as many or as few as apply) 
§ Friend's home Live music event 
Private party 
§ Pub Raves I Nightclub I Dance parties 
Your home 
6. Considering only the negative aspects of using ecstasy in the next 2 months, and ignoring the positives, what is your evaluation of 
ecstasy? (Please rate all of the following items) 
2 . 3 4 
slightly bad quite.bad extreme[y bad 
2 3 4 
not at all unenjoyable sl ightly unenjoyable quite unenjoyable extremely unenjoyable 
2 3 4 
slight!y h?rmful quite harmJul extremely harmful 
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7. I do not want to use ecstasy in the next 2 months 
1 2 3 
strongly disagree 
4 5 6 7 
strongly agree 
8. Considering only the positive aspects of using ecstasy in the next 2 months, and ignoring the negatives, what 
is your evaluation of ecstasy? (Please rate all of the following itemsl~~-~--.~~--~~~~~ 
.1 2 3 ... 4 
not all positive slightly positive quite pos~ive extremely pos~iv~ 
not at all safe 
2 
slightly safe 
3 
quite safe 
4 
extremely safe 
4 I 
~ extremely pleasant 
9. After reviewing the information from the websites, how has your intention to use ecstasy in the next 2 months changed? 
More unlikely to 
use 
2 3 4 5 
No change 
10. Please rate your preferred responses for each of the following statements. 
Using ecstasy In the next 2 months would: 
unlikely 
Make me sociable . 1 2 3 4 
4 
4 
4 
4 
Help have a brilliant night out 2 3 4 
2 3 . 4 -
2 3 4 
2 3·~ A 
2 3 4 
2 3 . 4 
Lead to a positive mood state 2 3 4 
2 · 3 
Bring on mood swings 2 3 
Ge.! m·e arrested 2 3 
Lead to a wider network of friends 2 3 4 
6 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
6 
6 
6 
6 
6 
6 
7 
More likely to 
use 
likely 
7 
7 
7 
7 
7 • 
7 
6 . 
6 7 
6 7 
6 7 
6 7 
6 7 
6 
6 7 
6 7 
6 7 
Section D: This section asks you about your responses in relation to GHB. Please answer all of the following items as honestly and 
accurately as you can: 
1. Considering only the positive aspects of using GHB in the next 2 months, and ignoring the negatives, what is your 
evaluation of GHB? Please rate all of the following_,..i_te,,,.m_s,.._.....,. __________ _ 
1 .. 2 3 
- not a.tall good slightly good qu!te good 
2 3 
not at all enjoyable slightly enjoyable quite enjoyable 
1 2 3 
not at all beneficial sl ightly beneficial quite beneficial 
4 · 
extremely good 
4 
extremely enjoyable 
. 4 
extremely beneficial 
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2. After discussing the information about GHB from the websites with your good friend, s/he decides to try one. Your good friend 
says that s/he would really like you to try it with him/her. 
Try it with your good friend? 
Yes I No (Please circle your response) 
How difficult was it for you to make that decision? 
2 3 
difficult 
4 5 6 7 
easy 
3. Considering onlv the negative aspects of using GHB in the next 2 months, and ignoring the positives, what is your 
evaluation of GHB? Please rate all of the following items 
. ·~ "' . --..-~-""'"'1!£1D'<l'"!"""""'I~~---...... -..~---,,.., 1;~, 
not at all negative 
not at all dangerous 
. 2, 4 
slightly negative, 
2 3 
slightly dangerous quite dangerous 
3 
quite unpleasant 
., extrefl')ely negative 
4 
extremely dangerous 
4 
. extrer:nely unpleasant_ 
4. In which of the following settings would you intend to use GHB in the next 2 months? (Tick as many or as few as apply) 
§ Friend's home Live music event 
Private party 
§ Pub Raves I Nightclub I Dance parties 
Your home 
5. If a friend offered you GHB in the next 2 months in the following places, In which setting would you probably accept the 
offer? (Tick as many or as few as apply) 
§ Friend's home Live music event 
Private party 
§ Pub Raves I Nightclub I Dance parties 
Your home 
6. Considering only the negative aspects of using GHB in the next 2 months, and ignoring the positives, what is your evaluation of 
GHB? (Please rate !!lJ. of the following Items) 
1 • . 2 
· not at al! b11d· · slightly l:lad 
1 2 
not at all unenjoyable slightly unenjoyable 
2 
. slightly harmful 
7. I do not want to use GHB in the next 2 months 
2 3 
strongly disagree 
3 
quite bad 
3 
quite unenjoyable 
3 
quite harmful 
4 5 
4 
extremely bad 
4 
extremely unenjoyable 
. 4 . 
extremely harmful 
6 7 
strongly agree 
8. Considering only the positive aspects of using GHB In the next 2 months, and ignoring the negatives, what 
is )'Our evalua~ion ~f GHB? Please rate all ofth_e following._1_·te_m_.s"------------------
1 2 -. 3. 4 
not all posltive slightly positive quite pos~ive extremely positive 
not at all safe 
· not at. all pleas~nt 
2 
slightly safe 
2 
. slightly pleasant 
3 
quite safe 
3 
quite pleasant 
4 
extremely safe 
4 
extremely pleasant. 
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9. After reviewing the information from the websites, how has your intention to use GHB in the next 2 months changed? 
2 3 4 5 6 7 
More unlikely to No change More likely to 
use use 
10. Please rate your preferred responses for each of the following statements. 
Using GHB in the next 2 months would: 
unlikelj' likel 
Make e sociable 1 2 3 4 5 6 7 
Make me feel depressed 2 3 4 5 6 7 
2 3 4 5 6 i 
2 3 4 5 6 7 
- 2 3 4 6 
2 3 4 5 6 7 
2 3 4 5 6 7 
Be exciting 2 3 4 5 6 7 
l..'.ead on to even harder dru s 2 3 4 5 6 7 
2 3 4 5 6 
. 1 2 4 5 6 
2 3 4 5 6 7 
2 5 6 7 
2 3 4 5 6 7 
- 2. 3 4 5 6 7 
Lead to a wider network of friends 2 3 4 5 6 7 
Section E: Please read and consider this following scenario as realistically and honestly as you can. After that. please respond to 
ALL the items below. 
1. "You just had a birthday party and your friends decided to pull a prank on you and buy you some weird presents. The presents 
include a box of vibrating condoms, a glow-in-the-dark thong as well as some real ecstasy pills and GHB vials." 
Would you try at least one of the ecstasy pills in the next 2 months? 
Yes I No (Please circle your response) 
How difficult was it for you to make that decision? 
2 3 4 5 6 7 
difficult easy 
Would you try at least one of the GHB vials in the next 2 months? 
Yes I No (Please circle your response) 
How difficult was It for you to make that decision? 
1 2 3 4 5 6 7 
difficult easy 
2. Knowing what you know now after reading the websites about ecstasy and GHB, what are your intentions towards them? 
Would you try ecstasy in the next 2 months? 
2 3 4 5 6 7 
definitely not definitely yes 
Would you try GHB in the next 2 months? 
1 2 3 4 5 6 7 
definitely not definitely yes 
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Section F: Please resi;iond to the following statements in regard to the groui;i of websites ~ou have visited toda~ {as a WHOLE}. 
1. The sites provide information that is neutral. 
1 2 3 4 5 6 7 
strongly disagree strongly agree 
2. The sites do not provide in-depth information. 
1 2 3 4 5 6 7 
strongly disagree strongly agree 
3. The sites have my interests at heart. 
1 2 3 4 5 6 7 
strongly disagree strongly agree 
4. The sites appear to have experts on the topic discussed. 
1 2 3 4 5 6 7 
strongly disagree strongly agree 
5. The sites provide information that is not balanced. 
1 2 3 4 5 6 7 
strongly disagree strongly agree 
6. The sites are not comprehensive. 
1 2 3 4 5 6 7 
strongly disagree strongly agree 
7. The sites are uncaring about their visitors. 
1 2 3 4 5 6 7 
strongly disagree strongly agree 
B. The sites are ethical. 
1 2 3 4 5 6 7 
strongly disagree strongly agree 
9. The sites are biased in the information it provides. 
1 2 3 4 5 6 7 
strongly disagree strongly agree 
10. The sites offer everything you need to know on a topic. 
1 2 3 4 5 6 7 
strongly disagree strongly agree 
11. The sites are not concerned about their visitors. 
2 3 4 5 6 7 
strongly disagree strongly agree 
12. The sites appears to be a leader in their area of specially. 
1 2 3 4 5 6 7 
strongly disagree strongly agree 
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Appendix 3: Survey at Follow-up 
1. 
L 2· . • 
3. 
r 4. 
5. 
t 6. 
7. 
I 8 . . 
9. 
I 10. 
11 . 
I 12. 
13. 
( 1~. 
15. 
Section A: The following questions aim to examine your knowledge about GHB and Ecstasy. Please respond TRUE or FALSE 
to the following statements for both Ecstasy and GHB. However. please respond DK (Don't Know) to any statements that you 
are verv unsure about. 
Ecstasy GHB 
(circle one answer from here) (circle one answer from here) 
[Ecstasy/GHB] has been used to treat insomnia. TRUE FALSE DK TRUE FALSE DK 
It is possiql!fto be psychologitj:llly addicted to ,\I TRUE ~ FALSE · DK ' TRUE FALSE DK [ecstasy/GHB]. · 
... " 
Overdose is unlikely on [ecstasy/GHB]. TRUE FALSE DK TRUE FALSE DK 
When ·sold in powder form, [ecstasy/GHB] is US!Jally TRUE . FALSE DK TRUE FALSE DK dissolved before consumed. 7 . h ' .. 
-
~ ., 
-
The scientific evidence on neurotoxicity from TRUE FALSE DK TRUE FALSE DK [ecstasylGHB] use is controversial at this time. 
One of the ·main problems with [ecstasy/GHB] is ".~ TRUE FALSE I ~ DK TRUE .. FALSE DK determining its purify. 
' 
i.. 
' 
Unintentionally falling into a temporary comatose state TRUE FALSE DK TRUE FALSE DK is quite common with [ecstasy/GHB] use. 
Muscle tension is a C:ommon effect ofusing ~}~'' DK ~ FALSE -[ecstasy/GHB]. , . . · · · '· · ;:.< TRl,JE FALSE TRUE ;. [J DK . r. . 
. 
... 
[Ecstasy/GHB]is usually sold in liquid form. TRUE FALSE DK TRUE FALSE DK 
One of the main problems with [ecstasy/GHB] is 
' 
;·· 
' 
-~ 
FALSE determining its dosage levels. "' . ) TRUE FALSE DK TRUE DK 
Users feel less socially inhibited when on TRUE FALSE DK TRUE FALSE DK [ecstasy/GHB]. 
The mqst likely risk of death from [ecstasy/GHB] is " -
\! TRUE FALSE DK TRUE FALSE , DK overheatina. 
" " 
.. 
-
', 
~ 
Dehydration is a very common when you use TRUE FALSE DK TRUE FALSE DK [ecstasy/GHB] 
•'{l!t~.; I /•' • ·' .~ :'!~. ,ill! : .... t [E~s,ta;yl~HB} ;an. cause _p~ysJcal addiction._ TRWE FALSE DK TRUE .. FALSE DK [\ 
-
... 
People usually report only mild or no headaches the TRUE FALSE DK TRUE FALSE DK day after using [ecstasy/GHB]. 
Section B: Please evaluate how good or bad ALL of the following outcomes would be to you in general 
bad good 
3 5 6 
2 3 4 5 6 7 
4 6 7 
2 3 4 5 6 7 
2 · 3 4 · 5 6 7 
2 3 4 5 6 7 
2 4 6 7 
2 3 4 5 6 7 
3 
Feeling run down would be 2 3 4 5 6 7 
2 3 4 5 5 · 7 
2 3 4 5 6 7 
2 4 5 .. 6 
Having mood swings would be 2 3 4 5 6 7 
a ested woula be 3 4 5 ' 6 
Having a wider network of friends would be 2 3 4 5 6 7 
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Section C: This section asks you about your responses in relation to ecstasy (MOMA). Please answer all of the following items as 
honestly and accurately as you can: 
1. Considering only the positive aspects of using ecstasy in the next 2 months, and ignoring the negatives, what 
is your evaluation of ecstasy? Please rate all of the following,_1_·te_m~s,,,_ ___________ _, 
2 
not all positive . slightly. positive 
1 2 
not at all safe slightly safe 
1 2 
not at al pleasant slightly pleasant 
·'· 
2. I do not intend to use ecstasy in the next 2 months 
1 2 3 
strongly disagree 
3 
quite positive 
3 
quite safe 
3 
quite pleasant .. 
4 5 
4 
extremely positive 
4 
extremely safe 
4 
extremely pleasant 
6 7 
strongly agree 
3. Considering only the negative aspects of using ecstasy in the next 2 months, and ignoring the positives, what 
is your evaluation of ecstasy? (Please rate all of the following items) 
1 . 
not at all bad 
not at all unenjoyable 
2 
sligfitly bad 
2 
slightly unenjoyable 
3 
quite bad 
3 
quite unenjoyable 
3 
quite harmful 
4 
extremely bad 
4 
extremely unenjoyable 
" 4 
extremely harmful 
4. If I was in a situation where I was offered some ecstasy in the next 2 months, I would not be willing to use it. 
1 2 3 4 5 6 7 
strongly disagree strongly agree 
5. Considering only the negative aspects of using ecstasy in the next 2 months, and ignoring the positives, what 
is your ~valuation of ecstas ? (Please rate §L~l _o_f _th_e_fi_o_ll_o_w_in_,,g ... 1 ... ·te .. m- s) __ _, _ __. _______ _ 
2 3 4 
slightly negativ~ quite negative extremely negative 
2 
not at all dangerous slightly dangerous 
3 
quite dangerous 
". 3 
quite unpleasant 
4 
extremely dangerous 
4 
extremely unpleasant 
6. How many times do you think it is likely for you to use ecstasy over the next 2 months? 
(a) Never 
(b) Once 
(c) Twice 
(d) Three times 
(e) Four times 
(f) Five times 
(g) More than five times 
7. Considering only the positive aspects of using ecstasy in the next 2 months, and ignoring the negatives, what is your 
evaluation of ecstasy? (Please rate al~ of the following._1_·te_m_.s)_.....,. _________ _ 
· 1 2 3 4 
not it ari a?od sligtitly good quite good ' ' extremely good 
2 3 4 
not at all enjoyable sl ightly enjoyable quite enjoyable extremely enjoyable 
2 3 4 
not at all befneficial •. &ligh.tly b~nefic}al quite beneficial extremely beneficial 
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8. Your good friend who wanted to try ecstasy, purchased some with you in mind and left them with you for you to decide to 
take it or not. 
Use at least one? 
Yes I No (Please circle your response) 
How difficult was it for you to make that decision? 
2 3 4 5 
difficult 
9. I want to use ecstasy in the next 2 months 
1 2 3 4 5 
strongly disagree 
10. Please rate your preferred responses for each of the following statements. 
Using ecstasy in the next 2 months would: 
unlikely 
1 2 3 4 
2 3 4 
2 3 4 
2 3 4 
2 3 4 
2 3 4 
2 3 4 
2 3 4 
2 3 4 
2 3 4 
2 3 4 
2 4 
2 
2 3 4 
2 
Lead to a wider network of friends 2 3 4 
6 
6 
5 6 
5 6 
5 6 
5 6 
5 . 6 
5 6 
5 6 
5 6 
5 6 
5 6 
5 6 
5 6 
6 
5 6 
5 6 
5 6 
7 
easy 
7 
strongly agree 
likely 
7 
7 
7 
7 
7 
7 
7 
7 
7 
.T 
7 
7 
7 
7 
Section D: This section asks you about your responses in relation to GHB. Please answer all of the following items as honestly and 
accurately as you can: 
1. Considering only the positive aspects of using GHB in the next 2 months, and ignoring the negatives, what 
is our evaluation of GHB? Please rate all of the following_.,.i,..te_m_s~--------------.---
not at ail safe 
not at ail pleasant 
. 2 
slightly positive 
2 
slightly safe 
2 "" 
slightly pleasant 
2. I do not intend to use GHB in the next 2 months 
2 3 
strongly disagree 
4 
3 
quite safe 
- 3 
quite pleasant 
5 6 
4 
extremely safe 
4 
extremely pleasant 
7 
strongly agree 
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3. Considering onlv the negative aspects of using GHB in the next 2 months, and ignoring the positives, what is your 
evaluation of GHB? (Please rate all of the following_ itemsl~--~---~--~--..... 
1 2 3 4 
not at all. bad slightly bad quite bad extremely bad 
2 3 4 
not at all unenjoyable slightly quite extremely unenjoyable 
unenjoyable unenjo able 
1 ~~ 2 3 : 4 
not·at all harmful sl_ightly harmful quite harmful extremely harmful 
4. If I was in a situation where I was offered some GHB in the next 2 months, I would not be willing to use it. 
1 2 3 4 5 6 7 
strongly disagree strongly agree 
5. Considering only the negative aspects of using GHB in the next 2 months, and ignoring the positives, what is your 
evaluation of GHB? Please rate all of the following,-'i"'-te'""'m-'s''----~----..--~----
1 2 3 4 . 
not at all negative slightly negative , quite negative extremely negative 
2 
not at all dangerous slightly dangerous 
1·. 2 
not at all unpleasant slightly unpleasant 
3 
quite dangerous 
3 
quite unpleasant 
4 
extremely dangerous 
4 
extremely unpleasant 
6. How many times do you think it is likely for you to use GHB over the next 2 months? 
(a) Never 
(b) Once 
(c) Twice 
(d) Three times 
(e) Four times 
(f) Five times 
(g) More than five times 
7. Considering only the positive aspects of using GHB in the next 2 months, and ignoring the negatives, what is your 
evaluation of GHB? (['lease rate all of the following: ... i_te_m_s,,_ _________ __,.,.... ..... 
. 1 . 2 3 
. not at all good slightly good . quite gooq 
1 2 
not at all enjoyable slightly enjoyable 
3 
quite enjoyable 
3 .. ... 
quite beneficial 
4 
extremeJY good 
4 
extremely enjoyable 
4 
extremely beneficial 
8. Your good friend who wanted to try GHB, purchased some with you in mind and left them with you for you to decide to 
take it or not. 
Use at. least one? 
Yes I No (Please circle your response) 
How difficult was it for you to make that decision? 
2 
difficult 
9. I want to use GHB in the next 2 months 
2 
strongly disagree 
3 
3 
4 5 
4 5 
6 
6 
7 
easy 
7 
strongly agree 
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10. Please rate your preferred responses for each of the following statements. 
Using GHB in the next 2 months would: 
unlikel likell' 
Make me sociable 1 2 3 - 4 5 6 7 
Make me feel de ressed 2 3 4 5 6 7 
Make me feel lethargic 2 3 4 5 6 7 
Make me happy 1 2 3 4 5 6 7 
.1 2 3· 4 5 · 5 7 
2 3 4 5 6 7 
3 . 4 5 6 7 
3 4 5 6 7 
3 5 6 7 
2 3 4 5 6 7 
3 4 7 
2 3 4 5 6 7 
2 3 .4 5 6 7 
Bring on mood swings 2 3 4 5 6 7 
Get me arrested · 2 3 4 5 6 7_ 
Lead to a wider network of friends 2 3 4 5 6 7 
Section E: Please read and consider this following scenario as realistically and honestly as you can. After that. please respond to 
ALL the items below. 
"Suppose you were with a group of friends at a party and some of them were using ecstasy and GHB. There are some extra ecstasy 
tablets and GHB vials that you could have if you wanted." 
Would you try at least one of the ecstasy pills? 
Yes I No (Please circle your response) 
How difficult was it for you to make that decision? 
2 3 
difficult 
Would you try at least one of the GHB vials? 
Yes I No (Please circle your response) 
How difficult was it for you to make that decision? 
1 
difficult 
2 3 
4 5 
4 5 
6 
6 
7 
easy 
7 
easy 
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Appendix 4: Website Extracts 
Harm Reduction Condition 
a) Club Drugs 1 (excerpted from www.ravesafe.org; last updated April 1ih2007) 
• Extracts ofMDMA-related information:-
" ... Leah Betts, the teenager who collapsed after taking an Ecstasy tablet in England, died as a 
result of drinking too much water, which made her brain swell .... 
Overheating and dehydration are known risks of taking Ecstasy, a stimulant which can keep 
young people dancing for hours, and drug agencies advise users to drink plenty of water and 
take frequent rests. 
Although she had not been dancing energetically for hours, it is understood that when Leah 
began to feel unwell at the party she made repeated trips to the bathroom to drink water. She 
believed mistakenly that this was the way to ward off the ill-effects of the drug ... 
Dr Berridge said the advice from drug agencies to young people to drink plain water could have 
fatal consequences, as in Leah 's case. They should drink water or soft drinks with salt added at 
the rate of two teaspoons per litre or isotonic sports drinks. If taken in excessive amounts these 
could lead to swelling in the body tissues but would not cause swelling of the brain because the 
salt would maintain plasma sodium levels ... " 
• Extracts of GHB-related information:-
" ... Whilst GHB 's most noticeable effect is euphoria, it can also be a downer. A small dose - half 
a capful - ofGHB will make you fell relaxed and uninhibited, kind of tipsy. More can cause 
sedation, and will slow you down until you fall asleep. No hallucinations or visual effects occur 
and GHB makes you extroverted rather than introspective. With larger doses, noticeable effects 
include verbal diarrhoea, slurring of speech, drowsiness, nausea, incoherence, difficulty 
focussing and regrettable behaviour. The effects of GHB may become apparent after about 5-15 
minutes, and come up strongly after 20-30 minutes. The effects can last for up to 2 - 4 hours. 
One of the biggest dangers of using GHB is the difficulty of determining a safe dosage. It all 
depends on the body weight, general state of health and mind at time of use and also the 
concentration of the liquid. Taking too much GHB can lead to amnesia, respiratory difficulties 
and loss of consciousness. If someone passes out on GHB put them in the recovery position and 
let them sleep it off. Check their vital signs regularly to see if they are OK They will awake a few 
hours later with no recall of their sleep. Other side-effects are abnormal muscle movements, and 
occasional emergence delirium ... " 
b) Club Drugs 2 (excerpted from www.torontovibe.com; last updated April 17th 2007) 
• Extracts of MD MA-related information:-
" ... Ecstasy can lead to emotional openness, euphoria, an intense, energetic, spiritual high; and 
can connect people freely and openly with each other, promote deep inner thinking and analysis, 
or lead to a reduction in cynical or critical thoughts ... 
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Ecstasy pills (E) can contain a wide variety of substances. Some pills contain MDMA, others 
contain MDMA mixed with other drugs, and some contain other drugs but no MDMA at all. 
Chemical analysis has found ingredients including: PMA; DXM; PCP; ketamine; caffeine; 
ephedrine; methamphetamine ... 
The buzz is dependent on many factors, including the ingredients of the pill. Other factors 
include how you are feeling before you take the pill, how much food is in your stomach and what 
environment you are taking the drug in. 
When swallowed, the effects can come on within 20 minutes, or may take as long as 90 minutes. 
Pills generally act like stimulants, increasing body temperature, blood pressure and heart rate. 
Some pills produce greater feelings of happiness and contentment (feeling "loved up") while 
others produce a more energetic "wired" body buzz. The "loved up" feeling is usually with pills 
that have a greater MDMA content, while the more energetic pills probably contain more 
amphetamine like ingredients ... " 
• Extracts of GHB-related information:-
" ... GHB can create feelings of inner peace, happiness, pleasure touching, and relaxation. Some 
people enjoy having sex while high because of possible heightened sense of touch, disinhibition, 
enhanced erection, and an increased intensity of orgasm ... 
Passing out: It is easy to become unconscious when using 'G'. There can be a small difference 
between a dose that can give you a good high and a dose that can cause sudden loss of 
consciousness or sedation. Being passed out puts you at risk of sexual assault, and if you vomit -
death (you choke on your vomit) ... 
GHB is typically sold by the vial as a clear liquid with a consistency slightly thicker than water ... 
Initial feelings of relaxation and a reduction in anxiety that lead can make the user more 
sociable ... " 
c) Club Drugs 3 (excerpted from www.buzzcode.org; last updated April 1?111 2007) 
• Extracts ofMDMA-related information:-
" ... MDMA works primarily on the neurotransmitter serotonin. Serotonin (5-hydroxytrtamine, 5-
HT} is one of the major neurotransmitters in the brain. It is synthesized in serotonin neurons and 
stored in synaptic vesicles (parts of a brain cell that store neurotransmitters). As our brain goes 
about its normal routine, these vesicles release serotonin into the synaptic cleft (the space 
between brain cells), as a means of communicating with other brain cells. An important aspect of 
this communication process is "serotonin re-uptake". Once serotonin is released from one cell 
and enters the synaptic cleft, it is then taken back into the serotonin neuron and stored in vesicles 
or it is metabolized (broken down) by the body-primarily by the enzyme monoamine oxidase 
(MAO). Serotonin is responsible for many psychological and physiological states including 
mood and sleep. It has been particularly associated with major depression and obsessive-
compulsive disorders. With the normal transmission, re-uptake, and metabolism of 
neurotransmitters, we experience both a stable psychological experience and stable physical 
experience ... 
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Depending on how much and how recently one has eaten, MDMA generally takes 30-60 minutes 
(although sometimes as long as 2 hours) to take effect. The duration of the drug's effects is 
usually three to five hours, depending on what you've eaten and the amount you've ingested For 
many people there is an additional period of time (2-6 hours) where it is difficult to go to sleep 
and there is definitely a noticeable difference from everyday reality, but which is not strong 
enough to be considered 'tripping'. Some users report feeling buzzed or sketched out-but not 
high-up to 24 hours later ... " 
• Extracts of GHB-related information:-
" ... GHB usually comes as an odourless liquid with a salty or bitter taste. More often than not, it 
comes in small bottles or vials. There is some claim that that GHB comes in powder and capsule 
form. Most people consume it by mixing it with a beverage like water, pop, or juice. We have no 
idea what a recreational dose is and would not dream of making any recommendation as to what 
an appropriate dose looks like. Given the high dose-response curve, the idiosyncrasies of your 
body's metabolism (including what you just ate), and the problem with not knowing the 
concentration of the drug you have in your hand, a "recreational dose" is likely to change 
constantly. Just because it's sold in vials doesn't mean that a vial is a dose. In fact, taking the 
contents of an entire vial is probably something you should consider not doing ... 
GHB is naturally found in the human body in minute quantities. It is a minor inhibitory 
neurotransmitter that acts along with one of the major inhibitory neurotransmitters gamma-
aminobutyric acid (GABA) to slow down the transmission of dopamine mediated signals in 
certain areas of the brain (Li, Stokes, Woeckener 1998, Tunniclif 1997). In practical terms, this 
means that your brain slows down in itsfunctioning if you are taking GHB. What this means is 
that GHB is a nervous system depressant, like alcohol. The effects ofGHB at recreational doses 
are similar to alcohol. At lower doses, its effects are similar to mild alcohol intoxication causing 
decreased motor skills, relaxation, reduction of social inhibitions and mood lift. By all the 
accounts we 've heard, GHB seems to heighten feelings of sexuality. Users commonly claim that 
the drug makes them feel sexually more aggressive ... " 
Fear-based Condition 
a) Party Dmgs 1 (excerpted from www.theantidrug.org; last updated April 17th 2007) 
• Extracts ofMDMA-related information:-
" ... MDMA, called "Adam," "ecstasy," or "XTC" on the street, is a synthetic, psychoactive 
(mind-altering) drug with hallucinogenic and amphetamine-like properties. Its chemical 
structure is similar to two other synthetic drugs, MDA and methamphetamine, which are known 
to cause brain damage ... 
Psychological difficulties, including confusion, depression, sleep problems, drug craving, severe 
anxiety, and paranoia during and sometimes weeks after taking MDMA (in some cases, psychotic 
episodes have been reported) ... 
Long-term effects. Recent research findings also link MDMA use to long-term damage to those 
parts of the brain critical to thought and memory. It is believed that the drug causes damage to 
the neurons that use the chemical serotonin to communicate with other neurons ... " 
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• Extracts of GHB-related information:-
" ... Gamma-hydroxybutyric acid or GHB, is a compound that was initially used by body builders 
to stimulate muscle growth. In recent years it has become popular as a recreational drug among 
club kids and partygoers. 
This "designer" drug is often used in combination with other drugs, such as Ecstasy. GHB is 
synthesized from a chemical used to clean electrical circuit boards, and is available in clear 
liquid, white powder, tablet and capsule form ... 
GHB users risk many negative physical effects including vomiting, liver failure, potentially fatal 
respiratory problems, and tremors and seizures, which can result in comas ... 
GHB has reportedly been used in cases of date rape. Because GHB is odorless and tasteless, it 
can be slipped into someone's drink without detection ... " 
b) Party Drugs 2 (excerpted from www.drugs.health.gov.au; last updated April 17th 2007) 
• Extracts ofMDMA-related information:-
" ... The symptoms of using ecstasy can include: 
• Increased blood pressure and pulse rate 
• Raised body temperature 
• Sweating 
• Overheating 
• Jaw clenching ... 
Consequences of using ecstasy can include: 
• Chronic sleep problems 
• Cracked teeth through grinding 
• High blood pressure 
• Dehydration 
• Anxiety ... 
Ecstasy is the street term for a number of substances that are similar to the chemical 
methylenedioxymethamphetamine (MDMA), a stimulant with hallucinogenic properties. Like any 
illegal drug, there's no 'quality control' during the manufacturing of ecstasy, and so you can 
never be sure what you are actually taking. While the active ingredient of ecstasy is MDMA most 
pills do not contain any MDMA and are more likely to be made up of methamphetamine (speed) 
combined with a synthetic hallucinogen ... " 
• Extracts of GHB-related information:-
" ... The symptoms of using GHB can include: 
• Drowsiness 
• Induced sleep 
• Nausea 
• Reduced inhibitions ... 
Consequences of using GHB can include: 
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• Extreme drowsiness/grogginess 
• Hallucinations 
• Difficulty focussing eyes 
• Vomiting ... 
Gamma-hydroxybutyrate (GHB) is a depressant drug that contains sedative and, at sufficient 
doses, anesthetic properties (that means it knocks you out). Depressant drugs slow brain and 
central nervous system activity. 
GHB has been identified as a 'date-rape drug' because it leaves users with amnesia, impaired 
movement and speech. It can be easily camouflaged in drinks as it is difficult to taste ... " 
c) Party Drugs 3 (excerpted from www.drugstory.org; last updated April 17th 2007) 
• Extracts ofMDMA-related information:-
" ... Some people believe Ecstasy is a miracle drug. Users claim to experience unparalleled highs 
without the immediate hangovers and "crashing" that are associated with alcohol and illicit 
drugs. However, there are serious side effects associated with Ecstasy use. Past studies find that 
the drug seriously impairs the brain's serotonin system, which is involved with thought, memory, 
mood regulation and feelings of pleasure. Researchers have also recently discovered that the 
amount of brain damage is related to the total amount of Ecstasy users have taken, suggesting a 
direct link between drug use and decreased brain function ... 
Ecstasy is a lucrative business. Relatively cheap to make overseas, it can be sold for a 
substantial profit in the United States. Just one Ecstasy pill costs 15 to 25 cents to make in 
Europe but can be sold in the United States for $20 to $5 0. As a result, officials have seen an 
astnonomical increase in Ecstasy trafficking. According to USA Today, in 2000, the DEA and 
other agencies confiscated more than 11 million pills, up from a few hundred thousand in 1995. 
International crime groups have also become involved in the Ecstasy market, causing violent turf 
wars among dealers with young, low-level dealers caught in the cross-fire ... 
Although the name gives the drug a strange allure and piques the interest of young people 
looking for a good time, Ecstasy is a dangerous drug that has proven to cause short- and long-
term damage to the mind and body. Accurate information regarding Ecstasy must be available to 
counter rumors and media sensationalism that often understate Ecstasy's harmful effects and to 
keep others from experimenting with the drug. Experts also say to watch out for other illegal 
substances that are popular in the club culture, such as Ketamine, GHB and Rohypnol, as they 
become more mainstream in Ecstasy's wake and recreational use begins to rise. " 
• Extracts of GHB-related information:-
" ... Banned in 1990 by the Federal Drug Administration (FDA), Gamma hydroxybutyrate is a 
central nervous system depressant that was widely used for its alleged anabolic steroid effects 
and is still abused by individuals interested in gaining muscle mass easily and quickly. However, 
GHB 's high profile association with date-rape incidences caused former President Clinton to 
sign the Hillary J. Farias and Samantha Reid Date-Rape Prohibition Act of 2000, which labeled 
the drug as a Schedule I substance (a drug that has been classified by the federal government as 
having no medical purpose, and which is at high risk for abuse). Unfortunately, the highly 
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addictive drug is now entering the club scene. Users abuse GHB for its intoxicating effects, and 
many believe it is an aphrodisiac ... 
Side effects caused by lower doses include drowsiness, dizziness, nausea, and visual 
disturbances, while higher dosages can lead to unconsciousness, seizures, severe respiratory 
depression (especially when combined with alcohol), and even coma. According to the Substance 
Abuse and Mental Health Services Administration, emergency room visits involving GHB nearly 
quadrupled.from 1998 to 2000. In/act, GHB overdoses are reportedly more common than 
MDMA overdoses, although abuse is much more prevalent. In 2000, 2,482 GHB users were 
treated/or an overdose, as compared with 1, 742 Ecstasy users, a nearly 30% increase, 
according to an article in USA Today. Signs of overdose include drowsiness, nausea, vomiting, 
headache, loss of consciousness, loss of reflexes, impaired breathing, and ultimately death. I 0 
According to the DEA, 73 people have also died.from GHB since 1995. By contrast, there have 
been 27 Ecstasy-related deaths from 1994 to 1998, the most recent available statistic as reported 
by USA Today." 
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